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SUMMARY
We investigated the effects of subanaesthetic doses of 
isoflurane and enflurane on the auditory evoked response, 
and two tests of psychomotor performance, the choice 
reaction time and tracking task. The use of subanaesthetic 
doses of isoflurane has been used for dental sedation.
Thirty fasting volunteers (mean age 24y) had scalp 
electrodes placed at vertex and both mastoids. Fifteen were 
randomly allocated to receive doses of isoflurane of 
inspired concentrations (0, 0.31, 0.5, 0.75%), placebo or
enflurane (0, 0.17, 0.42, 0.6%) and 15 received isoflurane 
(0, 0.2, 0.31, 0.4%) or placebo. At each step change in 
volatile agent concentration 2Omin were allowed for 
equilibration. The reclining volunteers received the gases 
through a Hudson mask connected to a Bain circuit 
(flow > lOlmin”^), delivering 30% oxygen in air. Basic 
physiological variables, heart rate, arterial pressure, 
axillary temperature, and oxygen saturation were monitored 
throughout each 2.5h experiment. End-tidal concentrations of 
carbon dioxide could not be practically measured in these 
conscious volunteers. Control baseline brainstem, and long 
latency recordings were made before introducing the volatile 
agents or placebo. A probability of p s 0.05 was considered 
significant.
The basic physiological variables remained within normal 
ranges throughout each experiment. The brainstem auditory
evoked responses (BSAER) latencies and amplitudes did not 
change significantly for either drug compared with the 
placebo, except for the wave V latency which increased 
significantly at 0.5% isoflurane and 0.42% enflurane.
The NlOO latency of the long -latency auditory evoked 
responses (LLAER) increased significantly from the placebo 
at 0.3, 0.4, 0.5% isoflurane and enflurane 0.42%. The NlOO 
amplitude differed significantly from the placebo at 0.2,
0.3, 0.5% isoflurane and 0.6% enflurane. The NlOO latency 
seems to produce a graded response to isoflurane which might 
be useful in automatic control of anaesthesia, providing the 
waveforms can be reliably identified automatically.
The two tests of psychometric function were affected by the 
drugs. Mean reaction times and tracking times increased. The 
variability of the above two measures increased as measured 
by the coefficients of variation.
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CHAPTER ONE
INTRODUCTION AND HYPOTHESIS
HYPOTHESIS
The hypothesis to be tested:-
Subanaesthetic doses of isoflurane and enflurane alter two 
tests of psychometric function, and the components of the 
auditory evoked response.
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INTRODUCTION
The visit to the dentist is a disturbing event for most 
people. Unfortunately there are some who will not tolerate 
local anaesthesia and require some form of sedation. Local 
anaesthesia is safe and reliable, but the present forms of 
sedation i.e. iv benzodiazepines, midazolam and diazepam, 
are prone to problems. A slow onset makes dosing often 
difficult to judge and is time-consuming. Patients may be 
left with a hangover effect which may make them drowsy until 
the next day. This, as with day case surgery, may have 
implications on the ability of the patient to drive and work 
etc.
The use of inhalation agents for dental sedation has many 
attractions. The patient does not require an iv injection, 
and the anaesthetist is able to use a technique which is 
easy to control and safe. If the patient becomes too drowsy, 
the dose can be easily reduced. As there is rapid excretion 
of the agent from the lungs there is likely to be rapid 
recovery.
The traditional inhalation agent for dental sedation is 
nitrous oxide in subanaesthetic concentrations. Although a 
useful agent, more recently its toxic effects on vitamin B 
metabolism in patients, associated with its prolonged use 
and also on staff using it on a regular basis, have lead to
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its poor acceptability in this field. Staff have been shown 
to have bone marrow changes and neurotoxicity associated 
with the use of nitrous oxide regularly in the surgery where 
room ventilation and scavenging methods are poor. In some 
individuals it is often difficult to achieve adequate 
ssdation, and is therefore not the perfect agent.
McLeod and colleagues used isoflurane for analgesia in 
labour. They reported that subanaesthetic concentrations of 
isoflurane produce potent analgesia, [McLeod, Ramayya, 
Tunstall 1985]. They were followed by Parbrook and co­
authors who assessed the efficacy of subananesthetic 
concentrations of isoflurane for inhalational sedation in 38 
anxious patients undergoing oral surgery,[Parbrook, James, 
Braid 1987]. They concluded that isoflurane produced 
satisfactory sedation similar to that produced by nitrous - 
oxide. Concentrations of 0.15%, 0.25% and 0.35% were used. 
After, the induction the inspired concentration was 
increased or decreased by concentrations of 0.05%, according 
to the patient's responses to treatment.
McMenemin and colleagues (Table 2) compared the use of 
subanaesthetic doses of isoflurane 0.4% with 25% nitrous 
oxide, [McMenemin, Parbrook 1988]. They assessed performance 
using a choice reaction time, visual analogue score, tapping 
speed and some mathematical problems. The 0.4% isoflurane 
gave consistently greater effects than those from the 25% 
nitrous oxide. They also noted that the degree of sedation
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with 0.4% isoflurane was greater than that needed for most 
clinical procedures. Once administration of the agent had 
been stopped the objective tests showed no impairment of 
function, but the subjective tests demonstrated impairment 
during the recovery period for up to 15 minutes. They 
concluded that isoflurane was an acceptable agent for dental 
sedation in doses less than 0.4%, with the dose being 
reduced towards the end of the procedure to avoid excess 
sedation and prolonged recovery.
One of the problems of this method of sedation in clinical 
practice is that the patient response is variable. Factors 
which cause this are
a) a patient is required to breath through his nose 
using a nasal mask, causing dilution of the inspired 
mixture
b) anxiety may make a patient less susceptible to the 
effects of sedation; premedication is not available to 
this group of individuals.
c) patient variability is wide - some become sleepy, 
others communicative, while some show no obvious 
effects.
The objective of this project was to produce dose response 
curves for the effects of enflurane and isoflurane at low 
doses and the subsequent recovery characteristics of this 
method of sedation and to assess the concentration of 
isoflurane at which consciousness is lost in the absence of
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painful stimulation. The dose response data for these two 
agents is known at higher anaesthetic concentrations. The 
effects of the agents can be divided into separate areas
1. The effects on behaviour, impairment of function and 
performance.
2. The neurophysiological effects on the brain i.e. 
delay in neuronal conduction.
3. The effects on the respiratory, cardiovascular 
systems etc.
To assess the characteristics in 1), two tests of 
psychomotor function were used, a choice reaction time and 
tracking task. These were specially implemented for use on a 
computer by Dr W. Gray. The choice reaction time is commonly 
used in studies of recovery from anaesthesia. But the 
tracking task has been used more extensively in 
pharmacological studies and the selection of aircraft 
pilots than the assessment of recovery from anaesthesia.
To indicate the neurophysiological effects of the drugs on 
the brain we used the auditory evoked response.
Auditory Evoked Responses are being evaluated for use in the 
assessment of awareness. If these waveforms are to be useful 
they need to show gradual changes at low concentrations of 
anaesthetic agents. Ideally the signal would be easily
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produced, show similar changes with all general anaesthetic 
agents, be unaffected by muscle relaxants and show changes 
with brain injury [Jones 1987].
Other authors have assessed the effects of higher doses of 
isoflurane and enflurane on the AER. A clinical state 
evolves from consciousness through to adequate anaesthesia 
to relative overdose. Before consciousness is lost a window 
exists where the state of attention may vary in the 
transition from awake to asleep. Initially subjects are 
asleep but easily reusable, then a stage is reached where 
they fail to respond to commands. This is followed by the 
loss of the eyelash reflex and finally no response occurs to 
surgical stimulation. At some point the state of attention 
and arousal is lost. Few of these authors have assessed the 
effects on subanaesthetic doses of isoflurane and enflurane 
on. the AER in sedated rather than anaesthetised patients, 
where no other drugs have been used.
We therefore attempted to use the AER - brainstem, middle 
latency cortical and long-latency cortical waveforms, at 
various concentrations of both agents.
The effects in 3), were measured to ensure safety to the 
volunteer i.e. heart rate, blood pressure, respiratory rate 
and oxygen saturation.
'This thesis describes studies of thirty healthy volunteers.
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sedated with subanaesthetic concentrations of isoflurane and 
enflurane, the AER being measured as an indicator of 
neurophysiological changes in the brain and two 
psychometric computer tests being measured to ascertain 
performance and impairment of function.
CHAPTER TWO
THE AUDITORY EVOKED RESPONSE
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AUDITORY EVOKED RESPONSES
GENERAL BACKGROUND
With the introduction of neuromuscular blocking agents, the 
assessment of depth of anaesthesia has become difficult, as 
the clinical signs of spontaneous respiration and muscular 
movement are obscured. The anaesthetist has to rely on 
autonomic signs to assess depth of anaesthesia, which are 
often not reliable indicators. The standard 
electroencephalogram (EEG) has been used to assess the 
effect of anaesthetic drugs on the brain. Unfortunately it 
has been found that although anaesthetic drugs produce 
predictable changes, they do not produce them in the same 
sequence. This limits the usefulness of the standard 
electroencephalogram as a monitor of anaesthetic depth.One 
modification that may prove useful in the future is the use 
of sensory evoked potentials. These seem to have the 
advantage over the EEG of constant changes with different 
anaesthetic drugs.
The sensory evoked response can be defined as a computer 
averaged electrical response of the nervous system to 
sensory stimulation, [Spehlmann 1985]. When scalp electrodes 
are applied to the subject a background recording can be 
displayed. This shows microvolt potentials whose 
frequencies depend on the state of the subject but are 
unsynchronised in time. By applying a sensory stimulation
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repeatedly, a response that is time locked to the 
stimulation occurs which can be averaged on a computer, the 
background EEG activity being cancelled in the averaging 
process. This enhances the features of the response 
component that is time-locked to the sensory stimulus.
Evoked Potentials (EPs) can be elicited by auditory, visual 
or somatosensory stimuli. They are recorded from electrodes 
over the scalp or placed on the surface of the body. A 
series of waves is produced which have associated latency 
and amplitude.
CLASSIFICATION
GENERAL CLASSIFICATION
1. Auditory Evoked Potentials (AEPs) are subdivided by 
latency into short-latency AEPs (brainstem BAER), middle or 
early cortical AEPs (MLAEPs) and long -latency or late 
cortical AEPS.
2. Visual evoked potentials (VEPs) are divided by stimulus 
characteristics into VEPs to checkerboard patterns, diffuse 
light, and other types of stimuli.
3. Somatosensory evoked potentials (SEPs) are subdivided by 
the location of the stimulation i.e. arm or leg nerve 
stimulation.
Classification according to generator site
Waveforms of the various evoked responses are sometimes 
classified by the generator producing the potential. For 
instance : -
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1. Cortical EPs:
Cortical EPS are generated by primary sensory and higher 
cortical areas. They have latencies of over 10-20 msec and 
amplitudes of up to 10 microvolts.Although cortical VEPs and 
SEPs are derived with electrodes placed near the primary 
receiving areas in the occipital and parietal areas, 
respectively, cortical AEPs are recorded with electrodes 
not directly overlying the auditory cortex. In all three 
modalities, cortical EP peaks may be preceded by peaks 
generated by subcortical structures.
2. Subcortical EPs:
Subcortical EPs are generated by the chains of neurons in a 
sensory pathway to the cortical receiving area. These EPs 
have latencies of less than 10-20 msec. Because the brain 
stem and spinal cord are relatively far away from recording 
electrodes on the head and neck, potentials generated in the 
auditory and somatosensory afferent pathways are much 
attenuated by the intervening tissues and have amplitudes of 
usually less than IpV at surface recording electrodes.
Classification according to recording method 
As described above, cortical and subcortical EPs are 
recorded by near-field and far-field methods respectively ;-
1. Near-field recordings:
Near-field recording methods are used to record cortical 
EPS. One electrode is placed close to the area under study, 
and the other electrode is placed over an electrically 
quieter area several centimetres away. A recording between
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these electrodes yields responses of 1-lOpV and requires 
collection of only about 100 responses for a clear 
definition of the cortical EP. Repetition rates of 1-2/sec 
are usually used for transient cortical EPs because these 
EPS have relatively long latencies and durations and may 
interact with each other at higher rates.
2. Far-field recordings;
Far-field recording methods are used mainly for recording of 
potentials produced in the brain stem and spinal cord, i.e. 
far away from surface electrodes. The electric field 
generated deep in the brain has a wide distribution at the 
surface so that the exact location of recording electrodes 
is not critical although they must be fairly far apart to 
pick up the small voltage differences on the surface. The 
amplitude of the potentials is much attenuated at the 
surface and usually measures less than 1 microvolt, 
requiring averages of 1,000 or more responses for a clearly 
defined EP. Because subcortical EPs have short latency and 
duration and are resistant to fast repetition, stimulus 
rates of 5-10/sec or more may be used.
Classification according to stimulus characteristic
Stimulus rate
1. Transient EPs:
Separate responses are elicited by stimuli spaced so far 
apart in time that each response is completed before the
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beginning of the next one. This requires stimulus rates no 
faster than 1-2/sec for the relatively long-lasting VEPs and 
long-latency cortical AEPs and SEPs. Short-latency cortical 
AEPs and SEPs and subcortical EPs have much shorter duration 
and can be elicited as transient EPs at rates of 10/sec or 
more. Transient EPs are the most commonly used clinical EPs.
2. Steady-state EPs;
If repetitive stimuli are spaced so closely that each 
response interacts with the next one, the EP becomes a 
rhythmical wave which has peaks at the same frequency as the 
stimuli and may contain harmonic and subharmonic components 
at multiples of that frequency; at higher stimulus rates, 
EPs to individual stimuli can no longer be distinguished. 
Stimulus rates producing steady-state EPs vary with the EP 
type. The brief short-latency AEP can be driven to become 
a steady-state EP, or frequency following potential, at 
rates of about 250-1000/sec. The middle latency AEP can be 
driven into steady state at rates of about 40/sec.
3. EPS to unilateral and bilateral stimuli:
Auditory and somatosensory stimuli are usually applied to 
one side of the body at a time. Bilateral stimulation 
produces EPs that differ from the sum of the EPs to 
unilateral stimulation to an extent depending on the 
cortical and subcortical level of recording and on the 
anatomy of the sensory system under study.
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THE GENERATORS OF EPs.
The features of an EP only very grossly suggest its origin. 
In general, peaks of relatively high amplitude and 
restricted distribution on the scalp are likely to be 
generated in the cortex under one of the recording 
electrodes. Peaks of low amplitude and wide distribution are 
more likely to be generated in subcortical structures, 
especially if they have short latency.
The location of EP generators may be studied by mapping the 
distribution of the peaks in simultaneous recordings from 
many scalp electrode positions. The magnitude of an EP 
deflection at a certain latency is plotted for each 
recording point on a head diagram; points of equal potential 
are connected to give a map of concentric isopotential 
lines, which outline the maximum of the scalp potential and 
its gradient.
The general principles of the production of EPs by elements 
of the nervous system have been the subject of many 
experimental studies that suggest some conclusions 
[Spehlmann 1985]:
1. "Cortical EPs are due to the spatial and temporal 
summation of excitatory and inhibitory postsynaptic 
potentials generated at nerve membranes in response to the 
input produced by the stimulus. The potential differences 
produced generate currents which penetrate to the cortical 
surface and the scalp and produce electric fields, being
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modified by the properties of the intervening structures.
2. Subcortical EPs are probably a mixture of two components: 
Postsynaptic potentials generated in groups of neurons of 
subcortical relay nuclei, and action potentials of the 
connecting axonal tracts.
3. EPs recorded from sensory nerves are due to the 
depolarization wave propagated along the membrane of the 
nerve fibres when the axon fires. When passing under a 
stationary recording electrode on the skin, the wave 
produces a major surface-negative deflection that may be 
preceded and followed by minor positive deflections due to 
the approaching and disappearing wave. The compound action 
potential may include later deflections generated by fibre 
groups of lower conduction velocity, but these deflections 
are of low amplitude due to the greater temporal dispersion 
of slowly conducted impulses".
He stated that for all three kinds of EPs, the shape, size, 
and timing of an EP recorded from the scalp or skin depend 
on many factors:-
1. The spatial orientation and size of the generator 
potential in relation to the recording electrodes.
2. The distance between the generator and the electrodes.
3. The duration of the generator potential.
4. The electrical conductivity of the intervening tissues.
¥
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Figure 1 - Diagram of BAER, MLAER, and LLAER. Stimulation of 
one ear and recording between the ipsilateral earlobe and 
the vertex, different recording settings and gain settings 
used for each recording. Stimulation with rarefaction clicks 
at 60dB SL and continuous contralateral masking noise. MLAER 
and LLAER are displayed with a polarity opposite to that 
used for the BAER.
Reproduced from Spehlmann R, Evoked Potential Primer, 
Boston: Butterworths, 1985; Figure 11.1. 196.
Page No 14
AUDITORY EVOKED RESPONSES
Recordings between electrodes on the vertex and the earlobe 
or mastoid process yield AEPs of three latency and amplitude 
ranges.
1. The short-latency AEPs include peaks of up to 10 msec and
0.2 microvolts; they are generated in the brain stem.
2. The middle latency AEPs have several variable peaks with 
latencies of 10-50 msec and with amplitudes of about 1 
microvolt; they probably reflect early cortical excitation.
3. The long-latency AEPs, beginning after 50msec and having 
peaks of 1-10 microvolts, represent later cortical 
excitation, [Figure 1].
In contrast to VEPs, AEPS are classified by recording 
methods, not by stimulus characteristics. Most AEPs are 
elicited with click stimuli.
DATA PROCESSING 
Averaging
Averaging extracts the responses time-locked to a single 
stimulus from the background EEC and other electrical 
activity i.e. noise. The sensory stimuli are presented 
repeatedly, the responses collected and added to the 
preceding ones, the sum being divided by the number of 
responses. Averaging is carried out by a digital computer 
which records the electrical activity during the selected 
time interval , converts the voltage change of the analog 
recording into a series of numbers and adds the numbers from
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each recording to the preceding recordings and averages 
them. Each period of analysis is called an epoch or sweep, 
which is divided into equal segments of time called points. 
The analysis dwells on each point for a dwell time or bin 
width, equivalent to a fraction of a second per point. This 
is equal to the reciprocal of the sampling rate (Sampling 
rate equals the number of points sampled each second).The 
analog to digital conversion allows the amplitude of the 
segment being recorded in each bin to be measured and 
converted into a binary number. This results in a series of 
binary numbers, which are added to the preceding ones and 
divided by the number of responses collected to give a 
running average.
Most averagers have 2,4, or 8 channels for recording. 
Multichannel recordings may be used to record EPs either 
simultaneously from different areas, or to study EPs to 
stimulation of either side of the body. Successive 
recordings allow the reproducibility of EPs to be examined 
successively.
Amplifiers
Electrical potential differences are recorded between the 
two electrodes which are connected to two inputs of an 
amplifier. A differential amplifier subtracts the voltage at 
one input from the voltage at the other, and amplifies this 
difference. Cerebral potentials usually have different 
voltages and timing at the two electrodes. The differential
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amplifier discriminates between these and from the 
extracerebral potentials, or artifacts, which often have the 
same voltage and timing at the two electrodes and are 
therefore cancelled at the amplifier input.
Amplifiers used in Europe are wired to give a downward 
deflection at the output as a result of a relative 
positivity at input 1 and an upward deflection as a result 
of a relative positivity at input 2.
Simultaneous recordings of EPs in more than one channel are 
made by selecting different electrode pairs as inputs to 
each channel.
Differential amplification rejects only those artifacts that 
cause identical potential changes at both inputs; these are 
said to be in common mode. Artifacts greater at one 
electrode than the other are amplified like cerebral 
activity. Likewise, responses averaged in EPs are rejected 
if they have the same polarity etc at both inputs. The 
ability to reject common mode signals is expressed as the 
common mode rejection ratio. This is the ratio of the 
amplifier output produced by a signal applied 
differentially, i.e. between the two inputs, over the 
amplifier output produced by the same signal when it is 
applied in common mode, i.e. between both inputs tied 
together and the amplifier ground, [Spehlmann 1985]. The 
common mode rejection ratio of amplifiers used for EP 
recordings should be 10,000:1. Rejection of artifacts
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depends on the following:-
a) discrimination at the inputs eg if mains power-line 
interference (50Hz) appears with similar amplitude at the 
inputs of a differential amplifier, it is rejected.
b) electrode impedance. If the electrode impedance becomes 
unequal, due to partial or complete loss of contact between 
one electrode and the scalp, or if a break in the continuity 
of the electrode occurs. Then the amplifier no longer 
operates differentially but increases signals between the 
remaining input and the ground electrode.
c) the ground electrode. If the ground is not connected to 
the volunteer, the amplifier inputs "float" without a 
reference to the potential level at the recording site, and 
the amplifier will use its own internal ground potential 
level to subtract signals at input 2 from those at input 1. 
Input potentials that are equal with respect to the 
subject's head and would normally be cancelled eg ECG 
interference may not now be rejected. Cerebral potentials 
are generally not distorted with floating inputs, but safety 
from electrical hazards is increased in the absence of a 
ground electrode. If only one input is connected to the 
subject then the resulting recording between the input and 
ground electrode may resemble a normal trace but is 
contaminated by artifacts.
Gain/Sensitivity - the increase of the voltage of a signal 
between the input and the output of an amplifier. Gain is
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the ratio of signal voltage obtained at the amplifier output 
to the signal voltage applied at the input. Sensitivity is 
the ratio of input voltage to the size of the deflection it 
produces in the output.
Filters - exclude from the final recording those potential 
changes that have frequencies different from the frequencies 
represented in the response under study. They may reduce the 
number of responses required for a clear trace.
Filters may eliminate high or low frequencies outwith a 
middle range encompassing the frequencies of the EP under 
study. Analog filters reduce the amplitude of unwanted 
components before they are digitized, but may alter the time 
relationship between some of the desired signal components 
passing through the filter. This phase shift can be avoided 
by using digital filters. The middle range frequency between 
the low and high cutoff points, which is not affected by 
filter settings is called the bandpass or bandwidth.
The 50Hz notch filter reduces the signal amplitude in a 
very narrow band centering at 50Hz. The frequencies of the 
filtered band may be an important part of the EP, and the EP 
may be significantly distorted by the use of the filter, 
[Spehlmann 1985].
Digital filters are computer programmes that operate on the 
digitized responses before averaging or on the EP after
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averaging. Smoothing is a simple form of a digital filter. 
Digital filters can eliminate components of low or high 
frequency with very sharp cut off and without phase shift.
Digital smoothing can reduce high frequency noise components 
superimposed on the EPs by replacing each point of a digital 
trace by a moving average of the 3, 5, or more neighbouring 
points. Smoothing does not distort the phase relationship 
between EP peaks, it may change the EP shape by reducing the 
amplitude of short waves more than that of long ones.
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BRAINSTEM AUDITORY EVOKED RESPONSES
The brainstem auditory evoked response (BAER) recorded on 
the side of the stimulated ear contains five waves appearing 
in the first 10 msec after the stimulus and having peaks 
that are positive at the vertex with reference to the ear. 
These waves are usually labelled with Roman numerals I to V. 
The BAER recorded from the side opposite the stimulated ear 
shows no clearcut wave I; the negative peak preceding wave 
II is therefore sometimes used for measurements of 
interpeak latencies. Other peaks differ slightly but 
significantly on the two sides, [Figure 1].
Not all normal recordings contain all BAEP peaks. Wave V is 
present most often, waves I and III can usually also be 
identified. Wave II is often absent and wave IV may merge 
more or less completely with wave V. Wave V is sometimes 
followed by waves VI and VII. Peak and interpeak latencies 
of the BAEP waves are remarkably constant for a given set of 
subject, stimulus, and recording parameters. They vary 
little in repeated recordings in the same subject over many 
months; they vary only slightly more between recordings from 
the two sides of the same subject and between different 
subjects of the same age and sex. Latency is longer and more 
variable for condensation than for rarefaction clicks. Each 
laboratory must therefore establish its own normal values 
for these variables. Not all BAEP waves are present in 
every recording from a normal subject. A few practical 
manoeuvres are often helpful in enhancing and identifying
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FIGURE 2. Brainstem auditory evoked response and the 
anatomical pathway, represented by the various waveforms. 
Reproduced from Maurer K, Leitner H, Schafer E. 1980. 
Detection and localisation of brainstem lesions with 
auditory brainstem potentials; in Evoked Potentials (ed. 
C.Barber), p391. Lancaster: MTP Press.
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BAEP waves, [Figure 1].
Wave II, is often absent in normal subjects.
Wave III may be normally split into two peaks; its latency 
is then measured to the first peak or to the middle point 
between the two peaks. A split, or bifid,wave III must be 
distinguished from a partial fusion of waves III and IV or 
of waves II and III.
Wave IV often normally fuses with wave V to form a complex 
with a peak latency equivalent to that of wave IV, wave V, 
or an intermediate value. Wave IV often varies in the same 
individual with time.
Wave V is the most reliable peak. It may be identified by 
its low threshold, its persistence during repetitive 
stimulation up to 100/sec, and by the large negative 
deflection that commonly follows it. Occasionally, wave V 
consists of onlv a small inflection on the downslooe of wave 
IV.An unusually large negative deflection following wave IV 
may be a normal variant.
The seven peaks of the BAER have been ascribed to certain 
neurogenerators as follows:-
a) Wave I - the acoustic nerve
b) Wave II - the cochlear nucleus
c) Wave III - the superior olive
d) Wave IV - the lateral lemniscus
e) Wave V - the inferior colliculus
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f) Wave VI - the medial geniculate body
g) Wave VII - the thalamocortical radiations.
Waves I and II originate from the peripheral portion of the 
auditory nerve, [Figure 2] wave III from the pons, wave IV 
and V from the midbrain, and waves VI and VII from cortical 
components, [Stockard, Stockard, Sharbrough 1978]. The 
latency between waves I and III represents conduction from 
the periphery to the brainstem, The interpeak latency III-V 
represents brainstem transmission.
During the recording of the AEP, the subject either reclines 
in a comfortable chair or lies on a bed in a quiet room. In 
most recordings, special care must be taken to relax neck 
muscles by placing pillows under the head and adjusting the 
position of the body. The subject wears earphones or listens 
to a loud speaker. The recording room should be so quiet 
that the subject cannot hear any sounds except for the 
stimulus and the masking noise. As sleep relaxes scalp 
muscles and reduces biological artifacts the subjects are 
encouraged to sleep during these recordings. The MLAEP may 
be recorded in light sleep, but its threshold increases in 
deep sleep. LLAEPs vary not only with sleep but even with 
changes of attention.
The stimulus is most commonly delivered through an earphone. 
Earphones are usually of the moving-coil, electrodynamic 
type which have low impedance and, especially at high
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stimulus intensities, generate electromagnetic fields which 
induce stimulus artifacts that may require shielding of the 
earphone with mu metal. Electrostatic and piezoelectric 
earphones, having high impedance, require less current but 
higher signal voltage, and may not be able to generate sound 
levels as high as those produced by an electrodynamic 
earphone. These earphones produce mainly electrostatic 
stimulus artifacts that are more easily eliminated by 
shielding. In some laboratories, the stimulus artifact is 
reduced by separating the source of the sound from the ear 
by a piece of tubing that introduces a delay between the 
electric production of the sound and the AEP. Small 
earphones that fit into the external ear canal may be used 
for intraoperative monitoring of BAEPs.
STIMULUS CHARACTERISTICS
Stimulus type
Several types of stimuli may be used to elicit AEPS. Most 
AEPs are produced by clicks or tone pips. Click stimuli are 
very satisfactory for neurological studies because they 
produce sudden excitation resulting in a well-defined EP. 
However, clicks are not very suitable for audiological 
studies because they contain a wide range of tone 
frequencies, act mainly by virtue of their high frequency 
content, and do not test the lower frequency range which is 
important for speech. Stimulation with tones of lower 
frequency, although desirable for audiological purposes, 
creates several problems. Tones act as a stimulus mainly by 
virtue of their onset and should be short. However
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expression of the tonal frequency of a stimulus requires a 
tone duration of at least a few cycles. Tones of low 
frequency have a wavelength too long for an effective 
stimulus, especially in cases of short-latency AEPs. 
Furthermore , although a stimulus of sudden onset is needed 
for a clearly defined EP, the sudden onset of a loud tone of 
any frequency introduces a high-frequency transient element
i.e. it behaves like a click and thereby elicits an AEP that 
is not specific for the tone frequency. A compromise between 
the requirements of a specific tonal frequency and a well- 
defined onset is available in the form of the filtered 
click, the tone pip, or the logon, although low frequencies 
remain a poor stimulus for elicitation of AEPs. The 
receptors for low tones, located in the apical part of the 
cochlea, are not easily explored by AEP methods. The longer 
travel distance of sound waves to the apex of the cochlea, 
allows responses to low tones to be elicited later than 
responses to high frequencies, which excite the basal part 
of the cochlea. Also, because low frequency sound waves 
have a long duration, the responses are dispersed in time 
and have low amplitude. Response components to the low 
frequency contents of an auditory stimulus are therefore 
easily obscured by the earlier and larger response 
components generated by the more basal parts of the cochlea 
which respond to the high frequency content represented by 
the sudden onset of the stimulus. Attempts have been made to 
study BAEPs to low stimulus frequencies by masking high 
frequency components of the stimulus with continuous noise
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or to record slow brain stem AERs to low frequency tone
pips.
1. Broadband clicks:
Clicks may be produced by feeding electric monophasic 
square pulses into an earphone and thereby deflecting 
the earphone membrane. Even though the electric pulses 
are sharp and last only 1OOmicrosecs, the earphone 
membrane reacts imperfectly to the square pulse and 
generates pressure changes that are further modified by 
the material used for coupling the earphone to the head 
and by the intervening ear structures before they reach 
the sound receptors in the cochlea. These factors 
convert the original electric square pulse into a 
sequence of decaying pressure fluctuations with a peak 
acoustic power at 2-4 kHz. This sound stimulus still 
contains a fairly wide range of frequencies and is 
therefore called BROADBAND, or UNFILTERED click. A 
narrower band of stimulus frequencies can be obtained 
either by filtering the electric square pulse or by 
presenting broadband clicks on a background of a 
continuous masking noise that eliminates the effect of 
some of the frequencies in the click.
2. Filtered clicks and tone pips:
Filtered clicks are generated by simply passing a 
rectangular or sinusoidal wave through a filter with a 
narrow bandpass so as to produce a brief burst of waves
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of a frequency centred.at the filter bandpass. Tonepips 
have more symmetrical rising and falling phases and are 
produced either by passing one period of a sine wave 
through a bandpass filter of the same frequency or by 
modulating the amplitude of a pure tone electronically 
to give it the desired rise, fall and plateau times. 
Filtered clicks and tone pips are usually given rising 
and falling phases of two cycles and a plateau of one 
cycle. A logon is a tone with an amplitude modulated by 
the shape of a Gaussian distribution curve, said to give 
the best compromise between the definitions of stimulus 
onset and frequency. Filtered clicks, tone pips, and 
logons, must always start from the zero level and move 
in the same direction to give consistent AEPs.
3. Tone Bursts;
Tone Bursts with rise and fall times of at least 5msec 
and durations of at least 30 msec may be used for the 
LLAEP but are not suited for the MLAEP and BAEP.
Stimulus rate
The stimulus frequency varies for each AEP type. Transient 
short and medium latency AEPs such as the BAEP, slow brain 
stem AEP, ECochG, MLAEP are usually elicited at rates of 8- 
10/sec. The LLAEP requires stimulation at 1/sec or less. 
The steady-state 40Hz AEP is produced by tone bursts of 
various frequencies repeated at 40/sec; the fast frequency 
potential FFP can be obtained with tones of l O O - l O O O H z .
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Avoidance of synchronisation with the power-line frequency 
should be avoided as this can lead to interference in the 
average. The stimulus frequency is usually not altered 
during a stimulation, a brief tone of changing frequency and 
a change of the frequency of a sustained tone are also 
capable of eliciting AEPs.
Stimulus Intensitv
Although the stimulus intensity is usually not changed 
during the recording of an AEP, a change of the intensity of 
a continuous tone may also act as a stimulus and elicit an 
AEP.
Stimulus intensity is measured as a ratio of stimulus level 
to a reference level and is expressed in decibels. The 
number of decibels equals 20 times the logarithm^Q of the 
ratio of amplitude or voltage when expressing amplitude, or 
10 times the logarithm^Q of that ratio when expressing power 
or the square root of voltage. The same type of measurement 
is used to indicate hearing loss: A subject hearing a tone 
only if it is increased by 40 dB above the normal hearing 
level is said to have a 40-dB hearing loss for that tone. 
Several different reference levels are used to describe 
stimulus intensity in AEP studies eg hearing level, normal 
hearing level, sensory level, sound pressure level, and peak 
equivalent sound pressure level.
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Stimulus polarity
Click stimuli may be produced by electric pulses, which 
cause an initial deflection of the earphone membrane toward 
the eardrum, condensing or compressing the air in the ear 
canal and generating condensation, or compression, clicks. 
If the polarity of the electric pulse driving the earphone 
membrane is reversed, the pulse produces an initial 
deflection of the membrane away from the ear, rarefying the 
air in the ear canal and causing rarefaction clicks. The 
manufacturer or user must identify the electric polarity 
settings that produce rarefaction and compression clicks. 
Stimulus polarity is practically important for short-latency 
AEPs because condensation and rarefaction clicks produce 
slightly different BAEPs and ECochGs.
MASKING NOISE
When a sound stimulus is applied through an earphone to one 
ear, the sound is conducted by the skull and may reach the 
opposite ear. Although the stimulus is attenuated by about 
50-60 dB on its travel across the head, it may excite the 
other ear. Such cross-stimulation is especially likely to 
occur when the ear to be tested has a higher threshold than 
the other ear and is exposed to strong stimuli. Cross­
stimulation can be avoided by applying a constant masking 
noise through an earphone on the ear opposite the simulated 
one. The masking noise should have an intensity of about 
40dB below the stimulus intensity. Masking intensities of
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about 60dB SPL are sufficient for the stimulus intensities 
used in routine studies. Masking noise should contain either 
a wide range of frequencies at equal intensities (white 
noise) or include at least the frequencies of the 
stimulating sound. Masking is not necessary for the ECochG 
because the response is generated and recorded only at the 
stimulated ear. Masking noise may be used to mask unwanted 
frequencies of complex sound stimulus by mixing masking 
noise and stimulus sound at the same ear.
MONAURAL AND BINAURAL STIMULATION
Separate stimulation of each ear is needed for studies 
evaluating hearing, acoustic nerve, and brain stem function 
on each side. Simultaneous stimulation of both ears produces 
AEPs that differ from the sum of the AEPs to stimulation of 
each ear.
RECORDING ELECTRODES
For recordings of most AEPs, electrodes are placed on the 
vertex and on or near the ears. Ear electrodes may be placed 
on the lateral or medial surface of the left and right 
earlobe (Al, A2,) or on the scalp over the left and right 
mastoid bone (Ml, M2 ). Placement on the medial surface of 
the earlobe can reduce the stimulus artifact of the click. 
If necessary, the definition of the first wave of the BAEP 
may be improved by recording the ECochG from an electrode 
inserted into the ear canal or through the tympanic 
membrane.
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The same electrode combinations are used to record BAEPs, 
MLAEPs, and LLAEPs. For single - channel recordings, the 
vertex electrode and the electrode at the stimulated ear are 
connected to the two inputs of the amplifier and the third 
electrode connected to the amplifier ground. Dual-channel 
recordings are preferred for BAEPs, channel 1 recording 
between vertex and stimulated ear, channel 2 between vertex 
and nonstimulated ear. A ground electrode is placed anywhere 
on the head, e.g. at F2 , or elsewhere on the body and is 
connected to the amplifier ground.
The gain and filter settings, sweep length, and number of 
responses averaged vary with the AEP type. For every 
recording, at least two sets of averages must be 
superimposed to ascertain replication.
The polarity convention for AEPs is not uniform. Many 
laboratories record the BAEP so that an upward deflection at 
the output indicates increased positivity at the vertex. 
MLAEPs and LLAEPs are usually recorded with the opposite 
polarity convention: upward deflections indicate increased 
vertex negativity, [Figure 1].
REASONABLE NORMAL RANGES
Normal EPs vary between different subjects. Different 
laboratories must define their own set of "normal values", 
[Table 1]. These must represent the two sexes equally and 
generally the same age groups.
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The normal range of EP characteristics is defined 
statistically for each subject group, EP type and EP 
characteristic. A group should comprise at least twenty 
individuals. Although in the work in this project, each 
volunteer acts as his own control.
EPs are highly dependent on stimulating and recording 
conditions. It is therefore of great importance that each 
laboratory determines control values for each response type 
and does not rely solely on the values from other labs. 
Guidelines from the American EEG Society state that on 
setting up a new lab, 2 requirements must be fulfilled:-
1. Stimulus and recording conditions must be the same in 
the new lab as those of the reference lab.
2. Control values of at least 20 individuals from a 
sample population eg 95% or 99% fall within the normal 
values studied from the reference lab.
The following are necessary requirements for control 
subjects:
a) health and fitness
b) No history of CNS disease
c) no influence of drugs or alcohol
d) no disorder of the sensory modality under study. 
For AER, control subjects should have an audiometric 
examination.
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The normal range of EP measurement is dependent on the 
distribution of the values in normal subjects i.e. an 
attempt should be made to determine whether control values 
fit a "normal distribution" curve from the mean, SD , or by 
determining the deviation from normal or skewness. To 
determine a normal range the mean should be within 2-3 SD. 
Each laboratory must set its limits for normal ranges, this must 
represent a compromise between false positive and false negative 
numbers that can be accepted.
Various authors have published data on the AER waveforms, 
[Table 1].
Table 1. - Normal values for components of the 
auditory evoked response.
Brainstem AER
Author No I II III IV V
Picton (1973) 20 1.5 2.6 3.8 5.0 5.8
Rosenblum 6 1.6 3.7 5.8
(1982)
Thornton 6 1.6 3.7 5.8
1983 (SD) 0.17 0.22 0.5
Thornton 12 1.7 3.8 5.7
1984 (SD) 0.23 0.23 0.25
Schmidt 18 1.9 4.3 6.6
1986 (SEM) 0.46 0.38 0.26
Dubois 10 1.58 2.69 3.65 4.65 5.57
1982 (SEM) 0.02 0.05 0.08 0.08 0.07
Middle Latencv AER.
Author No No Po Na Pa Nb
Picton (1973) - 8.9 12 16 25 36
Thornton 28 39
1983 (SD) 2.9 3.1
Thornton 26 39
1984 (SD) 2.9 6.6
Lona-latencv AER.
Author PI N1 P2 N2
Picton (1973) 50 83 161 290
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FACTORS WHICH AFFECT THE VALUES OF BAER
PHYSIOLOGICAL
1. Attention
The brainstem components have been found to be stable during 
changes in subjective arousal and environmental conditions.
Picton and Hillyard (1974) demonstrated that there was no 
significant change in the early and middle latency 
components of the AER when attention was directed towards 
auditory stimuli to perform loudness discrimination. They 
concluded that there was no evidence from this work to 
support the theory proposed by Hernandez-Peon (1966) that 
there was a gating system in the mechanism for auditory 
attention prior to sensory analysis.
Picton and Hillyard (1974) noted that the early and middle 
components of the AER were stable to any changes in the 
subject's level of arousal. Due to muscle artifact during 
awake states, they found that more defined recordings could 
be obtained during sleep when the scalp muscles are 
relaxed, [Picton, Hillyard, Krausz 1974].
2. Arterial Pressure
Various work has shown that VEP are altered by heart rate 
and blood pressure, [Callaway, Buchsbaum, 1965].
Grundy and co-workers (1982) used BAER to monitor 
neurosurgical operations in the cerebellopontine angle. 
These workers noted two patients displayed BAER changes
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prior to incision which were temporarily related to a 
combination of hypocarbia and a degree of arterial 
hypotension.
In five cases, intervention with volume expansion with 
crystalloid or colloid, as a specific response to BAEP 
alteration was made, which improved the waveforms in some 
cases, [Grundy, Jannetta, Procopio, 1982].
In the majority of studies on the effects of anaesthetic 
drugs , an attempt is made to maintain systolic blood 
pressure > 80mmHg, so as to minimise changes in waveforms 
due to arterial hypotension.
3. Age
Due to conflicting reports of the effects of age on BAER, 
no age-specific standards have been established. Advancing 
age has often been reported to increase both peak and 
inter-peak latencies. Various authors reported that aging 
has no effect on peak latencies, [Beagley, Sheldrake, 1978].
Thornton ( 1 987 ) investigated the data from five 
laboratories. Only some found a significant age effect and 
then only at certain levels. Even for the same age ranges 
and stimulus characteristics, two different laboratories 
showed conflicting results. She classed the effect of age as 
having a small effect on BAER waveforms. Below the age of 
two years, interpeak latencies (IPL) are prolonged relative 
to adult values and vary inversely with age.
Page No 35
[Thornton, 1987].
BAERs may be absent in normal premature infants under 30 
weeks of conceptional age. BAER in full-term infants show an 
IPL I-V about 0.8-1msec longer than adults, mainly due to a 
longer latency of wave V. Latencies continue to decrease 
after term, [Stockard, Stockard, Westmoreland,1979].
The latency of wave I (peripheral conduction) reaches adult 
level at 6 weeks, and IPL I-V (central conduction) reaches 
that level at about 1.5 years. Age-specific normal values 
are required up to about 18 months of age.
4. Sex.
Females normally show shorter peak latencies and inter-peak 
latencies,III-V and I-V than do males, [Stockard, Stockard, 
Sharbrough, 1978].
The amplitudes of the waveforms tend to be higher and 
exhibit shorter stimulus to peak latencies; this may be 
related to smaller skull and brainstem anatomy.
PATHOLOGICAL
1. Temperature
Hypothermia may result in prolongation of both wave latency 
and IPL, [Stockard, Sharbrough, Tinker, 1978] . During
hypothermic cardiopulmonary bypass, the upper limit of 
normal for the I-IV/V IPL at normothermia was exceeded at 
an oesophageal temperature of 32  ^ °C and that for the I-
Page No 36
III, III-V IPLs at 28°C. A temperature decrease from 37.1 to 
34.5°C increases the latencies of wave I-V. Below 25°C waves 
totally disappear, [Kaga, Takiguchi, Myoka, 1979].
Hyperthermia has opposite effects on the BAER; slight IPL 
decreases are seen in humans and cats with mild 
hyperthermia, [Jones, Stockard, Weidner, 1980].
Variations of body temperature may explain circadian 
variations of these latencies, [Marshall & Donchin, 1981].
Changes in temperature of 0.5°C have negligible effects of 
latencies of BAER.
2. Ear Diseases.
BAER can be used to test hearing ability. The threshold 
stimulus intensity that produces a BAER is determined and 
the latencies of the various waveforms are tested. For 
instance, a click stimulus of 70dB is used to elicit a BAER, 
namely wave V which has the highest amplitude and lowest 
threshold. If wave V cannot be obtained, a click stimulus of 
20dB is used and if wave V appears at this level, the test 
is terminated, as it is consistent with normal hearing. If 
wave V is not elicited, stimuli are increased by lOdB, until 
the threshold of wave V is found. Evoked response audiometry 
is a difficult technique.The most effective stimuli i.e. 
clicks and brief tones, test only the audible frequency 
ranges. Lower frequencies especially those around which 
speech occurs cannot be effectively tested. The presence 
of a BAER does not exclude a hearing deficit. Mild hearing
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defects and defects in the low frequency ranges may not be 
identified.
Hearing loss will increase the threshold of a BAER, mostly 
that of wave V if the hearing loss involves the higher 
frequency range i.e. l-4kHz. BAEPs to clicks are, at the 
moment, the best electrophysiological tests of hearing.
Hearing loss will increase the latency of wave V above 
the normal level. Central lesions may be excluded with a 
normal IPL I-V.
A conductive hearing loss interferes with conduction of 
sound waves to the cochlea i.e. effectively a reduction in 
stimulus intensity. This results in a BAEP of lower 
amplitude and longer latency of all waves i.e. wave I 
latency is increased more than that of other waves, 
therefore IPL I-III and I-V are shortened. Increasing the 
stimulus intensity may not overcome a conductive hearing 
loss.
With a sensorineural hearing loss the amplitude of BAER 
waveforms is reduced and the amplitude ratio V/I is 
increased. The latency of wave V will be increased, but wave 
I will also be increased in latency, resulting in a normal 
or even abnormally short IPL I-V.
Rosenblum and colleagues (1982) demonstrated that nitrous 
oxide may cause changes in the AER due to a conductive 
hearing deficit, being produced by the effect of N 2 O on
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middle ear pressure, [Rosenblum, Gal, Ruth 1982].
3. Brain Diseases
BAEP are most useful clinically in
1. The diagnosis and prognosis of coma
2. The diagnosis of demyelination
3. The detection and localisation of posterior fossa 
tumours.
Coma; BAEPs may be useful in the differentiation of 
metabolic from structural causes of brainstem 
dysfunction. BAER are resistant to the majority of 
nonspecific CNS depressants and metabolic insults, 
unlike the EEG which may show suppression of normal 
activity.
If brainstem death is diagnosed clinically, the 
BAER usually shows IPL abnormalities or the absence 
of waves III and IV/V, wave I remaining present. 
This suggests a structural cause for the brainstem 
dysfunction and corresponding poor prognosis.
If BAER are recorded, cautious interpretation is 
required due to technological or otological 
problems.
Absence of all waveforms or all except wave I are 
the most common patterns seen in brain death. 
Lesser degrees of abnormality or no abnormality are
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seen in cases of cerebrocortical death in which 
there is no damage to brainstem auditory pathways.
Multiple Sclerosis: Patients with MS often have 
abnormal BAEPs. They occur most often in patients 
who have a diagnosis of MS and in those with 
brainstem involvement. Patients with likely MS but 
no brainstem clinical signs often have abnormal 
BAEPs.
There is no specific abnormality noted for MS, 
abnormalities depending on the site and location of 
disease.
BAER are less effective at detecting abnormalities 
in MS than VEPs to checkerboard stimulation and 
SEPs.
Posterior Fossa Tumours: Meningiomas and acoustic 
neuromas impinging on the brainstem, will produce 
BAER abnormalities. Acoustic neuromas are often 
diagnosed using BAER and CT scanning. Wave I is 
frequently absent, or of increased latency. The 
following waves are often grossly abnormal or 
absent. BAER recording has been used for 
intraoperative monitoring during surgical resection 
of acoustic neuromas, [Grundy, Jannetta, Procopio, 
1982] .
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PHARMACOLOGICAL 
Inhalation Agents 
1. Nitrous Oxide
Rosenblum and co-workers (1982) reported no change in the 
latency of waves I, III, V of the BAER with addition of 70% 
nitrous oxide to enflurane anaesthesia in normal patients. 
However, in patients with certain forms of peripheral 
hearing impairment, the absolute latencies of BAER may be 
increased by the presence of nitrous oxide. This probably 
results from the diffusion of nitrous oxide, causing an 
increase in middle ear pressure and resultant conductive 
hearing deficit.
Thornton and colleagues (1983) showed that concentrations of 
up to 50% nitrous oxide did not alter BAER latencies, 
[Thornton et al, 1983].
Sebel and co-workers (1984) confirmed the earlier findings 
of Thornton and colleagues, that concentration of up to 50% 
nitrous oxide given to healthy volunteers did not alter BAER 
latencies. But SEP and VEP amplitudes were reduced in a 
graded manner following administration of nitrous oxide and 
this must be borne in mind when evaluating EP recordings 
during anaesthesia, [Sebel, Flynn, Ingram, 1984].
As the effects on latencies and amplitudes seen with 
increasing concentrations of enflurane were graded, these 
were not due to the constant concentration of nitrous 
oxide. Nitrous oxide equilibrates to 95% of inspired
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concentration in the brain within 10 minutes of the start of 
inhalation and all the data collected in their analyses were 
collected after this time. The graded effects on wave 
latency and amplitude also reversed as enflurane was 
discontinued and the patient maintained in a constant 
environment of nitrous oxide.
Manninen and colleagues (1985) endorsed the work of the last 
two groups of investigators by showing that the addition of 
50% nitrous oxide had no effect on BAER during isoflurane 
anaesthesia, [Manninen, Lam, Nicholas, 1985].
2. Halothane
Duncan and others (1979) investigated the effects of 
halothane on BAER in children. They reported that halothane 
did not influence BAER in children, [Duncan, Sanders, 
McCullough 1979]. This study has been criticised for the 
lack of a control group.
Thornton and co-workers (1984) observed a graded effect of 
halothane on BAER latencies, [Thornton, Heneghan, James,
1984]. Others have also reported a graded increase in 
latencies of BAER with halothane in adults. With increasing 
end-tidal concentration the latencies of waves I, III, V 
increased, as did the IPL I-V and III-V and I-III. The 
amplitude of wave V decreased significantly. They noticed a 
recovery in latencies of waves III and V in two of the four 
patients who received halothane during withdrawal of the 
agent, [James,Thornton,Jones, 1982].
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3. Enflurane
Enflurane administrated at concentrations of 0.5-3%, 
significantly increased the latencies of peaks III, IV, V as 
well as the IPL I -V, [Dubois et al 1982].
Similar results have been reported by Thornton and co­
workers suggesting that the latencies of wave I, III, and V 
and IPL I -V and III -V increased in a graded manner in the 
brainstem response with increasing concentrations of end- 
tidal CO 2 . The graded fashion in which the latencies 
changed with increased end-tidal enflurane concentration 
suggested that these changes were due to the enflurane and 
not nitrous oxide, [Figure 3]. The changes also reversed 
with the removal of enflurane, although a constant 
environment of nitrous oxide was maintained, 
[Thornton et al, 1983].
Rosenblum and co-authors failed to show an effect of 
enflurane on BAER latencies. In this study the measurements 
were made while surgery was in progress, 
[Rosenblum, Gal, Ruth, 1982].]
Thornton and co-investigators investigated the effects of 
surgery on the early cortical AER and noticed that the 
amplitudes of waveforms were affected by anaesthetic 
concentration and surgical stimulation,[Thornton et al, 
1988]. Although the effect of surgical stimulation on BAER 
is not known, during light anaesthesia at 1.5% enflurane, 
the AER may return to normal in response to surgical
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Figure 3. Average BAER for one subject, before anaesthesia, 
following induction and at different concentrations of end- 
tidal enflurane (vols %).The vertical line indicates the 
position of waves I,III and V at the lowest enflurane 
concentration.
Reproduced from Thornton C, Catley DM, Jordan C, Lehane JR, 
Royston D, and Jones JG. Enflurane anaesthesia causes graded 
changes in the brainstem and early cortical auditory evoked 
response in man. British Journal of Anaesthesia 1983; 
55:479 - 485.
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stimulation, [Thornton et al, 1984].
Burchiel and co-workers demonstrated that AER amplitudes 
increased 3-5 fold at normocapnia (P^C02 = 40±5mmHg) with 
various enflurane concentrations. The introduction of 
hypocapnia(P^CO2=20±5mmHg)and enflurane, caused a 30-50 fold 
increase in amplitudes of AER over awake values. At relative 
hypercapnia (P^C02=65±lOmmHg) no spike-wave EEG discharges 
could be elicited unlike hypocapnia, and a progressive 
decrease in AER amplitudes was observed. These two reports 
give evidence of the generalised cerebral hyperexcitability 
reported with enflurane anaesthesia,[Burchiel et al, 1975].
4. Isoflurane
Manninen and colleagues (1985) investigated the effects of 
isoflurane on the BAER, so that intraoperative BAEP changes 
during neurosurgery could be interpreted. The BAER was 
examined in ten healthy volunteers during normothermic, 
normocapnie and normotensive conditions.
BAER were recorded at awake control, end-tidal isoflurane 
concentration of 1%; 1.5%; and 2%. Nitrous oxide was added 
at a concentration of 50% at each isoflurane concentration. 
Isoflurane increased the latencies of peaks III, IV, and V 
significantly above awake control levels. The addition of 
nitrous oxide did not influence these findings. The increase 
in latencies occurred at 1% end-tidal isoflurane and no 
further increase was noted after 1.5%. Similar changes were 
noted for the interpeak latencies, but nitrous oxide did not
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influence these findings. No consistent change was observed 
in the amplitude. They concluded that any prolongation of 
peak V latency beyond 1msec from awake control would have to 
be explained by factors other than a direct effect of 
isoflurane eg effect of retractors, hypotension, or 
ischaemia, [Manninen, Lam, Nicholas, 1985] .
Schmidt and co-workers (1986) looked at the effect of 
increasing end-tidal isoflurane concentration from 0.6%-2.4% 
on the BAER. The latencies of waves I, III, and V increased 
in a dose -related fashion. No indication of the actual 
concentration at which waveforms changed was given. The 
amplitude of wave V decreased with increasing isoflurane 
concentration. The authors commented on the increase in BAER 
latencies resulting from a non-specific influence of 
isoflurane on central conduction, through either enhancing 
inhibitory effects or depressing excitatory transmission in 
synaptic regions, [Schmidt, Chraemmer-Jorgensen, 1986].
Sebel and co-authors (1986) studied the effects of 
isoflurane on BAER in six patients. There was no consistent 
change in the latency of wave I, which was often difficult 
to identify. The latencies of waves III and V increased with 
increasing concentration of isoflurane. There was no change 
in the amplitudes of peaks III and V. The addition of 
nitrous oxide did not alter the BAER, [Sebel, Ingram, Flynn
1986] .
Heneghan and colleagues (1987) examined the effects of 
isoflurane (0.6-2.9% end-tidal) on the auditory evoked
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response. Confirming the work of other authors, they found 
that with increasing concentrations of isoflurane the 
latency of brainstem waves III and V increased, as did the 
interpeak latency of I -V, [Heneghan et al, 1987].
Both Thornton (1983),(1984) and Heneghan (1987) with their 
respective co-workers have shown that isoflurane , halothane 
and enflurane have similar effects on the brainstem AER in 
contrast to that of the intravenous induction agents 
etomidate [Thornton et al, 1985] and Althesin [Thornton et 
al, 1986], which have no effect on the BAER, but produce a 
profound effect on the early cortical waves. These two 
agents are noted for their minimal effect on respiratory and 
cardiovascular homeostasis. Thornton and co-authors 
suggested that this may be related to their minimal effects 
on the brainstem and thus brainstem auditory evoked 
potentials, [Thornton et al, 1985].
Other Drugs
Samra and co-workers, ( 1985) looked at the effect of 
scopolamine and morphine on the BAER in monkeys. Although 
the scopolamine produced clinical and cortical EEG effects 
on the CNS, it failed to have any effect on either the 
absolute or IPL latencies or the amplitudes of the BAER. The 
combination of morphine and scopolamine caused no change in 
absolute or IPL latencies or amplitude of the BAER. Others 
cited showed that cholinergic drugs had more effect on the 
late components of the AER, rather than the early
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components,[Bhargara, Salamy, McKean, 1978] [Samra et al, 
1985] .
Samra and colleagues (1984) showed that large doses of 
fentanyl had no effect on the BAER, [Samra et al, 1984].
Various authors have shown that barbiturates have no effect 
on the BAER, even when obvious changes in the spontaneous 
electroencephalogram are recorded [Newton et al 1983]; 
[Stockard et al 1977]; [Duncan, Sanders, McCullough, 1979].
Drummond and co-authors (1985) examined the effect of high 
dose sodium thiopental on BAER in humans. They used an 
infusion in excess of the time needed for the EEG to become 
isoelectric and showed progressive and significant increases 
in latencies of Waves I,III V and in the IPL I-III, III-V, 
and the I-V. The amplitudes of the BAER were not 
significantly altered. The authors concluded that the 
administration of a dose of STP in excess of twice that 
required to produce an isoelectric EEG can be compatible 
with effective monitoring of BAER, [Drummond, Todd, Hoi Sang
1985] .
Page No 4 7
CORTICAL AUDITORY EVOKED RESPONSES 
I THE MIDDLE LATENCY AER
MLAEPs are very sensitive to sonomotor responses which 
obscure them, therefore it is important to have the 
patient's neck muscles relaxed. Recordings are usually made 
between electrodes on vertex and ear or mastoid. Only one 
channel is used since MLAEPs to monaural stimuli recorded 
from the two sides of the head do not differ from each 
other. The amplification requires a gain almost as high as 
that of BAEPs because MLAEPs are only slightly larger than 
BAEPs. The low frequency filter is usually set at about lOHz 
to avoid distortion of slow components. High frequency 
filters settings of less than 150Hz may distort amplitude 
and latency of the MLAEP. Sweep length is usually about 
100msec. This results in a dwell time of about lOOmicrosec 
per point, or a sampling rate of about lOHz, for the usual 
average having 1024 points per channel. Usually 1000-2000 
responses are collected.
The MLAEP or early cortical AEP consists of several peaks of 
up to over one microvolt which occur 10-50msec after the 
stimulus, [Figure 1]. The MLAEP may show up to five peaks of 
negative and positive polarity at the vertex:
Nq at 8-10msec 
Pq at 10-13msec 
N^ at 16-30msec
Pg^ at 30-45msec usually the largest
Nj^  at 40-60msec.
A sixth peak Pj^ , at 50-90msec, is often found in recordings
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including the first 100msec after the stimulus and 
represents the early peak (PI) of the late cortical AEP. A 
decrease of stimulus intensity reduces the amplitude and 
increases the latency of the MLAEP. The MLAEP has a wide 
distribution with a maximum over the frontocentral areas. A 
generator for the MLAEP near the auditory cortex has been 
postulated and is supported by direct recordings from the 
surgically exposed temporal cortex.
The active electrode is positioned on the mastoid and the 
reference on the vertex, the latter being the midpoint 
between inion and nasion.
Picton and colleagues (1974) noted that tension in scalp 
musculature profoundly alters MLAEP recordings, [Picton et 
al 1974]. Four separate muscle reflexes have been 
described ; the posterior -auricular reflex, the frontalis 
reflex, temporalis, and the inion (neck muscle). Picton and 
colleagues (1974) attributed the middle latency components 
of the AER to be largely due to potentials originating in 
the auditory thalamus and cortex. The Pa response overlaps 
the inion sonomotor response.
STIMULUS CHARACTERISTICS
Although clicks and high frequency tone bursts are the most 
effective stimuli, tone pips and filtered clicks are often 
used. The response seems to depend as much on the sudden 
onset of the stimulus as on its frequency. Stimuli with a 
short rise time are more effective than stimuli with more
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slowly increasing amplitude.
With decreasing stimulus intensity the components of the AER 
decrease in amplitude and increase in latency, amplitude 
changes being more apparent for the middle and long latency 
components. Higher rates of stimulation decrease the 
amplitude of the components.
FACTORS WHICH AFFECT THE MLAEP
PHYSIOLOGICAL
1 .Sleep
The middle latency component is stable to changes in the 
subjects level of arousal. Due to attenuated reflex 
muscle tension, better recordings can be gained with the 
subject asleep rather than voluntary relaxing the 
muscles.
2. Attention
Picton and Hillyard (1974) showed that there was no 
significant change in the AER prior to the N1-P2 
components, when attention is directed towards auditory 
stimuli in order to perform a difficult loudness 
discrimination.
3 .Age
The latency of MLAEP peaks decreases only slightly 
between infancy and adulthood.
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PATHOLOGICAL
1.Neurological
MLAEPs are used infrequently in the diagnosis of 
neurological disease. When used in combination with 
BAEPs, they have been reported to increase the incidence 
of abnormal findings in multiple sclerosis.
2.Ear Diseases
The usefulness of MLAEP has not yet been convincingly 
proved. The relationship between MLAEP and hearing 
threshold is very variable, and the frequent problem of 
muscle artifact in tracings makes this test less than 
ideal as a hearing test especially in young children.
PHARMACOLOGICAL
Mild sedation does not alter the MLAEP. [Mendel et al, 
1975]; [Skinner, Shimotoa, 1975]
1.Nitrous oxide / Enflurane.
The latencies of Pa and Nb increase with increasing end- 
tidal enflurane concentrations in a mixture of oxygen 
and 70% nitrous oxide,[Figure 4]. Waves Pa and Nb show 
linear decreases in amplitude with increasing enflurane 
concentration. Although the nitrous oxide might exert an 
effect on latency and amplitude, the GRADED effects are 
unlikely to be caused by this agent. As the 
concentration in the brain of nitrous oxide equilibrates
with respect 
to vertex0.5.il V
Before
anaesthesia
After
induction
0.32
0.85
" D
UJ
1.22
20 40
Time (ms)
60 80
Figure 4 . Averaged MLAER for one subject, before 
anaesthesia, following induction and at different 
concentrations of end-tidal enflurane (vols %).Amplitude 
measurements of Pa indicated by vertical line. Reproduced 
from Thornton C, Catley DM, Jordan C, Lehane JR, Royston D 
and Jones JG. Enflurane anaesthesia causes graded changes in 
the Brainstem and early cortical auditory evoked response in 
man. British Journal of Anaesthesia 1983; 55: 479-485.
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by ten minutes after the start of inhalation, all 
Thornton's data were collected after this time. The 
amplitude of Pa and Nb decreases with increasing end- 
tidal concentration of enflurane to the point at 1.22% 
when they are nearly abolished,[Thornton et al, 1983]. 
These authors also concluded that after STP induction 
and the start of oxygen and nitrous oxide anaesthesia, 
there were no significant changes in the values of Pa 
and Nb from the awake values.
The effect of increases in carbon dioxide tension were 
associated with only small changes in the AER in this 
paper. The posterior-auricular response is a problem 
during consciousness, although it is less prominent at 
the inion than mastoid sites.
2.Halothane
The latency of waves Pa and Nb increases with increasing 
doses of both end-tidal halothane and enflurane. On 
withdrawal of these agents, waves Pa and Nb show partial 
recovery, [Thornton et al, 1984].
3.Isoflurane
Heneghan and colleagues (1987) examined the effect of 
isoflurane on the auditory evoked response in man. They 
looked at six patients before elective surgery. 
Isoflurane produced reductions in amplitude and 
increases in latency of the cortical waves Pa and Nb, 
and increases in the latency of brainstem waves III and
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V. When isoflurane was compared with halothane and 
enflurane using a MAC-based comparison, they found no 
differences in the effect of the three agents on the 
amplitude of the early cortical waves, although the 
latencies showed significant differences. They concluded 
that all the anaesthetics studied by these workers so 
far have a dose-related effect on the cortical part of 
the AER, whereas some spare the brainstem. These 
observations, together with studies of regional brain 
metabolism, lead these authors to believe that loss of 
consciousness in anaesthesia may be more closely related 
to depression of cortical rather than brainstem 
function, [Heneghan et al, 1987]
Madler and co-workers (1991) showed a graded and 
statistically significant increase in both Pa and Na 
latencies with isoflurane. They detected an increase in 
the short latency brainstem potentials (wave V) only 
between the awake state and 0.3% isoflurane, [Madler et 
al, 1991].
Newton, Thornton and Konieczko (1992) assessed the AER 
(MLAER) and awareness using sub-MAC concentrations of 
isoflurane. Amplitudes decreased and latencies increased 
progressively with increasing anaesthetic concentration. 
Amplitudes were greatest and the latencies shortest when 
there was full response to command. These authors noted 
that the fine gradations in behavioural changes that
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they expected were not shown, the loss of conscious 
awareness being an all-or-none phenomena rather than 
gradual. The 0.2MAC level produced the most interesting 
changes. The study group consisted of anaesthetists who 
may have been aware of the smell and likely effects of 
anaesthetic gases.
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II THE LONG-LATENCY AUDITORY EVOKED RESPONSE
Recording of the long-latency AER requires the subject to be 
relaxed and alert. The LLAEP is reported to be changed by 
factors such as sleep, [Kevanishvili, Von Specht, 1979]; 
[Mendel, Hosick, and Windman 1975]; [Ornitz and Ritvo 1967]; 
[Rapin, Schimrael, 1972], sleep deprivation [Gauthier and 
Gottesraann, 1983]; [Pressman, Spielman, Poliak, 1982] and 
changes of attention [Goodin, Squires, Starr, 1983]; 
[Picton, Hillyard, 1974]; [Salamy, McKean, 1977]; [Schwent, 
Hillyard, 1975]; [Schwent, Hillyard, Galambos, 1976].
Myogenic components are unlikely to obscure LLAEPs therefore 
relaxation of scalp and neck muscles is not necessary.
Stimuli are usually tone bursts of 250-2000Hz, given with a 
gradual rise over a time of 25-50msec and a plateau of 30- 
50msec and repeated at a rate of 0.5-2/sec. Recordings are 
made in a single channel between vertex and mastoid. 
Displacement of the vertex electrode by up to 6cm does not 
change the response. Amplification is not as high as for 
BAEPs or MLAEPs because LLAEP amplitude is higher, ranging 
from 1-1Omicrovolts. Filter settings that include a 
bandwidth of 0.2-lOOHz are ample. The sweep length is 
usually about 500msec. Only about 30-100 responses need to 
be averaged for one LLAEP.
The LLAEP has an inconstant vertex-positive peak PI at 50- 
70msec, a fairly large negative peak N1 at 100-150msec, and
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a positive peak P2 at 170-200msec,[Figure 1].
The prominent N1-P2 complex is usually followed by a 
negative peak N2. A third positive peak P3 at about 300msec, 
depends on cognitive processes rather than the stimulus. 
Long tone stimuli cause a sustained negative potential shift 
with a delayed onset.
The amplitude of the LLAEP decreases and its latency 
increases with increasing stimulus rate, with increasing 
stimulus rise time, and with decreasing stimulus duration. 
Similar changes occur with decreasing stimulus intensity, 
especially near threshold, and more so for clicks than for 
tone stimuli. Tones of low frequency elicit larger LLAEPs 
than high tones of equal sensation level, and the amplitude 
of LLAEPs to low tones increases more with increasing 
stimulus intensity than does the amplitude of LLAEPs to high 
tones. With increasing stimulus intensity, the LLAEP reaches 
a maximum after which a further increase of intensity may 
cause a decrease of amplitude. Latency does not depend on 
the tonal frequency of the stimulus.
The LLAEP has a wide distribution with a maximum at the 
vertex.
The distribution varies with stimulus frequency. Responses 
recorded from the side opposite the stimulated ear are 
slightly larger.
1. Age
In neonates, the LLAEP is quite variable and depends on the
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sleep stage. The variability decreases with age. the latency 
decreases and the amplitude increases, mainly during the 
first year of life. In adult and elderly subjects, LLAEP 
latency increases and amplitude decreases.
2. Neurological Disease
Multiple sclerosis produces abnormal LLAEPs. The following 
authors stated that the LLAEP could predict severity and 
outcome in head injuries [Greenberg, Newlon, Hyatt, 1981]; 
[Greenberg, Becker, Miller, 1977]; [Karnaze, Marshall, 
McCarthy, 1982]; [Lindsay, Karlin, Kennedy, 1981].
Spehlmann (1985) states that strokes and tumours in the 
frontoparietal region, but not in the frontal region, reduce 
the NlOO waveform.
Both alcohol and diazepam alter the LLAEP [Wolpaw, Penry, 
1978], [Herrmann, Hofmann, Kubicki, 1981].
COMPONENT STRUCTURE OF THE NlOO WAVEFORM
Nââtànen and Picton (1987) reviewed the literature on the 
component structure of the NlOO wave. They stated that six 
different cerebral processes contributed to the N1 wave of 
the scalp-recorded AEP, [Nààtànen, Picton, 1987].
The first three could be considered as true NlOO components, 
the other three often exist in the latency region of the N1 
wave but may occur independently.
Component 1 is generated in the cortex of the supratemporal
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plane [Vaughan, Ritter, 1970]. This component which has a 
peak latency at 100msec, is maximally recorded from the 
frontocentral scalp and may be enhanced by attention through 
some thalamocortical gating mechanism, demonstrated by 
magnetic recordings.
Component 2 is a biphasic component with a positive wave at 
about 100msec and a negative wave at approximately 150msec 
[Wolpaw, Penry, 1975]. It is generated on the superior 
temporal gyrus and is recorded from the scalp with a maximum 
amplitude at the midtemporal electrodes. This component is 
not picked up magnetically and is probably generated in the 
auditory association areas, activated by connections from 
the primary auditory cortex and also possibly the thalamus.
Component 3 is a vertex negative wave with a peak latency of 
approximately 100msec. The generator of this component is 
not known but is possibly from the frontal motor and 
premotor cortex under the influence of the reticular 
formation and thalamus. It is recorded from the scalp with 
maximal amplitude at the vertex and the lateral central 
electrodes.
Component 4 is the negative deflection, generated in the 
same area of the brain as component 1.
Component 5 is the negative waveform which is specific to a 
sensory stimulus. This begins at approximately 50-100msec 
and lasts during the processing of an attended auditory 
stimulus, being generated in the auditory sensory and
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association areas on the supratemporal plane and on the 
lateral aspects of the temporal lobe.
Component 6 is the "attentional supervisor” a second 
component of the processing negativity which is probably 
generated in the anterior frontal cortex since it receives 
information from the auditory association cortex.
Naàtanen and Picton also attempted to consider the 
functional significance of the first three components of the 
NlOO waveform. For component 1 they considered three 
possible functions for the neurons that are activated during 
the generation of component 1 of the N1 wave. The neurons 
may act to call attention to the availability of a stimulus, 
to read out sensory information from the auditory cortex, or 
to form a sensory memory of the stimulus within the auditory 
cortex. They could not describe any function of component 2, 
generated in the auditory association cortex on the lateral 
temporal lobe due to a lack of available data. Component 3 
they stated probably evolved from an extensive cerebral 
mechanism that functions to produce a widespread transient 
arousal of the organism. This arousal response enhances 
sensory and motor responses to the eliciting stimulus, 
causing the organism to be in a more efficient functional 
state. Component 3 also serves some aspects of detection and 
perception by alerting sensory association and motor cortex 
when a stimulus occurs after a period of quiescence.
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EFFECTS OF ATTENTION ON THE NlOO WAVEFORM
The NlOO wave is susceptible to three different modulations 
of the general state to the individual: [Nââtànen, Picton,
1987]
1. arousal due to sleep-wakefulness state, drugs and 
alcohol, circadian rhythms, and involvement in task 
performance.
2. a sensory acceptance-rejection factor which may enhance 
responses to all sensory inputs during expectancy for 
important, interesting or pleasant stimuli, and attenuate 
responses elicited during expectancy for irrelevant, 
uninteresting or unpleasant stimuli
3. the degree of time uncertainty with regard to the next 
significant stimulus. These nonspecific influences probably 
have more effect on component 3 than on the first two 
components.
Nââtânen and Picton (1987) stated that early experiments 
suggested that the NlOO wave of the auditory EP was larger 
when the subject was attending to a stimuli than when 
ignoring them. They decided on two effects that may increase 
the NlOO amplitude
a) prior uncertainty about stimulus timing
b) prior preparation for performing a demanding task.
They went on to suggest that in selective attention 
experiments, the timing of the attended and ignored stimuli
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was made unpredictable (thereby eliminating the possibility 
of selective prior preparation), there were no attention- 
related changes in the NlOO although there were problems in 
these experiments with the rate of delivery of stimuli. In 
summary, they concluded that auditory selective attention 
causes the superimposition on the NlOO wave of a processing 
negativity, consisting of two components (5 and 6 ) that 
overlap the true NlOO components. It is possible that under 
certain conditions attention may selectively enhance a true 
NlOO component, as suggested by [Hillyard, Hink, Schwent 
1973]. The enhanced component probably being the 
supratemporal component (component 1).
Attention is accompanied by a general and nonspecific 
increase in cerebral excitability which might increase the 
amplitude of the NlOO wave. Hillyard and co-authors 
suggested that the effects of arousal are mediated in the 
brain by the same processes that underlie the enhancement of 
the NlOO with selective attention. Picton and colleagues 
(1979) suggested that it is "probably impossible to change 
levels of arousal in the waking state independently of any 
attentional change." During increased states of arousal 
subjects usually increase their alertness or general 
attentiveness to the external world, [Picton, Ouellette, 
Hamel Smith, 1979].
Nààtànen and Picton (1987) indicated that various authors 
had published conflicting results on the effects of sleep on 
the NlOO waveform, some reported a decrease in amplitude
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while others reported no change.
The late components of the AER are affected by sleep. The 
NlOO component becomes attenuated during sleep and the 
addition of a large negative wave with a peak latency of 
300msec, called the N2 or sleep N2 wave, is present during 
the non-REM stages of sleep early in the night. Nâtâànen and 
Picton cited other authors who suggest that this wave is 
due to an excitatory phenomenon associated with unsuccessful 
attempts at arousal or an inhibitory wave preventing 
awareness.
They concluded that there is some evidence for task- or 
attention-induced stimulus-nonspecific increases in the 
excitability of some neurons which contribute to the NlOO 
deflection, causing the NlOO amplitude to be larger when the 
subject is occupied in some task, also the amplitude being 
larger in a demanding rather than less demanding task. While 
performing a continuous task, if the subject can predict 
the timing of delivery of the stimuli above the random 
chance level, these moments will be preceded by an 
excitability increase which causes the NlOO amplitude to 
relevant stimuli to be bigger than that elicited by the 
irrelevant stimuli. This increase in excitability may be due 
to a general increase in sensory sensitivity which might be 
independent of arousal, the brain possessing a general gain 
control over its own sensory input.
CHAPTER THREE
ANAESTHESIA AND PSYCHOMETRIC TESTING
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PSYCHOMETRIC TESTING AS USED IN ANAESTHESIA
Rapid and complete return of normal psychomotor and memory 
function are essential features of methods for dental 
sedation and anaesthesia for day case surgery. A review of 
the literature demonstrates that there are many methods for 
testing psychomotor recovery from anaesthesia. Unfortunately 
none of these tests are standardised and therefore it is 
difficult to evaluate one test and its ability to measure 
recovery, compared to another test.
Tests for recovery can be divided into various classes as 
described by Hindmarch and Bhatti, 1987. These are memory, 
intelligence, psychomotor function, attention and those that 
measure physiological characteristics.
1. Memory
Memory impairment may prevent the ability of patients to 
recall advice on ability to drive and drink alcohol and can 
be tested by asking patients about their spatial orientation 
and memory for recent events as used in normal neurological 
examination. The staff working with these patients may be 
able to assess their ability with regards to performance. 
Tasks to assess ability for the learning of new information 
and the retention of this information eg Wechsler's memory 
scale, are also available.
2. Intelligence tests
Tests such as the Wechsler adult intelligence scale are used
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for the testing of intellectual function, [Blundel 1967, 
Riis, Lomholt, Haxholdt 1983].
3. Tests of attention
Alteration in attention can be measured using an 
uninteresting, lengthy, boring task eg the letter deletion 
task in which the patient is presented with a foolscap 
sheet containing closely spaced letters, the patient being 
required to delete the letter p in a specified time. The 
number of letters deleted being measured and the number of 
errors,[Dixon and Thornton 1973].
4.Psychophysiological measures of recovery
The electroencephalograph records electrical potentials from 
the scalp. However problems exist with interpretation.The 
Maddox Wing measures the balance of extraocular muscles and 
gives a sensitive indication of the rate of recovery from 
general anaesthesia. The natural position of rest for the 
eyes is in divergence with a slight upward displacement and 
the maintenance of normal vision is an active process, 
depending on the degree of tone in the medial rectus 
muscles. The reduction in general muscle tone with general 
anaesthesia causes divergence of the eyes which can be 
quantified by using the Maddox Wing.
5. Psychomotor function
Psychomotor tests used commonly in the assessment of 
performance are the post-box; the peg-board; simulated 
reaction time and critical flicker fusion.
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In the post-box test patients are required to post as many 
shapes as possible through the lid of a child's post-box 
within a specified time limit.
The peg-board test contains a board with two sets of 48 
holes, one set of which was filled with tight fitting pegs. 
The subject was required to transfer as many pegs as 
possible to the other set of holes. The score was recorded 
in 45 seconds.
I Simulated driving tasks involve tracing shapes or drawing a
I pathway out of a maze without coming into contact with any
I of the edges. Computerised models also exist, reflecting
hazards that are met when driving, measuring brake reaction 
time or number of accidents etc, [Hakkinen 1976].
The critical flicker fusion test (CFFT) involves the use of 
an intermittent light whose flicker rate is increased or 
decreased within specified limits. As the frequency of 
flicker increases, a point is reached when it is perceived 
as continuous, this point being termed the flicker fusion 
threshold. When the intermittent light is observed as the 
frequency of flicker decreases there will be a point when 
the light that initially appeared constant begins to 
flicker, the fusion flicker threshold. Usually the mean of 
three ascending and three descending trials is accepted. The 
test has been shown to give a sensitive measure of central 
processing of perceptual information in a study conducted by 
[Moss, Hindmarch, Pain et al 1987].
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CFFT was shown to discriminate between different anaesthetic 
agents 19 hours after awakening. The scores on the two other 
tests; choice reaction time test (CRT) and Maddox Wing test 
both had returned to baseline earlier than those of the CFF 
test. Hindmarch (1980) concluded that critical flicker 
fusion threshold is the assessment of choice for 
investigation of change in the overall integrative activity 
of the CNS produced by psycho-active drugs, and that CRT is 
a verv sensitive measure of drua-induced chances in sensori­
motor performance, particularly if it is split into its 
motor and recognition components.
STREET-FITNESS
Due to economic considerations day-case surgery is being 
used more. Anaesthesia for day-case surgery requires the 
patient to be "street-fit" before discharge. This can be 
defined as a state in which cognitive and psychomotor 
skills are sufficient to permit the subject to indulge in 
everyday pursuits without hazard to themselves or others. 
Drowsiness may be associated with an impairment of attention 
and there is evidence that this occurs not as a stable 
phenomenon but in an episodic fashion. For most of the time 
a subject with lowered arousal will attend adequately to 
stimuli. But on occasion, performance will fall off 
markedly. The periods of inattention are associated with 
changes in the EEG, and are variously referred to as blocks, 
involuntary rest pauses of microsleeps [Bills 1931]. The 
frequency of such blocks, is increased by a number of
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factors that impair arousal, in particular, sleep 
deprivation and during prolonged repetitive tasks.
STANDARDISATION OF TESTS.
In 1989 NATO published a report describing the need for 
standardisation in the use of psychomotor tests, with the 
aim of introducing a more systematic approach to performance 
testing. The major applications of performance tests in 
military fields is for selection of personnel and research 
work into stress psychology. This working group produced a 
register of tests, and developed a protocol for the use of 
these tests with a proven record of success in stress 
research. In anaesthesia such tests are used to assess 
recovery profiles from drugs and to attempt to ascertain 
fitness for discharge of patients after surgery.
Human performance tasks can be used to evaluate the effects 
of environmental stressors, or to assess the information 
-processing abilities of individuals. Stressor effects are 
tested in comparison to control conditions eg the use of 
drugs, alcohol, illnesses, fatigue etc. The goal is to 
assess how the extent to which a particular stressor 
influences performance in real-life situations eg the 
effects of drugs used in day-case anaesthesia on the ability 
to drive a car.
In the use of performance tasks to assess information- 
processing abilities, the comparison is between individuals. 
Performance tests in laboratory conditions have to relate to
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real-life situations, but it is of course difficult to 
assess whether they do or not. When examining the effects of 
stressors, performance should vary markedly when 
environmental conditions change, but the variation due to 
individual differences should ideally be small. To assess 
individual ability, tests should be insensitive to 
variations in environmental conditions but sensitive to 
individual differences.
A general idea underlying most models of information- 
processing in man is of a single information-processing 
system equipped with memory stores eg Perception - Decision 
- Action model shown below.
PERCEPTION ] ECISION
ACTION
Various authors state that the primary failing in studies 
into recovery characteristics, is that the psychomotor tests 
used, have not been standardised. Furthermore they tend to 
measure several psychological functions simultaneously. When 
performance shows impairment it may be unclear which of 
these functions is affected, [Jones 1988] and 
[Zuurmond,Balk,van Dis, 1989].
Parrott attempted to establish a method of reliability, 
validity and standardisation of performance tasks for 
clinical use, [Parrott 1991,1991].
Page No 68
The establishment of the Recovery Interest Group may help to 
promote the use of sensitive and standardised tests.
BASELINE-PRACTICE EFFECTS
The reliability of a psychometric test is affected by 
practice. Performance improves until a "plateau" is reached 
ie the learning curve. Tests which are sufficiently 
sensitive to detect the presence of impairments, not 
clinically obvious, are often subject to practice effects. 
By giving patients a sufficient amount of practice they will 
overcome the steepest part of the learning curve.
At a later point a more refined learning may develop where 
there is a transition from "controlled" to "automatic" 
processing, during which time the amount of mental resources 
required to perform the task declines. If the test fails to 
provide consistent scores even after learning it may not 
measure adequately the attribute that it is designed to 
measure, [AGARD 1989].
Millar (1991) described that in the majority of papers 
written, the methodical details given, suggest that 
insufficient practice is usually provided. Figure 5 
illustrates the concept of a practice effect. Lack of pre­
training leads to the control group showing a distinct 
improvement in performance. The thiopentone and 
methohexitone groups will consequently be more grossly 
impaired than is evident in the graph.
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FIGURE 5. Mean reaction times of control subjects (squares), 
thiopentone subjects (circles) and methohexitone subjects 
(triangles) before, and at various times up to 24hrs after 
anaesthesia and surgery. Notice the decrease in reaction 
time with practice in the control group.
Reproduced from Scott WAC, Whitwam JG, and Wilkinson RT. 
Choice reaction time - a method of measuring postoperative 
psychomotor performance decrements. Anaesthesia 1983; 38; 
1162-1168.
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Herbert (1989) shows that in many studies recovery is 
assessed as a return to baseline (preanaesthetic) tests of 
psychomotor tests. This he suggests will bias the results if 
the effect of practice has not been adequately excluded. 
Methods to overcome the effects of practice:-
1. Prepractice sessions
2. Tests which are not subject to practice effects, but 
they may be too insensitive to show changes.
3. Include an untreated control group to allow practice 
effects to be assessed.
Motivational factors can affect the results in performance 
studies. The intentions of.volunteers, the level of payment 
and the expectations of the experimenter and subject can all 
have a profound influence on experimental results, [Ayd 
1972].
WITHIN AND BETWEEN-SUBJECT DESIGN.
A major issue in the use of psychometric testing is whether 
a subject should perform in both conditions (within-subject 
design /crossover design) or whether separate groups of 
subjects should be tested in each condition (between-subject 
design).
The benefits of the within-subject design are;
1. Each subject acts as his own control, reducing the 
intersubject variation.
2. Fewer subjects are needed.
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The between-group design gives better reliablity of data 
which is often worthwhile to use even considering the 
disadvantages.
Usually in within-subject designs half the subjects would 
undertake the condition under test initially and half would 
be assigned to the control group initially. This assumes 
that the effect of practice between the first and second 
conditions is identical regardless of which order the 
conditions are administered ie symmetrical transfer. However 
sometimes the initial performance under stress may lead to 
the adoption of inappropriate methods of completing the 
performance test, which may be carried over to the 
subsequent control conditions ie asymmetric transfer effects 
[Poulton and Freeman 1966, Millar 1983, Agard 1989].
Asymmetric transfer refers to the fact that reactions to 
different drugs may vary depending on which drug or 
condition was encountered first, and prior treatment with a 
drug may affect placebo conditions. Millar (1983) stated 
that adverse effects of a drug on the mental abilities of 
volunteers may be much greater in those who have already 
experienced a session under placebo than in those who have 
received the drug condition first and placebo second.
Asymmetrical transfer usually reduces the differences 
between test conditions and may therefore obscure 
potentially interesting findings.
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INDIVIDUAL VARIATION IN RESPONSE.
Many studies of recovery from anaesthetic agents only 
include mean values, omitting standard deviations or error 
ie they show no inter-subject variation, [Grant and McKenzie 
1985]. As some individuals will have been at the extremes of 
these groups, their recovery would probably be incomplete. 
Some authors showed that while most patients recover quickly 
from propofol, some do not recover normal psychomotor 
function until three hours after surgery, [Weightman and 
Zacharias 1987, Sanders 1989.
Others, have included information on variation,[Herbert et 
al 1983, Galletly 1988].
ENVIRONMENTAL CONDITIONS.
Expectations by a subject may affect their performance. 
Although ethically subjects need to be informed of the 
nature of drugs etc in use, the order should not be revealed 
to the subject, so as not to bias their performance, [Agard 
1989].
The laboratory conditions used for psychometric testing are 
usually not available when these tests are used in 
conjunction with anaesthesia. Patients perform these tests 
in the least ideal conditions, initially a busy noisy ward 
just after admission, when they are anxious. They may awaken 
and do the tests in a noisy recovery room.
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A learning curve if established is usually conducted with 
conditions of extreme anxiety, [Eysenck 1981]. Comparison is 
then made with recovery conditions when anxiety levels are 
much less, [Wallace 1987].
Anxiety can affect performance as Hindmarch described in 
his review 1980. He noted that all the following authors had 
shown that anxious patients had significantly lower CFF 
thresholds than age matched 'normals'. [Krugman 1947, 
Goldstone 1955, Jones 1958].
The effects of other drugs may confound studies eg 
antibiotics are known to have adverse effects on human 
learning, due to their effects on protein synthesis 
[Idzikowski and Oswald 1983] or premedicant drugs. Avoiding 
the use of premedication may help to eliminate this cause. 
Generally conditions should be controlled as possible. For 
instance lighting and heating should be controlled to a 
similar level on each day of the study, noise should be 
kept to a minimum. The position of the computer monitor 
relative to windows and light sources should be adjusted to 
avoid reflections on the screen and the distance of 
computer from subject should be constant (the Nato committee 
report, quote a distance of 60cm), [Agard 1989].
IMPAIRMENT.
Impaired performance is a term that is often used in the 
discussion of recovery from anaesthetic drugs. Millar 
(1992) described the problem with this term being a general
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lack of definition when one takes into account the problems 
associated with baseline recording of performance tests eg 
the effects of practice.
Millar (1992) states that investigators have termed 
impairment as a mean difference between the treatment and 
control groups ie beyond the P<0.05 level of significance, 
although a statistically significant difference may be so 
small as to be of no clinical relevance. He continued to 
state that the effect of an anaesthetic may be to make 
performance more variable. This variability may be masked by 
expressing the data as mean values and not median.
He cited the work of [Gardner and Altman 1986] and [Matthews 
Altman, Campbell et al 1990] who suggested that individuals 
whose performance is similar, may be graphed within the same 
subpanel of a multi-panel figure in order to illustrate 
common trends with the group ie confidence intervals.
Matthews and colleagues (1990) suggested that conventional 
measures of performance mask individual variation. But also 
by conducting separate significance tests at each time point 
as is normally the case, and not correcting them for 
multiple comparisons, or timing the points close together 
thus allowing one point to influence other points, another 
source of error is introduced, [Matthews, Altman, Campbell, 
et al, 1990].
A summary measure of performance for each subject can be 
calculated from the area of the graph under the individual
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subjects's performance curve [Matthews, Altman,
Campbell, et al, 1990].
Hickey and colleagues were also quoted, they adopted the use 
of intervals in their study of semantic recognition memory 
performance after propofol anaesthesia. They only assumed 
impairment if the confidence interval did not encompass the 
baseline, [Hickey, Asbury, Millar 1991].
Millar (1991) pointed out that the summary measure method of 
analysis was superior when data was missing, and more 
accurate if time points vary to the nature of hospital life. 
Although time points of maximal impairment may be masked, so 
performance should also be mapped out over time.
Cooper (1984) suggested that 95% confidence intervals on 
either side of average data should be examined.
RECOVERY
The concept of recovery is a difficult to define.
Herbert (1991) described recovery as being a return to the 
baseline performance level. Millar (1992) described this as 
being dependent on a stable baseline performance with the 
effects of practice being overcome. Herbert has emphasised 
the importance of the control group. Only by looking at 
this group can it be shown that "recovery” values ie post 
anaesthetic are the same as baseline, indicating impairment, 
if the control group's performance improves throughout the 
period due to a practice effect.
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TIME ON TASK
The time spent on a task may be one of the most important 
determinants of whether a stressor will show impairment in 
the performance of the individual.
Wilkinson (1969) has suggested that stress effects upon 
performance might be missed if the period was too short.If 
the test is short, a subject can arouse himself to maintain 
performance at a satisfactory level even when severely 
stressed. But if the test is prolonged, this ability cannot 
be sustained. Therefore very short tasks may miss the effect 
of the stress on performance. In the case of day-case 
surgery, subjects may be discharged when their performance 
returns to 'normal' although they are severely impaired.
Herbert (1987) showed that studies of immediate recovery 
from anaesthesia are based on the assumption that once 
performance has returned to pre-anaesthetic baseline levels, 
no further deterioration will occur, therefore tests are not 
extended for more than a few hours postoperatively. Folkard 
and colleagues suggested that if performance is 'naturally' 
poorer at some points of the day, the added effects of the 
drugs, may make patients more vulnerable or influence their 
normal circadian rhythms. Once baseline levels are achieved 
as a measure of recovery the patient may still be impaired, 
[Folkard,Simpson, Glynn 1979].
Zuurmond and co-authors used only three-minute letter
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deletion task and twenty reaction time trials in assessment 
of recovery. Trials like this have to be questioned, when 
the length of the task is so short, [Zuurmond, Balk, van Dis 
et al 1989] .
Millar and colleagues demonstrated this effect when they 
increased the time of a brief performance test to twenty 
minutes, demonstrating by doing this a significant 
impairment caused by the drug brompheniramine, [Millar and 
Standen 1982].
TIME OF DAY.
Hockey and co-authors showed that diurnal rhythm has an 
effect on psychological functioning as the day goes 
on,[Hockey and Colquhoun 1972].
Folkard (1975) stated that performance varies across the 24 
hour period.
Prolonged bedrest may itself have adverse effects on 
performance, [Edwards 1981].
DOSE RELATED EFFECTS.
Millar (1991) states the effects of anaesthesia on cognitive 
and psychomotor performance are difficult to evaluate with 
reference to dose-related effects. Although all doses used 
are in the clinical range, it is difficult to compare dose- 
related effects because all the studies differ in their 
methods - for instance amount of practice, presence or 
absence of control group, time on task, surgical treatment ,
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age of patients and other drugs administered. Nitrous oxide 
seems to show a curvilinear or threshold dose-response curve 
[Allison, Shirley, Smith 1979], [Wernberg, Nielson SF, 
Horamelgaand 1980].
Bruce (1976) demonstrated that small concentrations of 
nitrous oxide may produce significant performance decrements 
although other authors were unable to reproduce 
this,[Smith,Shirley 1978].
PATIENTS PERCEPTION OF THEIR OWN ABILITY.
Egber and colleagues noted that in several instances when 
subjects themselves felt completely recovered, a reaction 
time test showed that they were not back to normal, 
[Egber,Oech, Eckenhoff 1959]. Others have shown that those 
showing minimal performance effects continued to feel 
affected by the anaesthetic. This discrepancy may suggest 
that patients are not the best judges of their fitness for 
normal activity, [Herbert,Makin, Bourke et al 1985].
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CHOOSING A PERFORMANCE TEST.
1. The longer a test lasts the more likely it is to reflect 
impairment.
2. The less challenging the test, the better it is in being 
able to detect performance changes.
3. The larger batteries of tests may be counterproductive ie 
they may raise motivation levels, [Wilkinson 1969].
FEATURES OF A PSYCHOMETRIC TEST.
Psychometric tests should exhibit the properties of
1. Validity ie measure what it is supposed to measure.
2. Reliability - it should measure it consistently eg on re­
testing.
3. Sensitivity - the test should be able to detect 
environmental effects or individual effects to which it is 
sensitive, [Agard'89].
Herbert (1978) described tests as becoming more sensitive 
the more familiar they are, the longer they last, the more 
they demand sustained output or maintained concentration and 
the less if they are perceived as challenging or as novel 
and interesting.
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PROBLEMS OF INTERPRETATION IN PSYCHOMOTOR TESTS.
1. Healthy volunteers versus mixed age.
2. Varying doses.
3. Intra-operative events for instance hypoxia.
4. Use of premedicant and other drugs.
5. The hospital environment.
6. Degree of cooperation of the individual concerned.
Many of the above problems are unresolvable.
PROBLEMS IN THE DESIGN OF EXPERIMENTAL STUDIES.
1. Within-subject group and the problems of asymmetric 
transfer (between group designs better reliability of data).
2. Mean values better replaced by 95% confidence intervals.
3. Return to pre-operative baseline as an adequate criterion 
of postanaesthetic recovery.
4. Once return to unimpaired levels, researchers assume no 
subsequent deterioration. Few studies extend performance to 
the few days after anaesthesia. The added effects of diurnal 
variation and drugs may make impairment reappear. Herbert 
and co-authors, looked at 55 patients for hernia repair who 
were divided into three groups in which the method of 
induction of anaesthesia was varied (iv/inhalation) and 
ventilation (spontaneous/controlled),[Herbert, Healy, Bourke 
et al 1983] .
Performance in 5min serial reaction time and subjective 
estimates of coordination were assessed four times per day
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for two postoperative days. After considerable impairment 
initially, reaction times in all groups gradually returned 
towards control values; however, in patients breathing 
spontaneously during anaesthesia, impairment recurred during 
the second postoperative day.
Herbert and colleagues in a second study using herniorraphy 
patients, tested over two complete postoperative days. 
Anaesthesia was induced with STP or propofol. Compared to 
the control group, thiopental continued to exert adverse 
effects on reaction time into the second postoperative day , 
where propofol had no statistically significant adverse 
consequences at any postoperative measurement 
point,[Herbert, Makin, Bourke et al 1985].
If a test of psychomotor performance is affected by 
anaesthetic agents, then everyday tasks which appear to 
depend upon those abilities are also likely to be affected. 
Millar (1986) states that the degree of familiarity of a 
test may determine how well patients perform after general 
anaesthesia. Everyday tasks with which patients are familiar 
with may be more resistant to the effects of general 
anaesthesia.
Zuurmond and colleagues comment "The choice of psychomotor 
and cognitive recovery tests after anaesthesia is an 
important but difficult issue. Recovery tests should be 
complete, reliable and valid, to permit conclusions to be 
drawn from their results, and cover all aspects,otherwise
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patients may be sent home too soon. Different test 
situations measure different aspects of recovery, but in all 
cases basic cognitive and psychomotor functions must be 
assessed. Recovery tests should be as simple as possible, 
practical and cause the patient minimal strain. Measuring 
identical parameters should be avoided", [Zuurmond,Balk, van 
Dis, 1989].
Kortilla fl986) described the basic functions of psychomotor 
function - perception, coordination, motor function, and 
different aspects of cognition.
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THE CHOICE REACTION TIME
The reaction time can be defined as the speed with which 
people are able to react to the onset of a stimulus.
There are two types of reaction time:-
1. The Simple reaction time in which a response to a single 
stimulus is required.
2. The Choice reaction time in which a response is made to 
varying stimuli CRT. The serial CRT provides no opportunity 
for the subject to rest. The discrete method allows the 
subject to self-pace each trial, as they are required to 
return their hand from the response key to a" home" key to 
indicate readiness for the next signal.
SERIAL CHOICE REACTION TIME
All the papers discussed in the following sections, have 
been summarised in Tables 2,3,4. Factors such as 
randomisation, presence of a control group, time spent on 
each task and the presence of any practice effects can be 
identified from the tables.
Wilkinson (1991) described work done in the mid-50s on 
individuals with sleep deprivation. He noted that highly 
demanding complex tasks were not the most vulnerable to 
sleep loss, but the simple, boring tasks. Complex tasks by 
providing a source of stimulation negated the effect of 
sleep deprivation returning the subject effectively to 
normal. Simple boring tasks which failed to act as a 
stimulus caused accuracy to diminish but speed to be
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maintained.
The original five-choice serial reaction time was developed 
by Leonard (1959). Wilkinson continued this with the above 
factors in mind and it became the foundation of future 
research.
A subject was required to tap one of five discs when the 
corresponding light shone. Once this was completed another 
light would come on in a random fashion. Each test continued 
for twenty minutes with subjects responding as quickly as 
possible. Reaction time increased as the loss of sleep 
increased, as did the number of errors.
From his work on sleep deprivation, Wilkinson used his five- 
serial reaction time test, as a general test of assessing 
arousal experimentally or for use in other research 
projects, [Wilkinson 1975].
The essential features of the unit were a small light, 
portable apparatus to use in various settings. To enable it 
to be more portable, it was battery-powered. Ability to 
store data collected was a feature, as was ability to 
exchange software and compatibility with standard laboratory 
computers. After various redesigns the final product was a 
four-choice RT. The display consisted of four light bulbs 
(light-emitting diodes) producing the stimulus with four 
buttons for the response. The lights lit up in a random 
order, being extinguished when the response button was 
pressed, 120 seconds lapse until the next stimulus occurs.
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Storage of data was on a cassette tape in the form of tones 
- 4kHz for an error, 2kHz or a correct response. Retrieval 
of data was from a standard laboratory computer in the form 
of average reaction time and the number of errors and 
standard deviation.
Kortilla and co-authors (1977), [Table 2, Page 1] assessed 
recovery from anaesthesia in 34 healthy student volunteers, 
using a psychomotor test battery 1 and 5 hours and a driving 
simulator 2, 4.5, and 7 hours after 3.5min of anaesthesia 
with halothane or enflurane combined with nitrous oxide and 
oxygen. Psychomotor performances remained significantly 
(p<0.05 to P<0.001) worse than in an unanaesthetised control 
group for 5 hours after both halothane and enflurane. 
Impairment of driving skills 4.5 hours after anaesthesia was 
measurable only after halothane (P<0.05). It was concluded 
by these authors that after brief periods of halothane or 
enflurane anaesthesia patients should not drive or operate 
machinery for at least 7 hours. The magnitudes and durations 
of the residual effects of both agents on psychomotor 
performance were, however, less than those previously found 
after thiopental, methohexital, or diazepam. Reaction skills 
were measured with two choice-reaction tests. The first 
programme involved subjects having to react to 25 
consecutive light stimuli from two different lights. The 
second programme involved reaction times to 25 stimuli from 
two different lights or sounds. In both programmes there was 
a special light to which the subjects were told not to
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react. The reaction times were recorded as cumulative 
totals, and the inaccuracy of responses were recorded as the 
incorrect responses.
The residual effects of the anaesthetics were seen more 
clearly in the choice-reaction test when two light and two 
sound stimuli with a disturbance stimulus (programme II) 
were used. The improvement in the control group was 
probably due to practice effects, and this implies that the 
deterioration in the enflurane / halothane group is of a 
greater magnitude than expressed. In comparison to other 
psychometric tests the CRT is an acceptable measure of 
impairment post-anaesthesia.
Local anaesthesia has been suggested for outpatient 
anaesthesia due to the lack of effect on psychomotor 
function. Kortilla (1974) assessed psychomotor skills 
related to driving after intramuscular lidocaine. They used 
serial choice reaction time and noted impairment in 
psychomotor skills after 200mg of plain lidocaine. Reaction 
skills and presumably driving ability were impaired for 
0.5 - 1.5hrs after injection.
Kortilla and colleagues in a study of bupivicaine and 
etidocaine showed that despite practice, all improved 
performance with training in control group on the CRT and 
coordination tests, [Kortilla, Hakkinen, Linnoila 
1975],[Table 2,Page 1].
CFFF was significantly impaired with both etidocaine and
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bupivicaine compared with placebo. The tests used assess 
arousal, coordination and reaction times.
No mention is made of total time on each task, which may 
affect performance , if as stated the task was short enough 
to allow a subject to arouse themselves to perform the task 
but not long enough to elicit an element of boredom.
Kortilla (1977) repeated the above experiments; only using 
the local anaesthetic drugs prilocaine or mepivicaine, in 
place of etidocaine and bupivicaine. In contrast to the 
impairment in psychomotor performance caused by lidocaine, 
bupivicaine and etidocaine; mepivicaine and prilocaine were 
noted not to have any effects on the central nervous system, 
and were the preferred agents for out-patient practice. 
Again, despite an hour of training, there was still a 
practice effect on the saline control.
Hakkinen (1976) stated that CRT, coordination and attention 
tests have been shown to correlate with,the ability to 
encounter traffic accidents.
Bruce (1976) used a battery of psychomotor tests to assess 
the effect of trace concentration of anaesthetic gases on 
performance in volunteers. Subjects were allowed 15 minutes 
of practice although no control group was included to assess 
the effect of the practice session. As can be seen from the 
table, the AV reaction time was a sensitive test, and the 
authors suggest the test most closely allied to the 
anaesthetist's work. In view of the lack of control group
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data available and the use of healthy volunteers, it is 
difficult to assess the accuracy of this study.
Smith and colleagues used progressive visual reaction times 
to assess exposure of anaesthetist subjects to either 
halothane 100 - ISOppm in air or air alone, and demonstrated 
no significant difference between control and test 
situations. They also studied 15 psychology students using 
an audiovisual reaction timer and noted no significant 
differences in the subjects responses in other control or 
test situations. Each group was given a practice session 
with the reaction timer, but neither group demonstrated a 
significant practice effect. Volunteers were given caffeine 
to drink, to emulate theatre conditions, and it is known 
that this has a variable effect, both on simple and complex 
reaction times. Two types of choice reaction time were used 
both the serial and discrete forms. The discrete form should 
theoretically be more highly sensitive than the serial. But 
it is possible that it may not be sensitive enough to reveal 
the possible small change in mean reaction time with such 
small trace concentrations of gas. Again in this paper, 
there are a large number of variables such as concentration 
of gases used, type of reaction timer, use of anaesthetic 
and non-anaesthetic staff. With so many variables it is 
difficult to assess one variable against another,[Smith, 
Shirley 1977].
Wernberg and co-authors used a serial visual reaction timer 
to both single and double-handed usage. They compared these
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with a critical flicker fusion frequency test, using nitrous 
oxide in concentrations of 0, 10, 20, and 30%. With the
double-handed method a shortening of reaction time was seen 
at 10% nitrous oxide, the authors described this as being 
due to nitrous oxide at low concentrations facilitating the 
reaction to a stimulus. At 30% nitrous oxide the reaction 
timer (double-handed) was significantly prolonged. The 
single-handed reaction time was prolonged at 30%, no change 
was noted in the reaction time at 10 or 20%,[Wernberg, 
Nielson, Hommelgaand 1980].
The flicker fusion frequency was significantly increased at 
20% nitrous oxide and another increase noted at 30% nitrous 
oxide. The fusion flicker frequency did not alter until the 
concentration reached 30% nitrous oxide.
These authors concluded that critical flicker fusion 
frequency was a simpler, more time-saving and sensitive 
method for estimation of changes which nitrous oxide 
produced in healthy volunteers.
[Edwards, Rose, Schorow et al 1981], [Table 2 Page 2].
Millar and co-author (1982), [Table 2 Page 2], used the 
four-choice reaction time described by Wilkinson (1975) and 
a visual search task to assess the effect of a linear 
release system and non -linear release system of the 
antihistamine drug Brompheniramine Maleate lOmg,[Millar, 
Standen 1982]. They included not only a measurement of mean 
correct response latency but also of 'blocks'[Bills 1931].
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These are response latencies that are 1.5 times longer than 
the overall mean latency. Such blocks or pauses in 
performances are thought to indicate states of fatigue or 
low arousal. The linear release system showed increased 
pausing in serial reaction time at 5.5 hours post-dosage.
Scott and colleagues [Table 2 Page 2], used the four-choice 
RT described by [Wilkinson 1975], to measure postoperative 
psychomotor performance decrements in three groups of 13 
subjects, [Scott, Whitman, Wilkinson 1983]. Anaesthesia 
consisted of either thiopentone,nitrous oxide and halothane 
or methohexitone, fentanyl/nitrous oxide and incremental 
methohexitone. Tests were performed on the day before 
surgery and after at 2,4,6,8 and approximately 24hrs 
recovery, on both groups of patients and at approximately 
the same times on a nonoperated control group. The mean CRT 
of thiopentone and methohexitone subjects increased from 515 
to 550ms and 552 to 600ms respectively after 2 hrs recovery. 
Subsequent CRT decreased in both groups although 
methohexitone subjects were still significantly slower than 
controls after 6hrs. Thiopentone subjects were slower than 
controls at 2,4,and 8 hrs after recovery. There was no 
significant difference between the three groups of subjects 
after 24hrs recovery. The data from this study showed a 
considerable practice effect in the control group [Figure 
5]. The thiopentone and methohexitone group at 8 hrs had 
achieved the performance in reaction time equivalent to 
their baseline. By looking at the control group it is 
evident that a large practice effect has occurred. Therefore
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at 24hrs the thiopentone and methohexitone groups were still 
impaired relative to control values. The authors concluded 
that CRT was a sensitive test for psychomotor performance.
Herbert and co-workers used the four-choice CRT to study the 
impairment of mental function in 55 patients undergoing 
hernia repair. Patients were divided into three groups in 
which the method of induction of anaesthesia (iv or inhal) 
and ventilation (spontaneous or controlled) were varied 
(thiopentone/halothane). The serial CRT was used in a five 
minute test four times a day for two days postoperatively. A 
control group also being included. After impairment 
initially, the reaction times in all groups returned towards 
control values, but in patients breathing spontaneously 
during anaesthesia, impairment recurred during the second 
postoperative day. Herbert and his co-authors indicated that 
"this re-emergence of impaired reaction times two days after 
the operation emphasises the importance of extending the 
testing beyond the point where patients have apparently 
recovered. Without such testing results of the present study 
would have concurred with those of earlier reports showing 
that psychomotor consequences of general anaesthesia are 
fairly short-lived. This present data, however, suggests 
that it would seem wise to extend the warning not to drive 
to at least 48 hrs postoperatively".When we look at graphs 
of MRT there is some evidence of practice effects with the 
control group, [Herbert, Healy, Bourke et al 1983].
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Herbert and colleagues again used CRT to examine recovery of 
mental abilities following GA induced by propofol or 
thiopentone, using herniorraphy patents premedicated again 
with diazepam lOmg,[Herbert, Makin, Bourke et al 1985].
Five minute serial CRT were preformed before the premed, 90 
min after regaining consciousness and at four constant times 
across the mornings and afternoons of the next two 
postoperative days. Visual analogue scales to describe 
perceived level of coordination were also measured. Reaction 
times of all groups were similar before surgery, but 
propofol group were significantly faster than STP at all 
postoperative points. The performance of the thiopentone 
group remained significantly slower than that of controls up 
to and including the morning of the second postoperative 
day. The propofol group did not differ from controls at any 
measurement point. Herbert indicates that evidence from 
Visual analogue scales implies that individuals assessments 
of their perceived level of coordination should not be 
relied upon.
Barker and colleagues [Table 2 Page 3] used a serial CRT as 
a measure of recovery on patients sedated with midazolam 
and the emulsion formulation of diazepam in a cross-over 
study for 50 patients undergoing out-patient conservative 
dentistry using a four-choice reaction time [described by 
Wilkinson 1975]. They failed to show any difference in 
psychometric performance between the treatments. One 
criticism is that they only gave a practice period of thirty
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seconds with the CRT apparatus, [Barker,Butchart, Gibson et 
al 1986].
McMenemin and co-author used a serial choice reaction time 
test to assess the potency of 25% nitrous oxide compared to 
0.4% isoflurane. The CRT used was similar to that used by 
Smith and Shirley (1977). Both nitrous oxide and isoflurane 
prolonged performance compared to control. The effect of the 
isoflurane was greater than the nitrous oxide, although the 
isoflurane did not reach its maximum effect until 15 mins. 
Within five minutes subjects gained values similar to those 
obtained while breathing oxygen. No practice effects were 
evident, [McMenemin, Parbrook 1988].
Baillie and co-workers used a battery of computerised 
psychomotor tests to assess the effects of temazepam 
premedication on cognitive recovery following alfentanil- 
propofol anaesthesia. They showed significant deficits in 
attention and memory following anaesthesia, which increased 
in range and magnitude with temazepam. These were obvious 
30minutes after surgery but had largely but not completely 
recovered at four hours,[Baillie, Christmas, Price et al 
1989].
Kortilla and colleagues used a task of serial multiple 
reaction time to a visual or auditory stimulus and their 
combination (computer-assisted). Psychomotor performance 
remained significantly worse compared to control for one 
hour after propofol and five hours after thiopental. They 
concluded that propofol is ideal for day-case surgery due to
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its fast and complete recovery of psychomotor performance. 
Driving and psychomotor skills are impaired for as long as 
eight hours after brief thiopental and methohexital 
anaesthesia. This study was appropriate in that only 
thiopental and propofol were used and no other premedicant 
drugs or anaesthetic agents,[Kortilla,Nuotto, Lichtor et al 
1992.
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DISCRETE CHOICE REACTION TIME
The discrete CRT is effectively a subject-paced test, in 
that the subject has to return their finger to a 'home' key 
to await the next signal. The Leeds Psychomotor Performance 
Tester is a compact portable apparatus measuring critical 
flicker fusion threshold (CFFT) and Choice reaction time. In 
the CRT the subject scans an array of six small lights which 
are illuminated on a random basis. As soon as he detects a 
light he touches the appropriate button to extinguish it. 
The latency of this response is an assessment of the 
integrity of sensori-motor function and an accurate measure 
of psychomotor performance. The distance the subject has to 
move his hand to touch the response button is the same for 
each light, making it possible to measure motor time 
separately from recognition time. The CFFT is an sensitive 
index of CNS arousal and the ability to integrate discrete 
units of sensory data,[Hindmarch, Parrott 1977].
Landauer and colleagues examined the decision and movement 
time components of a visual discrete choice reaction time 
task, using healthy volunteers. The results of two separate 
studies showed that women have a faster decision time than 
men, and that men have a faster movement time. Since these 
two effects are in an opposite direction, no sex differences 
in the mean choice reaction times were found. It was 
concluded that on this particular task the cognitive 
performance of women was superior,[Landauer, Armstrong 
,Digwood 1980].
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MacKenzie and co-authors [Tables Pagel] assessed the 
recovery characteristics of anaesthesia induced with 
propofol, thiopentone and methohexitone. Propofol showed a 
superior recovery, with virtually no side-effects and little 
impairment of psychomotor function 30min after anaesthesia. 
No practice effects were evident, [MacKenzie and Grant 1985
a] .
MacKenzie and colleagues compared propofol with 
methohexitone in patients undergoing light general 
anaesthesia [Table 3 Pagel]. The choice reaction time and 
critical flicker fusion threshold were assessed as can be 
seen from the table. Both agents depressed the Critical 
Flicker Fusion Threshold in a similar manner. With propofol 
this was significant at all times, but with methohexitone it 
was no longer significant after four hours. Similar 
impairment of CRT was also seen with the two groups. 
Recovery after anaesthesia was rapid in both groups however 
the quality of recovery was superior following propofol, in 
that side effects such as headache, nausea and vomiting 
occurring much less commonly than after 
methohexitone,[MacKenzie and Grant 1985 b].
Sanders and co-authors [Table 3 Page 2] findings were in 
conflict with the previous authors. They found no 
significant difference between the unpremedicated propofol 
group and the unpremedicated thiopentone group, the only 
difference being halothane in the technique rather than
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enflurane. It was apparent that the motor functions of the 
patients were significantly affected by the anaesthetic 
drugs up to 3 hours later. The authors noticed that 
"patients are still significantly impaired in psychomotor 
functions at the time when they are customarily discharged 
from hospital." As can be seen from the table no control was 
included and there is no indication of the number of 
practice sessions given to each patient initially, therefore 
there may be a large practice effect that is unaccounted 
for, with a larger degree of residual impairment being 
present, compared to baseline,[Sanders, Issac, Yeomans, et 
al 1989].
Hickey and co-investigators assessed recovery from 
outpatient anaesthesia with propofol in which 10 patients, 
were followed using a semantic recognition memory test 
(SemRT) ,choice reaction time and critical flicker fusion 
threshold (CFFT). Group analysis of results revealed an 
effect on psychomotor performance as measured by the Sematic 
recognition memory test (SemRT) and Critical flicker fusion 
test (CFFT) but not the CRT, 30 mins after the end of the 
procedure. Performance on all three tasks had returned to 
baseline values within 60min of completing the anaesthetic. 
Group analysis, however, masks individual impairment which 
may be clinically important as was discussed earlier. There 
was no statistically significant correlation between 
postanaesthetic task performance and age, sex, dose of 
propofol, anxiety or depression score,[Hickey,Asbury, Millar 
1991]. The CRT was of the Leeds psychomotor testing system
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as previously described. The return of patient performance 
to pre-anaesthetic levels occurred within 6Omins of 
discontinuing the anaesthetic [cf MacKenzie and Grant 
1985a].
Anderson and colleagues investigated the nature and duration 
of cognitive effects of atropine and hyoscine. The tests 
they used included orientation questions, memory tests, a 
CRT and two tests of visuo-motor coordination. The results 
showed th^ .t hyoscine had detrimental effects on memory and 
on motor tasks compared with placebo, while atropine did 
not. These effects on motor performance had not disappeared 
three hours after the operation,[Anderson, McGuire, McKeown 
1985].
This study had shown that clinical doses of atropine have 
minimal effects on cognitive performance compared with 
placebo. Hyoscine showed a slowing of motor speed and visuo- 
motor coordination which lasted a sufficient length of time 
to allow such patients to be affected after discharge from 
day-case surgery.
Fagan and co-authors looked at the effects of three separate 
doses of alcohol (0.2,0.4,0.8g/kg) when given to eight 
volunteers compared with a placebo trial. They used a 
battery of psychometric tests including a CRT and CR latency 
repeatedly performed for 3.5hours. Alcohol, even in the 
highest dose, had little effects on psychomotor performance. 
All the psychometric tests used had previously been shown to
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be sensitive to the effects of moderate doses of other CNS 
depressant drugs,[Fagan, Tiplady and Scott 1987].
Moss and colleagues, [Table 3 Page2] compared the results of 
a battery of psychometric tests using an alfentanil 
anaesthetic technique and inhalational halothane technique. 
Both groups showed an initial large impairment of 
psychomotor function, gradually increasing during the 
afternoon and returning to baseline next morning. Only the 
CFF test demonstrated a difference in the two anaesthetic 
techniques. The alfentanil group were found to be 
significantly less sedated than the halothane patients on 
the morning after anaesthesia,[Moss, Hindmarch,Pain 1987].
Zuurmond and co-investigators attempted to determine the 
minimum requirements for a battery of psychomotor tests to 
assess recovery from anaesthesia. They used six recovery 
tests, choice reaction time (CRT), CRT doubletask, finger 
tapping test (FTT), critical flicker fusion frequency 
(CFF),Maddox wing , and p-deletion test. These tests, cover 
basic cognitive, motor and perceptive functions as well as 
concentration , were analysed and compared with each other. 
Correlation between the tests after recovery from 
standardised general anaesthesia was calculated in 22 
patients. Moderate to high correlation was found between CRT 
and CRT doubletask(r=0.62 to r=0.73), when parameters of six 
different tests were compared. Finger tapping correlated 
moderately with the movement time of both the CRT and the 
CRT doubletask (r=0.46 and r=0.47 respectively). They
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concluded that the CRT test, which measures initiation and 
movement time might replace the CRT doubletask and the FTT. 
The CFF correlated moderately with the initiation time of 
the CRT doubletask but because a slightly different function 
seems to be involved, further research is needed. Maddox 
wing and the p-deletion test correlated with no other test. 
Results indicated that recovery is differentiated in at 
least four distinct psychomotor functions which should be 
tested by CRT (to measure initiation and movement time), 
Maddox wing and p-deletion, [Zuurmond, Balk, van Dis et al 
1989] .
They used a discrete CRT, in which several processes can be 
differentiated within the reaction, of which the choice 
reaction time test subsequently estimates the initiation 
time ( a cognitive component of the reaction time, measured 
by the release of the initially held button) and the 
movement time ( a motor component of the reaction time, 
measured by the movement from the initially held button to 
the stimulus button). Initiation time and movement time 
together make up the total reaction time. The CRT 
doubletask measures the reaction time but the patient also 
has to count the appearing stimuli. One out of the five 
possible stimuli buttons must be excluded; at each 
subsequent presentation of the CRT doubletask, a different 
stimulus button must be excluded to prevent recognition. The 
patient's attention is divided, and the reaction time is 
slowed down as a result of the simultaneous counting and 
reacting. The order of the stimuli and the interstimulus
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intervals are again randomly defined, as with the CRT test. 
These authors concluded that as recovery is not a 
unidimensional concept that several tests are necessary to 
measure street-fitness, home-readiness or full recovery. To 
include all aspects of recovery important in the decision to 
send patients home, motor ability and coordination as well 
as perception and cognitive recovery need to be tested. The 
choice reaction time, the Maddox wing and p-deletion tests 
were the tests recommended by these authors.
Sanders and co-authors assessed recovery over 48 hours after 
anaesthesia with propofol or thiopentone as sole anaesthetic 
agent in 36 unpremedicated gynaecological patients, [Table3 
Page2]. There was a substantial practice effect with the 
choice reaction time, digit span and aiming task which may 
have obscured impairment. The authors concluded that better 
recovery profile after propofol was still evident at 
24hours,[Sanders, Clyburn, Rosen, et al 1991].
The review of the literature on choice reaction time 
apparatus demonstrates that this test is a sensitive 
indicator of impairment after anaesthesia or from other CNS 
depressant drugs. However there are many problems when 
comparing one drug against another. There seems to be no set 
parameters for the CRT design. In effect authors are using 
CRT apparatus that is designed,operates differently and in 
many cases is measuring different parameters ie no of 
mistakes, mean RT etc. The general design of the studies 
indicates problems with [Table2 &3] lack of initial training
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and the effect of practice , inadequate length of the CRT 
test to elicit boredom, and in some cases the lack of a 
control group to enable comparisons to be made.
From the papers reviewed it is apparent despite all these 
criticisms that the effect of anaesthetic drugs can last 
well in to the recovery period. Patients undergoing day-case 
anaesthesia should be warned of these effects and the 
importance of refraining from driving etc for 24hours and 
possibly even 36-48hours.
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TRACKING TASKS
A tracking task can be defined as a task in which a 
volunteer is required to make a response to a visual cue 
provided by the relative positions and rates of travel of a 
target and cursor. Tracking tasks are also known as rotary 
pursuit tests or tests of visuo-motor coordination.
Visual tracking is used frequently in the study of general 
human behaviour.
Lincoln and colleagues looked at the transfer in training in 
tracking performance at different target speeds. They 
studied the effect of training in performance at one target 
speed upon later performance at different target speeds. The 
subjects' task was to track a small target rotating at 
varying speeds, using a mechanical tracking device that 
tested the specificity of tracking training in relation to 
target speeds. Thirty-six subjects were divided into three 
groups equated as to initial tracking ability. Each group 
was trained at a different target speed. After completion of 
this training, the groups were transferred to tests run at 
the three training speeds, so that all groups tracked for 
one day at each of the three speeds.
The data showed significant differences between performances 
at the three target speeds, and practice appeared to be 
relatively ineffective as a means of increasing accuracy 
scores. Subjects trained at medium target speed made scores 
significantly superior to those made by groups trained at 
low and high target speeds,when later tested on low and
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medium target speeds. The same group, showed poorer scores 
when tested on high speeds. The authors concluded that 
training at certain target speeds leads to better 
performance when particular speeds are introduced at a later 
time,[Lincoln, Smith 1951a].
In another paper written by these authors, they established 
that accuracy of performance is greater and the degree of 
learning is less in direct tracking than in types of 
tracking in which some aid is provided to the operator. 
These differences they thought were due to the tracking 
device modifying the movements of the observed cursor, 
[Lincoln and Smith 1952b].
Lincoln and co-authors again looked at visual tracking but 
this time as a response pattern composed of simultaneous 
adaptive reactions of position, rate and acceleration 
control, rather than as a direct response to sensory cues. 
These authors set out to determine how tracking accuracy 
varied with the brightness of the target area, width of the 
target and with changes in the pattern of the target and 
cursor. Their experiments were designed to determine the 
nature of target-width effect relative to variation in 
target brightness and target-cursor pattern. They found that 
the pattern relations of target and cursor were indeed 
related to the accuracy of visual tracking. A discrete 
relation of target and cursor generally produced more 
accurate performance than an overlapping pattern of target 
and cursor when the colour of both was the same. The
Page No 104
illumination level of the target and cursor also reflected 
in the accuracy of tracking. Accuracy was poor at low levels 
of illumination but this involved complex
interactions,[Lincoln ,Smith 1952c].
The most important result of the study was the observation 
that an increase in the width of the target produced no 
marked change in the level of tracking accuracy.
From these results the authors concluded that "tracking 
behaviour was due mainly to the phenomenon of organisation 
of visual pattern rather than tolerances of alignment and 
misalignment of visual contours. The tracker's accuracy is 
determined by precision in scaling or bisection of the 
visual pattern rather than in terms of the optical 
resolution of limiting contours that define the visual 
presentation. The above interpretation of the psychophysical 
organisation of tracking implies that any aspect of the 
tracking situation which does not alter the critical 
oscillatory features of response will not change materially 
the level of accuracy in the situation."
Lincoln in 1953 described three types of instrumental 
alteration of motion in remote-control tracking devices:
1. TRANSLATIONS - the motion of the cursor directly 
reflect the characteristics of the motion made by the 
operator, these translated motions being either 
amplifications or reductions of the operators' motions.
Instrumental Alterations of the Operator Motions 
Required to Achieve Control of the Position 
and Rate of Travel of the Cursor
T>q)e of 
Tracking Positioning Motion Rate Motion
Direct Translated into cursor 
positioning
Translated into rate 
of cursor travel
Velocity
Transformed into di­
rection of cursor travel
Transformed into rate 
of cursor travel
—
Translated into cursor 
positioning
Aided Transformed into rate 
of cursor travel— the 
translation and trans­
formation are inte­
grated.
—
FIGURE 6. Instrumental alterations of the operator motions 
required to achieve control of the position and rate of 
travel of the cursor.
Lincoln RS. Visual Tracking: III. The Instrumental Dimension 
of Motion in Relation to Tracking Accuracy.The Journal of 
Applied Psychology 1953; 37:489-493.
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2. TRANSFORMED MOTIONS- reflect the operator's movements 
only in a special way, since the system output is not a 
direct counterpart of the motion input.
3. INTEGRATIONS of motion involve the combination of 
one output of a simultaneous translation and 
transformation of the same movement of the operator. 
Three instrumental alterations of motion have been 
described
a) Direct tracking system
b) Velocity tracking system
c) Aided tracking system, [Table 6].
Direct tracking involves two translations of motion, 
velocity tracking produces two transformation of motion. 
Aided tracking system involves the integration of the 
simultaneous translation and transformation of the same 
positioning motion.
Lincoln's study was designed to show acquisition and 
transfer of skill in the operation of remote control 
tracking devices.
Eighteen subjects were divided into three groups each of 
which received training on either direct, velocity or aided 
tracking for a period extending through six successive days. 
On the seventh day, twelve subjects form each training group 
transferred to different types of tracking while the 
remaining six subjects in each group continued on the device 
on which they had been trained. The authors described that
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the instrumental characteristics of control devices are 
prime determinants of the accuracy with which those devices 
may be operated. The accuracy of direct tracking was 
consistently superior to both aided tracking and velocity 
tracking. Aided tracking was superior to velocity tracking. 
The effects of training are highly specific in nature, the 
best performance in transfer to any type of tracking is 
achieved by subjects who are trained on that specific type. 
Negative transfer effects appear when subjects transfer from 
aided or velocity tracking to direct control tracking. While 
on transfer from direct control to aided or velocity, 
positive transfer effects appear.
Borland and colleagues have done extensive work using an 
ADAPTIVE TRACKING TASK .In this version of the tracking task 
the subject is required to position a spot inside a randomly 
moving circle displayed on an oscilloscope. The movement of 
the spot is controlled by a hand-held stick, and an error 
signal, proportional to the distance between the spot and 
the centre of the circle, controls the difficulty of the 
task by modulating the mean amplitude of the movement of the 
circle. The apparatus provides the adaptive component which 
maintains optimum performance of the operator. Experiments 
were carried out in sound-attenuated rooms. Subjects were 
required to reach a steady level of performance on the task 
before the studies commenced. Each assessment of performance 
lasted ten minutes, with only the mean amplitude of the task 
over the final 500sec being computed. Healthy male subjects
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were used. Avoidance of alcohol was ensured. These authors 
described decrements in performance lOhours after 200mg 
heptabaritone ,at 10 and 13hours after 300mg and 10h,13h,16h 
and 19hrs after 400mg of heptabarbitone,[Borland, Nicholson 
1974] .
Borland and colleagues using pentobarbitone sodium showed 
the residual decrement in performance after overnight 
ingestion of 200mg was very similar to those observed after 
heptabarbitone 400mg. Residual effects on visuo-motor 
coordination were related to dose both in their persistence 
and in the decrement at a given time interval ie impaired 
performance persisted longer with higher doses (although 
still within the therapeutic range).The above studies using 
the tracking task, established it as a sensitive tool in the 
investigation of performance related effects. It was 
therefore used to investigate the residual effects of 
benzodiazepines - diazepam, flurazepam HCl, nitrazepam . 
Performance was impaired for 16hrs after flurazepam HCl 30mg 
and to, 19hrs after nitrazepam lOmg, the effects with 
diazepam lOmg were more limited,[Borland, Nicholson 1975].
Kortilla and colleagues,[Table 4 Pagel] in a study comparing 
etidocaine and bupivicaine demonstrated that despite 
practice, all subjects improved performance with training in 
the control group on the CRT and coordination 
tests,[Kortilla, Hakkinen, Linnoila 1975].
Two different tracking tasks were used to measure 
coordination. Subjects attempted to keep a black ball on an
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illuminated track by turning a steering wheel. Tracking test 
I was driven at a fixed speed, while tracking task II was 
driven at a free speed, and the driving time recorded. 
Measurements made were
a) the number of mistakes ie no of times the subjects went 
off the track)
b) mistake percentage ie the percentage of the total length 
of the track the subjects were off).
Neither bupivicaine or etidocaine impaired CRT compared to 
placebo. Bupivicaine impaired the parameters measured in the 
coordination tracking tasks. The mistake percent in tracking 
task II was significantly (P<0.05) higher after bupivicaine 
than after the saline placebo, whereas a significantly 
(P<0.05) lower percentage was observed with etidocaine than 
after saline. Driving times were unaltered during the entire 
experiment. CFFF was significantly impaired with both 
etidocaine and bupivicaine compared with placebo. The above 
tests give a suitable battery of tests to assess arousal, 
coordination and reaction times.
No mention is made of total time on each task, which may 
affect performance , if as stated the task was short enough 
to allow a subject to arouse themselves to do the task and 
not long enough to elicit an element of boredom.
Nicholson (1979) concluded that studies on the immediate and 
residual effects of benzodiazepines, showed impaired 
performance after diazepam lOmg, which was limited to a few
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hours after ingestion and there was little likelihood of 
residual impairment with overnight ingestion, as long as the 
dose did not exceed lOmg.
Kleinknecht and colleagues reviewed the effects of diazepam 
on a variety of psychomotor and cognitive tasks. The 40-50 
different tests used in the studies reviewed were grouped by 
the authors into six classes according to similarity of 
functions tested. As with other reviews the number of 
variables eg dosage level, route of administration, type of 
subject etc render the results difficult to 
compare,[Kleinknecht,Donaldson 1975]. They reviewed the 
pursuit rotor test - which is similar to a tracking task. 
They included details on Milner and Laudauer (1973) who 
administered lOmg of diazepam over a 14hour period and found 
the pursuit rotor test to be unaffected. Also included was 
work by Hughes and colleagues who devised a "pursuit meter" 
to measure attentive motor performance - which Kleinknecht 
et al described as having similarities to both driving 
simulators and the pursuit rotor task. They found no effect 
on this test from 6mg of diazepam for 48hrs prior to 
testing,[Hughes, Forney, Richards 1965].
Clarke and Nicholson (1978) studied the effects of diazepam 
and its metabolites 3-hydroxydiazepam (temazepam) and 3 
hydroxy, N-desmethyldiazepam (oxazepam) on performance using 
a tracking task. Performance was observed from 10-16hours 
after overnight ingestation of diazepam 5 & lOmg, temazepam 
10,20 and 30mg and oxazepam 15,30 and 45mg and from 0.5 -
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6.5hrs after morning ingestion of diazepam lOmg,temazepam 
2 Omg, oxazepam 3 Omg. Vi suo-motor coordination (VM 
coordination) was not impaired by overnight ingestion of 
diazepam 5& lOmg, temazepam 10,20 and30mg or oxazepam 
15&30mg.But with temazepam 30mg there was a residual effect 
on performance, (oxazepam, performance lOhrs after 
ingestation).
With morning ingestion VM coordination was impaired at 0.5 
and 2.5hrs after diazepam,lOmg, at 0.5h temazepam 20mg, and 
at 2.5 and 4.5hrs after oxazepam 30mg.
These results of impaired performance a few hours after 
ingestion of diazepam are in keeping with results by other 
authors using other performance tests (eg auditory 
vigilance, reaction time, digit symbol substitution), 
showing that the adaptive tracking task is an accurate test 
for the detection of impaired performance. No control groups 
were included in this review.
Various authors have questioned the reliability of 
psychomotor performance tests with reference to general 
everyday activities that patients are involved in, on 
discharge from hospital. Are the psychomotor tests really a 
good reflection of driving ability? Hindmarch and co­
authors, compared three coinmonly used psychomotor tests with 
an objective measure of car driving performance, brake 
reaction time which they developed. These tests were used to 
evaluate a new antidepressant ZIMELDINE in comparison to 
placebo and amitriptyline,[Hindmarch, Subhan, Stoker 1983].
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The tracking task that was used was computer-controlled 
similar to those of an adaptive tracking procedure using 
parallel information processing. A joystick control was used 
to keep a cursor in alignment with a moving target. A visual 
stimulus was also presented in the peripheral field of 
vision. Two measures of performance were
1. 'Tracking accuracy' - the root mean square deviation 
of movements of the cursor from the 'track' programme.
2. Reaction time to peripheral stimuli.
Other laboratory tests included CRT, CFFT.
Brake reaction time was carried out in a SAAB 900 TURBO. A 
VDU fixed to the windscreen presented visual stimuli, to 
which the subject was required to respond by depressing the 
brake pedal as quickly as possible. One hour after treatment 
with both drugs, no significant differences in tracking 
accuracy were found. Significant differences were seen four 
hours after treatment - amitriptyline produced a significant 
reduction in tracking accuracy compared to placebo and 
zimeldine. There was no significant difference between 
zimeldine and placebo at this time.
The peripheral awareness component produced no significant 
differences either at one hour or four hours post treatment.
The brake reaction time was significantly prolonged for 
measurements taken two hours after treatment, but no 
statistically significant difference after five hours. As
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the authors stated, there seems to be a significant practice 
effect in this test, which has not been adequately resolved 
by the learning period.
This paper has attempted to compare a tracking task with a 
more realistic form of driving. The major problem from the 
point of comparison being the different times at which 
measurements were made due to practical problems - the 
laboratory tasks preceding the BRT by one hour. The maximum 
effect of amitriptyline was seen at two hours for BRT but at 
4 hours for tracking task - suggests a peak effect between 
2-4 hours. The effect of practice also has to be taken into 
account for the BRT falling between 1 & 5 hours for all 
treatments.
No significant treatment differences were found for the 
reaction time obtained from the peripheral awareness 
component of the tracking task either at one or four hours 
post-treatment.
Borland and Nicholson (1984) attempt to define the basic 
forms of visuo-motor coordination tasks - compensatory and 
pursuit. In a compensatory tracking task the display 
presents a stimulus which shows only the difference between 
the forcing function and the system output. In a pursuit 
tracking task there is a visual presentation of both the 
forcing function and the system output. They both require 
the operator to maintain a minimum error score; in the 
pursuit task the operator can use an element of anticipation 
based on the knowledge of the parameters of the forcing
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function.
The tracking task they used was a micro-processor based 
pursuit tracking task, in which the mean amplitude is 
automatically adjusted to match the subject's skill.The 
target circle (1.5cm diameter) was driven in X & Y planes 
across a screen of a Cathode Ray Oscilloscope (CRO) (25cm x 
25cm). The subject was seated 40cm from the display and 
used a two axis joystick to maintain the marker dot within 
the moving circle. A gradual increase in the mean amplitude 
of the target movement occurs if trials are successful and a 
decrease occurs if failures occur. Each test run lasts 
600sec and the last 500sec is scored.
Borland and Nicholson included two criteria into their 
tracking task - ensuring that the overall difficulty of the 
tasks should remain constant from run-to-run, but also the 
movements must change enough to prevent subjects remembering 
parts of the task. They achieved these objectives by 
selecting a random starting point within X and Y for each 
trial, digitally low-pass filtering a random sequence to 
produce a task with the required amplitude and frequency, 
but lasting l/8th of the total time required, they also 
selected two subsequences (x & y ) of different length, 
within the main sequence, enabling no discontinuity of 
movement to be detected. And finally by playing out x in the 
forward direction and looping these back at the appropriate 
points to produce a continuous task of the desired length. 
The circle and dot positions were updated by the computer 40
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times per sec and a radial error signal calculated and 
compared to the circle radius. For precise mathematics see 
original paper [Borland, Nicholson 1984]
VMC was used by Nicholson and Stone to assess the central 
effects of and H2 antagonists. The
antagonist triprolidine(1Omg) being used as an active 
control.
Nicholson and co-authors assessed the effects of single oral 
doses of mequitazine (Sand lOmg), terfenadine (60mg) and 
triprolidine (lOmg) as active controls using a tracking 
task, digit symbol substitution, CFF test and dynamic visual 
acuity. Mequitazine (5mg) impaired visuo-motor control 7.5hr 
after ingestion, the authors attributing this to a chance 
result, as there was no effect on other tests, [Nicholson 
and Stone 1983].
Nicholson and colleagues also used a tracking task to 
assess the effects of single oral doses of cimetidine (200 
and 400mg) and rantidine (150 and 300mg). There were no 
adverse changes in performance. The triprolidine being used 
as an active control and impairing visuo-motor 
coordination,[Nicholson,Stone 1984] .
They concluded that use of a VMC task (tracking) in drug 
studies was a very sensitive task providing useful 
information on the persistence of a drug effect, but the 
interpretation of the impairment as that of the obvious 
skill implied by the task may not be entirely correct.
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Denis and co-authors [Table4 Page 2], attempted to assess 
the reliability and validity of three psychomotor tests of 
recovery from anaesthesia; rotary pursuit, pegboard, or 
track tracer. The used a Lafayette polar pursuit apparatus 
(No 30013) - an illuminated stimulus 1.9cm long and 1.85 cm 
wide moved in a clockwise direction in a circle with an 
outside diameter of 15.9cm and at a constant speed of 
20rpm,[Denis,Letourneau,Londorf 1984]. The subject required 
to keep a photoelectric wand inside the target in motion as 
long as possible. A counter-clock connected to the apparatus 
was inhibited each time the wand was off the target. Each 
run lasted 30 sec. This test was compared with a pegboard 
and trace tracker. They concluded that both the rotary 
pursuit test and pegboard had significant practice effects 
and the experimental groups ie those anaesthetised did not 
reach the baseline at the end of the trial. Only the 
patients on the trace tracker returned to baseline testing 
levels, but the authors themselves point out that this may 
be in part due to the short period of time the task is in 
use, which may have an arousal effect on higher cortical 
functions.
Miles and colleagues used a tracking task as the primary 
task and a secondary (signal detection ) task to assess the 
interactive effects of mood induction and alcohol 
consumption. Although tracking ability was independently 
sensitive to both time on task and alcohol, no interaction 
between alcohol and mood was observed, [Miles, Porter, Jones
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1986] .
Moss and co-investigators [Table 4 Page 2] assessed recovery 
after anaesthesia using the Maddox Wing test(MW), Critical 
flicker fusion test (CFFT),Choice reaction time (CRT), Line 
analogue rating scales (LARS), a tracking test and a test of 
semantic memory in 44 patients who had undergone minor 
gynaecological surgery,[Moss,Hindmarch, Pain et al 1987]. 
The patients were allocated randomly to one of two groups 
and received either methohexitone, nitrous oxide, oxygen and 
halothane or methohexitone, alfentanil, nitrous oxide and 
oxygen. Except for the CFF test, which showed the alfentanil 
patents to be less sedated than the halothane patients on 
the morning after anaesthesia (P<0.05), the results of the 
tests were similar in both groups and showed, initially, 
substantial impairment of psychomotor functions which 
gradually returned to baseline values. The CFFT test was 
found to be the most sensitive test of cognitive function 
following anaesthesia. This comparison with halothane 
anaesthesia indicated that a technique using methohexitone 
and alfentanil is suitable for day-case surgery. The study 
suffered from inadequate time for training, as tests on the 
morning after anaesthesia indicated that performance in both 
treatment groups had improved on baseline as a result of 
practice. The authors point out that it is essential to 
provide adequate practice when using tasks with a pronounced 
learning effect. This paper again emphasises that 
psychomotor function may not have returned to normal for
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some hours after either anaesthetic technique, confirming 
the need to warn patients not to drive for at least 24hrs 
after day-case anaesthesia.
Maylor and colleagues looked at the effects of alcohol and 
extended practice on divided-attention performance using a 
tracking task and auditory detection task, [Maylor,Rabbitt, 
James et al 1990]. Previous work has suggested that practice 
has an effect on performance as practice leads to the 
development of automatic, processes,(Schneider and Shiffrin 
1977). Craik (1977) suggested that alcohol is thought to 
reduce attentional capacity or cognitive processing 
resources. Therefore alcohol will show a greater decrease in 
performance on tasks requiring effortful processing (early 
in practice) than on tasks requiring less effortful and 
more automatic processing (late in practice). Maylor 1990 
used a computerised visual tracking task incorporating a 
joystick. This controlled the movement of a cross on the 
screen measuring 11mm xllmm. The joystick allowed the cross 
to move in one of eight directions (N,NE,E,SE,S,SW,W,NW). 
The target was a regular octagon (12mm diameter) that moved 
randomly around the screen (but never beyond it), also in 
eight directions. It changed direction every 1.33sec. Both 
target and cross moved at constant speeds. When a finger 
controlled trigger button on the joystick was held down, the 
cross doubled its speed, and when the trigger was released, 
the cross returned to its original speed.
Performance in the tracking task was not significantly
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affected by alcohol, but it did improve with practice. The 
effect of a dual-task condition with tracking was to impair 
performance.
From the above, it can be seen that tracking times have been 
used extensively in pharmacological research. Again few are 
standardised in time, apparatus and drugs used and 
environmental conditions. But generally it is regarded as a 
sensitive tool in the assessment of psychomotor impairment 
(coordination).
ABBREVIATIONS FOR TABLES 2.3.4
AC - active controls
AN - anaesthetists
atps - attempts
ATT - adaptive tracking task
attent test - attentional test
BC - baseline
CFFT - critical flicker fusion frequency
DP - dental patients
Enf - enflurane
GP - gynaecology patients
Hal - halothane
HV - healthy volunteers
OC - own controls
OP - orthopaedic patients
PM - premedication
Prg - programme
PS - psychology students
SP - surgical patients
STP - sodium thiopentone
T - trials
TT - tracking task
T 1 - increase/decrease
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METHOD
Ethical committee approval was obtained.
DESIGN
Volunteers were randomly sedated with subanaesthetic doses 
of isoflurane (0.2 - 0.75%) and enflurane (0.2-0.6%). During 
each sedation session the components of the auditory evoked 
response (AER) were measured at each concentration step, 
along with two measurements of performance, the choice 
reaction time and a tracking task, both presented to the 
volunteer on a computer.
RECRUITMENT OF VOLUNTEERS.
For the initial part of the study 10-15 volunteers were 
required. They were required to be within the age range of 
16-65 and to be healthy. Volunteers were recruited in three 
ways.
1. Three advertisements were placed in the Glasgow Herald in 
three successive weeks. Volunteers were asked to apply to 
the stated address, as can be seen below.
2. Notices were placed in the unions of Glasgow University, 
asking for volunteers to apply (with the exception of 
medical and nursing students, who were excluded by the 
protocol) .
3. Notices were also placed in Glasgow hospitals, other than
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the Western Infirmary.
The responses from the three areas were good, and about 50 
names were collected initially.
Once volunteers applied to the advertisements, they were 
sent a questionnaire on their general medical health. These 
were returned to the department and analysed for selection. 
The following were criteria for exclusion
1. Age other than from 16-65.
2. General ill health
3. People with chronic pain.
4. Neurological disease
5. Females likely to be pregnant.
6. Alcohol abuse.
7. Those on sedative drugs.
8. Solvent abusers or drug addicts.
Selected volunteers were then asked to visit the hospital, 
for their initial session to assess fitness.
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SESSION ONE
Volunteers were questioned if there were any queries on the 
initial questionnaire. A full physical examination was 
undertaken to exclude cardiovascular, respiratory and 
neurological disease and to assess hearing ability. The ears 
were examined with an auriscope to check for the presence of 
wax or any disease. Volunteers then undertook an audiometric 
test using a screening audiometer, [Figure 7 and 8]. 
Clinical assessment of the airway was also performed.
Ability to obtain adequate AERs was an essential part of the 
study. This was assessed at the initial visit when the 
volunteers would lie on a bed, and have three electrodes 
placed on their head, after thorough cleaning of the skin 
with Omniprep (SLE) and alcohol. The active electrode was 
placed on the right mastoid, the reference electrode at the 
vertex and the ground electrode at the left mastoid. 
Headphones were applied to stimulate the right ear.
The long -latency and brainstem AERs were measured. 
Parameters for AER are given under the section on equipment. 
The two performance tests used for this project were:-
1. A choice reaction time task (CRT)
2. A tracking task (TT).
Volunteers needed a period of time to learn the two tasks, 
they were therefore allowed to perform the tests five times 
each. The first group of volunteers (Group A containing 15 
volunteers) performed these tests while sitting at a desk
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FIGURE 7. Photograph showing audiometric equipment.
m  n
FIGURE 8 The photograph shows a volunteer having his hearing 
tested.
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with the computer in front of them. It subsequently became 
clear that they could attain faster mean reaction times 
(MRT) and tracking times (TT) in this position, than while 
sitting in a bed with the computer in front of them.
Finally 20mls of blood were obtained for the following tests.
1. Full Blood Count and Platelets
2. Urea and electrolytes
3. Liver function tests.
Several volunteers were excluded for the following reasons:-
1. Hypertension
2. Previous myocardial infarction (noted from 
questionnaire)
3. Inability to perform performance tests adequently on 
a computer
4. Minor biochemical upsets eg Gilbert's syndrome.
Thirty volunteers were assessed. They were divided into two 
groups A & B. Group A each attended three sedation sessions, 
and were given isoflurane 0, 0.31, 0.5, 0.75%(actual
concentration),enflurane 0, 0.17, 0.42, 0.6%(actual
concentration); the layout of the placebo session was the 
same as that for the isoflurane and enflurane. Group B 
attended for two sedation sessions and were given a placebo 
run and isoflurane 0, 0.2, 0.31, 0.4% (actual
concentration). Actual mean concentrations are given as the 
vaporisers were calibrated using an accurate gas 
chromatography technique, [Gray ,1986].
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SEDATION SESSION - PREPARATORY RUN
A preparatory run of the sedation session was performed to 
ensure that small practicalities were correct before the 
procedure took place.
The following points were obvious problems:-
1. A tilting bed was necessary in the event of 
regurgitation and vomiting of a sedated volunteer. The 
bed was positioned and experience gained of the tilting 
mechanism.
2. The gas delivery system needed to be positioned to 
allow access to the patient with the Bain circuit 
connecting and access to the four size G air and oxygen 
cylinders, [Figure 9].
3. The computer and apparatus necessary to measure AER 
was positioned on the right side of the bed.
4. A table was obtained to place the computer on, over 
the bed, allowing the volunteer to see the screen 
easily. A small portable lap tray was obtained to 
accommodate the keyboard and mouse, allowing the 
volunteer to manipulate them.
5. Monitors to measure heart rate, blood pressure, 
axillary temperature and oxygen saturation were 
positioned and attached to the patient. All the above 
measurements were made with one system, a Criticare
FFIGURE 9 . Photograph illustrating the arrangement of 
equipment on the volunteer, and the anaesthetic machine and 
auditory evoked equipment in the background.
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monitor.
6. As volunteers were required to wear a large amount 
of apparatus around the head and neck, a system for 
placing this on with the least inconvenience was 
devised. Initially the Hudson mask was fitted in a 
comfortable position for the volunteer. The AER 
electrodes were placed behind the two mastoids and on 
the vertex, after preparation of the skin. These were 
secured with a swab and micropore tape. Finally the 
headphones were adjusted for size and placed on the 
ears.
7. The brainstem AER, early and late cortical AERs were 
measured.
8. The Normac monitor to measure end-tidal C02 was 
calibrated using calibration gas.
The Normac was not quite in calibration but compensation was 
possible. Reading on normac was 1% higher than actual 
enflurane concentration.
Normac reads Actual enflurane
0.15 0
3.8 2.8
Monitor was reset and recalibrated (subtracting 1% from each 
reading). The Normac was not used throughout the study 
because the information in gave was unreliable.
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BASIC FORMAT FOR SEDATION SESSION
For each visit ie placebo, enflurane, isoflurane, volunteers 
underwent a common sequence of events.
Initially they signed a consent form and agreed to be 
accompanied home or to go home by taxis. They then reclined 
on a bed , their neck muscles were supported with pillows. 
Monitoring equipment for non-invasive blood pressure, heart 
rate, saturation and temperature were attached to the 
volunteer. A Hudson oxygen mask was applied (the side ports 
being occluded), and the electrodes for the AERs were 
I applied behind both mastoids and on the vertex, [Figure 10].
I These were secured with tape and the headphones applied. The 
I volunteer was asked if the computer for the psychometric
I tests was easily visible, and if the keyboard and mouse were
j
in a comfortable position.
Baseline results were then collected in the following order
1. Long latency AER (LLAER)
2. Brainstem AER (BSAER)
3. Middle latency AER (MLAER)
4. Tracking task (TT)
5. Choice reaction time (CRT)
6. Heart rate (HR)
7. Blood pressure (BP)
8. Saturation (SaO^)
9. Respiratory rate (RR)
10. Volunteers are were asked about smell, taste, 
diplopia, dizziness.
fFIGURE 10. The arrangement of electrodes and headphones on 
the volunteer.
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Both 4 & 5 are repeated until the volunteer attains a stable 
result or achieves the results that he/she attained at the 
previous visits. During each session twenty minutes was 
given for each concentration of gas to equilibrate before 
any measurements were made.
At each concentration of volatile agent and equivalent 
placebo level, the volunteer underwent the above tasks and 
was also assessed as to their ability to cooperate with the 
tasks, verbal contact, patency of the airway or snoring, and 
general state of consciousness from fully conscious, 
conscious but uncooperative, to unconsciousness.
Recovery was assessed at ten minutes and twenty minutes 
after the gas was switched off. Psychometric tests were
assessed at ten minutes along with cardiovascular
parameters, the AERs are measured after this, and finally 
the cardiovascular parameters and psychometric tests were 
again assessed.
The placebo session was conducted similarly, the time scale 
being the same ie at each " level" twenty minutes was given
to allow "equilibration" as for the isoflurane and
enflurane sessions.
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INITIAL SEDATION SESSION WITH VOLUNTEER
On 22/10/91 the first sedation session, using a volunteer 
was performed.The volunteer was a 28 year old male, 
previously in good health
1. An audiogram was initially performed, which was 
normal. The volunteer rested on the bed in a sitting 
position to enable him to see the computer.
2. The gas measuring probe was taped to his cheek to 
measure end-tidal carbon dioxide and end-tidal 
enflurane and isoflurane at 1457hrs. The Hudson mask, 
AEP electrodes and headphones were all applied. A 
control brainstem and late cortical AEP was 
performed. The volunteer was then asked to perform 
baseline performances tests.
3. The gas cylinders at the start of the session showed 
the following pressures:-
Air cylinder 13700kPa 
Oxygen cylinder ISOOOkPa.
A flow of 101/min of gas was supplied, with an FiÜ2  
of 0.3 through an Quantiflex mixer.
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4. The first trials of AERs showed marked interference - 
a regular sine wave, due to the AC current from the 
computer and fluorescent lights. The plug 
arrangements were adjusted and the computer (Amstrad 
PC1512) was switched off. The interference on the 
trace was no longer present. If ambient lighting 
decreased, tungsten bedside lamps were used instead.
The session continued in the following way:-
ISlOhrs the first BSAER was completed.
1516hrs the first LLAEP was completed.
ISlBhrs enflurane was switched on at 0.2%. The volunteer 
noticed this immediately, at this point he 
seemed very relaxed.
1520hrs volunteer feeling fine, not sleepy as yet. NORMAC 
shows a respiratory swing.
1525hrs volunteer comfortable, all well.
1526hrs computer on for loading programs.
1528hrs no feelings of sleepiness.
1533hrs respiratory swings on NORMAC obviously less, but
still showing very small movement - not sleepy, 
but feels relaxed.
1538hrs reaction time completed
Mean Reaction time (MRT) 1.05s
Reaction time Coefficient of Variation (RCV) 12.5s 
Reaction success (RS) 97%
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1544hrs
Mean Tracking time (MTT) 0.709sec
Tracking time Coefficient of Variation (TCV) 40.67 
Both tracking time and reaction time showed a small but 
probably non-significant decrement in both.
1544hr8 computer off to facilitate AERs, good BSAER.
1557hrs enflurane increased to 0.4%.
1603hrs all well
1604hrs volunteer feeling drowsy (equivalent to about half 
a pint of beer).
1618hrs CVS observations made, reaction time started, 
significantly more mistakes made.
MRT 1.15 
RCV 13.15 
RS 93.3 
MTT 0.72 
TCV 44.83
1623hrs AERS measured, computer off.
Marking of AERs during next run, saves time.
1631hrs AERs going well, time overrunning, from estimated
time, volunteer informed of this, and agreed to 
stay.
1635hrs enflurane increased to 0.6%, need to keep flow of 
Bain circuit at lOOmls/kg.
1642hrs all well, may need to start earlier, as recovery 
room closes at 5pm.
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1644hrs volunteer describing ' feeling of floating', 
probably equivalent to 4-5 pints.
1655hrs
MRT 1.32 
RCV 2.52 
RS 86%
MTT 0.915s 
TCV 42.43s
(subjects approach to target different - target is 
circled).
1657brs AERs 
1705hrs no problems
1707hrs slight snoring, saturation 98%.
1708hrs volunteer very sleepy, no spontaneous movement, 
enflurane to zero %.
1712hrs sleeping comfortably, no airway problems.
1714hrs awakened by gently shaking and saying of name.
MRT 1.353 
RCV 15.06 
RS 100%
MTT 0.738 
TCV 34.07
1719hrs volunteer still feels sleepy, equivalent to 4-5 
pints of beer.
Page No 131
1722hrs volunteer now feeling less sleepy,but aware that he 
'dozed off'.
1728hrs Final performance tasks
MRT 1.12 
RCV 10.32 
RS 100%
MTT 0.711 
TCV 40.89
1731hrs final AER
1744hrs mask off, volunteer feeling well.
This initial run of the experiment allowed us to predict any 
problems, for instance the interference on the AER computer 
from other ac mains sources such and the Amstrad computer 
and fluorescent lightening. The normac vapour analyser, 
demonstrated respiratory swings, but gave no useful 
readings, as the scale was too small.
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PSYCHOMOTOR TASKS
CHOICE REACTION TIME
A choice reaction task is a task which requires the 
volunteer to react to the onset of a discrete random 
! stimuli. The magnitude of this reaction time is measured.
In this project we used a computerised CRT task developed 
by Dr W. Gray. The volunteer views the monitor, by keeping 
his finger on the letter "B" key, a random number will then 
appear on the screen; the numbers used are 4,5,6,7,8,9. The 
volunteer presses the appropriate number key in response. 
The sequence involves 30 trials ie 30 numbers each requiring 
a response. The computer programme checks that the starting 
key has been pressed initially, and checks that it remains 
pressed after one second and subsequently after every 0.1 
second. These times correspond to the times the computer 
waits before the first (Is) and subsequent (0.1s) auto­
repeats of a pressed key.
The programme allows a minimum delay, between pressing the 
letter B and a number appearing on the screen, is one 
second, although this delay period varies between one and 
three seconds, [Figure 11].
At the end of each sequence the computer displays the number 
of trials, number of successes, success rate, mean reaction 
time(sec), standard deviation, coefficient of variation.
FIGURE 11. Volunteer attempting the tracking task
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TRACKING TASK
In a typical tracking task a volunteer is required to make a 
response to a visual cue provided by the relative positions 
and rates of travel of a target and a cursor.
We have used a computerised tracking task developed by Dr 
W. Gray. On the monitor a small circle appears along with a 
cursor in the form of a cross. The movement of the cursor is 
controlled with a mouse by the volunteer. The small circle 
moves randomly. The volunteer attempts to place the cursor 
in the circle, at which point the circle changes colour to 
white.
The circle starts in the middle of the screen and moves 
with a fixed step length in a random direction. Obviously if 
the circle moves to the edge of the screen, as will have 
eventually happen with a randomly moving object, the task 
will become easier as it will allow the cursor to be placed 
in the circle more easily. To avoid this, there is a large 
invisible "boundary" circle within which the small circle 
is restricted, preventing the small circle approaching the 
edge of the screen.
The large boundary circle has a diameter of 90% of the 
screen height. The target circle diameter has diameter of 4% 
of the screen height. The fixed step length by which the 
small circle moves is twice the diameter of the small 
circle.
The default values for the mouse cursor were changed in the
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computer programme to allow the cursor to have the same 
sensitivity to mouse movement in the x and y directions.
In the original version of the programme, once the circle 
was moved to a new position a fixed time would elapse before 
a trial was considered a success or failure, and this would 
then be expressed as a percentage success. This was altered 
in the version used in this study. Once the circle has moved 
to a new position, the cursor catches up and the time is 
measured. This alteration was made to prevent the volunteer 
with practice achieving 100% success with practice. Each 
sequence involves 100 trials.
Previous tracking tasks have measured at the end of a fixed 
time the distance of the cursor from the circle, [Hindmarch, 
1980].The cursor on a computer used with the mouse is 
usually an arrow, this has been changed to a cross for ease 
of use. To prevent the subject moving the cursor straight 
through the circle but not halting inside it, the programme 
ensures that the cursor is inside the circle for 0.25sec 
before it is registered as a success. This 0.25 sec is not 
taken into account when the time is calculated. If the 
cursor does not remain in the circle for 0.25sec, the 
programme continues and keeps on adding to the time for that 
trial.
The final display shows
Number of trials
Mean tracking time (sec)
tr
FIGURE 12. The photographs show the volunteer attempting the 
tracking task, and the display of results once it had been 
completed.
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Standard deviation
Coefficient of variation, [Figure 12].
The computer programme for both the choice reaction time and 
tracking task were written in Borland Turbo Pascal Version.
Calculation of Results
Significance values of the means were calculated using a 
Mann-Whitney test.
The following comments apply to both the table of values for 
each variable and the accompanying graph. Significance 
values have been calculated for the means at each specified 
gas concentration and its corresponding lower concentration, 
and also the means at each specified concentration of 
isoflurane and enflurane compared to the corresponding 
placebo values.
STATISTICAL ANALYSIS
PROBLEMS
The data presents several analytical problems:- 
First, within the data there are two studies A and B, and 
some concentrations of the same volatile agent occur in both 
groups; can the groups be combined?
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Second, the numbers in some subgroups are dissimilar because 
excessively sedated volunteers, were been taken out of the 
study for safety reasons. For example in some cases there 
are 15 placebo results and 3 results at the high volatile 
agent concentrations.
Third, every hypothesis testing method makes assumptions 
about the data, and a common assumption is that the results 
in the subgroups (eg the CRT at 0.3% isoflurane) are 
technically independent of each other. The independence of 
the measurements made in the same patients at on week 
intervals (ie the exposures to the placebo, isoflurane and 
enflurane) occurred is obvious.
When comparing the effects of different concentrations of 
any agent (placebo, isoflurane or enflurane) during one 
exposure session in the same patient, the assumption of 
independence becomes more difficult to sustain.
Fourth, there is always a danger when undertaking multiple 
comparisons that by chance alone significant results might 
arise.
Method
Before combining data from the same concentration of 
volatile agents in volunteers from groups A and B, the data 
was tested to determine whether it could be considered to be
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part of one population, by comparing both parts (ie A and B) 
using the Mann Whitney test. The data was only combined if 
the probability was less than 0.01. This testing of the 
Group A placebo against the Group B placebo, and the Group A 
concentration (eg 0.3% isoflurane ) against the Group B 
concentration data for 0.3 isoflurane. In no case was there 
a significant difference between the groups, and therefore 
the groups were combined.
To analyse the differences between the placebo data and the 
data at each individual concentration a Mann Whitney test as 
implemented in Minitab 7 was used with a probability less 
than 0.01 being considered significant. The Mann Whitney 
test readily copes with the problems of different numbers in 
the groups.
To analyse the data between different concentrations the 
Wilcoxon Signed Ranks test was used; this was achieved in 
Minitab 7 by simple differencing between the relevant 
columns and then performing a one sample rank sum test 
(WTEST) on the difference results, a probability less than
0.01 being considered significant. Note that the 
differencing using the ’LET" Minitab command puts a missing 
data in the column, and WTEST ignores these. This
effectively means that this Wilcoxon Signed Ranks test copes 
with the problem of imperfect data pairing by ignoring data 
that is not paired.
The problem of the multiple comparisons was dealt with by 
choosing a more conservative level at which to assign
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significance, ie a probability less than 0 .0 1 , rather than 
the conventional 0.05.
CHAPTER FIVE
EQUIPMENT
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EQUIPMENT
1. THE GAS DELIVERY SYSTEM
The apparatus required for the delivery of the gas mixture 
was assembled'specifically for this project. The following 
requirements had to be fulfilled:-
a) The apparatus required to deliver a high flow of gas, 
sufficient to adequately supply a Bain circuit.
b) A Bain circuit was chosen as it connects easily to a 
lightweight Hudson mask ( the air vents at the side 
were taped over, to prevent dilution by air).
c) A mixture of air and oxygen was chosen to prevent any 
possible side-effects from the delivery of 1 0 0 % 
oxygen, or from the supply of an inadequate amount of 
oxygen present in air, in a sedated patient.
d) Two specially calibrated vaporisers were obtained 
from Penlon to deliver low concentrations of volatile 
agent. As these were not of the Selectatec variety, 
they had to be mounted on the back bar of an 
anaesthetic machine.
2. COMPONENTS OF GAS DELIVERY SYSTEM
a) Four size G cylinders of each of oxygen or air.
b) A reducing valve and pressure indicator for the 
cylinders in use (one cylinder oxygen and one 
cylinder air were kept as back up cylinders).
FIGURE 13. The photograph shows the equipment used to 
deliver the anaesthetic gases. The Quantiflex mixer is on 
the left of the machine, the two vapourisers on the right 
and a Bain circuit on the extreme right. Oxygen cylinders 
can be seen in the background. On the lower shelf the 
Criticare monitor for measuring blood pressure, heart rate 
oxygen saturation and temperature can be seen.
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c) On the Boyles machine a Quantiflex oxygen/air mixer 
was mounted, along with the two Penlon vaporisers for 
enflurane and isoflurane.
d) The Bain circuit, [Figure 13].
3. CALIBRATION
Flow through the Quantiflex vaporiser was calibrated using a 
pneumotachograph, the following results were obtained.
Flow through Quantiflex Reading on Pneumotachograph
51/min 5.11/min
71/min 7.11/min
1 0 1 /min 1 0 1 /min
The vaporisers were calibrated using a gas chromatography 
technique. The definitive calibration using the above 
technique gave the following calibrations.
Using concentration of 30% oxygen in air. Air flow being 
1 0 1 /min, therefore a total flow of about 1 1 1 /min.
Isoflurane
Dial Setting Actual cone
1 st mark 0 . 1
2 nd mark 0 . 2
3rd mark 0.25
0.2 click stop 0.31
5th mark 0.4
0.4 click stop 0.57
Enflurane
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Dial Setting Actual Cone
0.2 click stop 0.17
0.4 click stop 0.42
0 . 6  click stop 0 . 6
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EQUIPMENT USED TO MEASURE AUDITORY EVOKED RESPONSES.
The equipment used to measure the AER was a Bio-logic 
Traveller Express portable computer. This computer is an 
IBM/AT compatible 80286 machine with 1MB RAM and two 5.25" 
360K floppy disk drives, [Figure 14].
This computer is equipped with a supertwist electro­
luminescent backlit LCD, 10.5in diagonal size, 640x400 
resolution. There is a detachable keyboard and a mouse is 
present.
Hardware/software interface.
The apparatus comes complete with single or dual channel, 
optically-isolated preamplifiers which have the following 
f eatures: -
Gain - 10-300,000
Noise level - 0.6 microvolts RMS
Input impedance - >100Mohm
Common Mode rejection ratio - > llOdB at 50/60Hz
Built in impedance test - 20Hz sinewave
Active filters - 2-pole Butterworth - (12dB/octave)
High pass - (low cut) DC to 300Hz 
Low pass - (high cut) 30Hz to lOkHz 
50/60 Hz notch filter
Filter cutoffs, gains, and notch filter under 
software/operator control.
FIGURE 14. Photograph showing the computer used to measure 
auditory evoked responses. The screen displays the BAER and 
LLAER waveforms.
FIGURE 15. Photograph showing the electrodes used to measure 
the auditory evoked response.
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Software and transducer
The computer is capable of measuring auditory, visual, 
somatosensory and electroneurography evoked responses. The 
operating system is Microsoft MS-DOS.
The auditory software enables the operator to programme 
stimulus type;- click, filtered click, single sine wave,and 
tone bursts.
The transducer used for this project was a TDH-39 
earphones.
The frequencies, intensities, durations, rise/fall times are 
all programmable.
I Stimulus rates: 0 . 1  to 2 0 0 /sec in 0 . 1  per sec steps are 
available.
Stimulus intensity : 0-125 dB peak-equivalent SPL(sound 
pressure level) or user specified nHL (normal hearing 
level) .
Masking is available with white noise, the intensity of 
which is programmable.
Analysis time: 2.56 to 9,999msec.
Analog/Digital converter: 8 -bit resolution, 2 channels, 1.2 
microsec conversion time per channel.
The use of keyboard or mouse controlled cursors, allows 
interactive positioning on waveforms during data analysis.
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and calculation of absolute and interpeak latencies, 
amplitudes, and amplitude ratios.
A choice of 256 or 512 points per trace
The impedance of the electrodes was kept below five kohms.
I  This was achieved by careful preparation of the skin with
!
I Omniprep, a ground glass abrasive fluid and further cleaning 
! of the skin with alcohol swabs. As the surface often came 
off the silver chloride electrodes with use, it was very 
important to maintain the electrodes adequently by placing 
them in Milton 0.01% hypochlorite solution for 24hrs. When 
the coating disintegrated it became very difficult to obtain 
low impedances, [Figure 15].
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PARAMETERS USED FOR RECORDING OF AUDITORY EVOKED POTENTIALS 
BRAINSTEM
Channel 1.
Points 512/trace.
High filter 3000Hz.
Notch filter in.
Electrodes Cz/mastoid 
Stimulus-alternating click 75dB 
Max no stimulations 2048.
Stimulus rate 11.1/sec.
Stimulated ear right.
Masking white noise to left ear 45dB. 
Stimulator headphones.
LONG-LATENCY CORTICAL AER.
Window 10.24 
Gain 150,000 
Low filter lOOHz.
Artifact rejection enabled
Window 250 
Gain 24000 
Low filter IHz.
Artifact rejection enabled.
Channel 1.
Points 512/trace.
High filter 150Hz.
Notch filter in.
Electrodes Cz/mastoid.
Stimulus-alternating tone burst 75dB 
Frequency lOOOHz. Plateau 180
Stimulated ear - right Rise 10
Ramp linear
Masking white noise left ear.
Max no stimulations 50. Stimulus rate 0.5/sec.
Stimulator headphones
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MIDDLE LATENCY CORTICAL EVOKED RESPONSE.
Channel 1. Window 100.
Points 512/trace. Gain 150,000.
High filter 300Hz. Low filter lOHz.
Notch filter in. Artifact rejection enabled
Electrodes Cz/mastoid.
Stimulus-alternating click 75dB.
Max no stimulations 2048. Stimulus rate 10/sec. 
Stimulated ear right. Stimulator headphones.
Masking white noise left ear.
The middle latency AER proved to be very difficult to 
measure due to artifact, most probably from muscle activity. 
This did not seem to be abolished with sedation until the 
volunteer was unconscious, although in many cases even this 
did not abolish the interference. Other causes of 
interference were excluded, such as electricity sources. 
When these caused interference the pattern was not the 
same, and much more obvious.
OTHER EQUIPMENT INVOLVED
1. Criticare combined non-invasive blood pressure, 
temperature, ECG, and pulse oximeter.
2. Amstrad 512 IBM compatible personal computer for 
performance tasks. This computer has two 5.25" floppy 
disk drives and 512kB of RAM, [Figure 12 & 13].
CHAPTER SIX
RESULTS.
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RESULTS
Thirty volunteers were assessed, of those 19 were males 
(63.3%) and 11 were females (36.6%). The median age of the 
group was 22.5 years and the median weight was 67.5 kg.
Axillary temperature was measured and all values were 
within normal limits. Blood pressure, temperature and carbon 
dioxide levels which are all reputed to alter the AERs were 
measured and all those values that were measured were 
within normal limits. Oxygen saturation was measured for 
safety and no volunteer had a value below 96%.
Otherwise no major side-effects were noted. Volunteers 
noticed the smell of the two gases when the concentration 
was altered. But by the time it came to measuring the 
variables after 2 0 min the majority could not detect the 
smell.
For each of the variables examined, there is a table showing 
numbers in each group, the mean, median, standard deviation 
and interquartile range at each concentration of volatile 
agent and corresponding placebo.
PIQQ Latencv - Table 5. Isoflurane and enflurane increased 
the latency of the waveforms compared with placebo but not 
significantly, with the exception of one value 0.75% 
isoflurane and the recovery period at 10 minutes. When the 
PlOO at each concentration of gas is compared with the 
corresponding placebo value they are all non-significant
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with the exception of the 0.4% isoflurane concentration. The 
values for standard deviation and IQR also increase with 
increasing concentration of enflurane and isoflurane, while 
those for placebo remain stable.
PlOO Amplitude - Table 6 . Again the majority of PIOOA values 
are non-significant with the exception of the difference of 
the means between 0.3% and 0.4% isoflurane, and 0.75% 
isoflurane compared with placebo.
NIQO Latencv- Table 7. No significant differences were found 
between the isoflurane concentration steps and placebo 
values. Mean values of NIOOL at concentrations of 
isoflurane 0.3% and 0.5% compared with the corresponding 
placebo levels were highly significant as was the enflurane 
0.4% level compared with its corresponding placebo value. 
0.4% isoflurane was significantly different from the 
corresponding placebo value. The placebo level compared with 
isoflurane 0.75% was non-significant, but this may have been 
due to the low numbers in the group (2). Standard deviations 
and IQR increased for both isoflurane and enflurane,while 
those for placebo also increased.
NIOQ Amplitude- Table 8 . Again significant differences 
between mean NlOOA's were found at 0.2% isoflurane and 0.6% 
enflurane in comparison to placebo. The mean NlOOA's at 0.3% 
and 0.5% isoflurane were highly significantly different when 
compared with equivalent placebo means.
Page No 149
P2QQ Latencv- Table 9. Significant differences in mean P200L 
were found at 0.4% and 0.5% isoflurane and 0.4% enflurane 
when compared with placebo.
P20Q Amplitude - Table 10. A highly significant difference 
in means was noted between 0.3% isoflurane and 0.6% 
enflurane and the corresponding placebo levels. The mean 
,P 2 0 0A at 0.5% isoflurane compared with placebo was 
significantly different, as was the comparison between 0.4% 
and 0.6% enflurane and placebo. A significant difference was 
noted between 0.6% enflurane and recovery at lOmin.
Brainstem Waveforms - Table 11-20.The means of the latencies 
and amplitudes of the brainstem waveforms did not change 
with increasing concentrations of enflurane or isoflurane. 
The mean of waveform V latency at 0.5% isoflurane was 
significantly different from the corresponding placebo 
level. Although there were significant differences with 
0.5% isoflurane and 0.42% enflurane compared with their 
respective placebo means. No significant differences were 
noted for the mean of BSVlat at 0.75% isoflurane and the 
corresponding placebo mean, but as there were only three 
volunteers in the group who were still reusable, the data 
can not easily be interpreted.
The means for brainstem waveform V amplitude showed no 
significant differences except for the placebo mean between 
baseline, the placebo equivalent of 0.2% and 0.3%, and a
Page No 150
highly significant difference between means of placebo 0.3% 
and 0.4%.
Mean Tracking Time - Table 21.
Mean tracking time is the mean of the mean of 100 attempts
on the tracking task which constitutes one trial.
1.Isoflurane affects the mean MTT significantly at 0.3%
compared with placebo values. The IQR (a measure of 
dispersion based on the median, the 50th percentile, i.e. 
the distance between the 25th and 75th percentiles) becomes 
larger, as does the standard deviation. By the recovery 
period all these values have returned to pre-anaesthetic 
levels or below.
I
! The standard deviation and IQR of the placebo group, remain
I
essentially the same. The median values for baseline placebo 
and recovery do not change significantly.
2. Enflurane sedation changes the mean MTT at about 0.42% 
when compared with placebo and at higher values. Again the 
standard deviation and the IQR are altered with increasing 
concentration of volatile agent, but return to baseline with 
recovery. Recovery values are not significantly altered from 
placebo values.
Tracking Coefficient of Variation - Table 22.
The tracking coefficient of variation is the standard 
deviation divided by the mean expressed as a percentage.
The median can be seen to be rising with a maximum at 167%
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at (0.75% isoflurane), the standard deviation and IQR rising 
as well. The placebo means do not significantly differ from 
baseline.
Again enflurane has altered the mean TCV significantly, 
initially at 0.4% when compared with placebo. The IQR and 
standard deviation also increased. Notice that although the 
median value at recovery lOmins has attained baseline 
levels, the mean value was significantly lower than 
baseline.
Recovery for isoflurane and enflurane are not significantly 
different from placebo.
Mean Reaction Time - Table 23.
The mean reaction time is the mean of the mean of 30 
attempts of the reaction time task which constitute one 
trial.
Mean Reaction times became highly significantly different at 
0.3% isoflurane when compared with placebo. Standard 
deviations and IQR again increase with increasing 
concentrations of isoflurane up to 0.75%. Placebo median 
values do not change significantly, and standard deviations 
and IQR do not alter.
Enflurane causes significant changes in MRT at 0.17% and 
0.42%, the standard deviations and IQR values increasing as 
well. At recovery 20 mins ,these values have all returned to 
baseline.
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Mean Reaction Time-Coefficient of Variation - Table 24.
The mean reaction time coefficient of variation is the 
standard deviation divided by the mean expressed as a 
percentage.
The mean MCV becomes significantly different at 0.3% 
isoflurane compared with placebo. By recovery lOmin the 
median values are equivalent to baseline levels.
The placebo mean values remain non-significantly different 
with the exception of 0.75% isoflurane and recovery 10 mins. 
Enflurane causes no significant change in the MCV compared 
with placebo although the median values do change.
Reaction Success - Table 25.
The reaction success became significantly different at 0.3% 
isoflurane compared with placebo, the recovery values 
approaching baseline.
Again-the IQR and standard deviations increase with 
increasing concentration.
The placebo values again being not significantly different. 
Enflurane cause a significant difference at 0.4% compared 
with placebo; The IQR and standard deviations increasing.
TABLE 5. Long-latency cortical AER PlOO latency. A, 
indicates significance with respect to the previous 
concentration. B, indicates significance with respect to 
the placebo concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane
0 . 0 29 42.7 7.4 43.0 12.7 - NS
0 . 2 1 2 47.4 7.8 46.6 13.7 NS NS
0.3 28 44.8 8 . 8 43.5 9.6 NS NS
0.4 14 51.3 13.4 46.4 26.0 NS S
0.5 14 46.2 14.1 46.2 23.7 - NS
0.75 2 58.6 1 1 . 1 58.6 - NS NS
RIO 28 39.2 7.5 38.8 1 0 . 0 NS NS
Placebo
0 . 0 28 42.3 8.3 41.5 1 1 . 8 -
0 . 2 15 41.2 9.5 39.6 19.0 NS
0.3 27 40.8 6.9 41.5 1 0 . 2 NS
0.4 1 2 39.4 7.9 39.6 1 2 . 0 NS
0.5 14 39.1 7.1 41.0 8.9 NS
0.75 13 41.8 10.4 40.5 5.4 NS
RIO 27 41.9 8.5 42.5 10.3 NS
Enflurane
0 15 41.6 5.9 42.0 8 . 8 - NS
0.17 15 39.4 1 0 . 6 42.5 14.1 NS NS
0.42 14 43.4 8.5 44.4 1 2 . 8 NS NS
0 . 6 1 2 49.1 12.7 44.2 2 2 . 2 NS NS
RIO 28 39.2 7.45 38.8 1 0 . 0 NS NS
TABLE 6 . Long-latency cortical AER PlOO amplitude. A, 
indicates significance with respect to the previous 
concentration. B, indicates significance with respect to 
the placebo concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane
0 29 -1 . 8 2 . 0 -1.5 2.7 - NS
0 . 2 1 2 -1 . 8 1.7 -1 . 8 3.2 NS NS
0.3 28 -2.3 1.7 -2 . 2 2.5 NS NS
0.4 14 -1 . 1 1.4 -1 . 2 2.4 S NS
0.5 14 -2 . 2 1.9 -1.9 1 . 6 - NS
0.75 2 -4.2 0 . 1 -4.2 - NS S
RIO 28 -2 . 0 2 . 0 -1.7 2 . 6 NS NS
Placebo
0 28 -1 . 8 1.5 -2 . 2 2.5 - -
0 . 2 15 -1 . 1 2 . 6 -0.3 3.2 NS -
0.3 27 -1 . 8 1.7 -2 . 1 1.7 NS -
0.4 1 2 -1.4 2 . 1 -1.4 3.5 NS -
0.5 14 -1.7 1.4 -1 . 8 2 . 0 NS -
0.75 13 -1 . 0 1 . 8 -0 . 6 2.7 NS -
RIO 27 -1 . 6 1.7 -1 . 8 2 . 1 NS -
Enflurane
0 14 -2 . 0 1.7 -2 . 1 1 . 6 - NS
0.17 15 -1 . 2 2.4 -1 . 0 3.6 NS NS
0.42 14 -1.9 1.7 -1.7 2 . 8 NS NS
0 . 6 1 2 -2.4 2 . 0 -2.4 3.6 NS NS
RIO 14 -1.9 1.5 -2.5 2.7 NS NS
TABLE 7. Long-latency cortical AER NlOO latency. A, 
indicates significance with respect to the previous 
concentration. B, indicates significance with respect
to the placebo concentration at each level.
Cone No MEAN SD MEDIAN IQR A B
Isoflurane
0 30 94.9 6 . 1 96.2 7.68 - NS
0 . 2 15 1 0 0 11.81 97.7 15.6 NS NS
0.3 30 1 0 2 . 6 10.5 1 0 0 . 8 8 . 6 NS HS
0.4 13 105.1 13.3 106.4 25.2 NS S
0.5 14 105.4 1 1 . 1  . 103.8 13.4 - HS
0.75 2 95.5 4.5 95.5 - NS NS
RIO 30 94.4 8.7 95.7 10.7 NS NS
Placebo
0 30 95.2 7.0 94.2 7.4 - -
0 . 2 15 95.3 7.4 96.2 8 . 8 NS -
0.3 29 93.0 7.6 91.8 9.5 NS -
0.4 15 92.6 7.95 91.8 10.3 NS -
0.5 15 8 6 . 2 17.2 91.3 15.6 NS -
0.75 13 96.7 13.8 91.3 2 0 NS -
RIO 28 94.2 8.3 95.0 1 0 . 1 NS -
Enflurane
0 15 94.8 7.4 92.8 7.81 - NS
0.17 15 94.3 11.9 90.8 16.1 NS NS
0.42 15 1 0 2 . 2 11.7 1 0 1 . 6 14.6 NS HS
0 . 6 13 104.9 16.3 1 0 0 . 6 24.9 NS NS
RIO 15 92.7 1 1 . 6 95.2 17.1 NS NS
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FIGURE 16. Graph showing the NlOO latency (median values). 
Values for enflurane and isoflurane show a significant 
difference from placebo values. Values have achieved 
baseline at the recovery period.
Table 8 . Long-latency cortical AER NlOO amplitude. A, 
indicates significance with respect to the previous 
concentration. B, indicates significance with respect 
the placebo concentration at each level.
Cone No 
Isoflurane
Mean SD Median IQR A B
0 30 7.0 2 . 0 7.0 2 . 6 - NS
0 . 2 15 5.9 1.4 6 . 1 1.9 NS S
0.3 30 5.6 2 . 1 5.6 3.1 NS HS
0.4 13 4.9 2.4 4.8 3.5 NS NS
0.5 14 4.5 2 . 6 4.4 3.7 - HS
0.75 2 6 .6 1 . 6 6 .6 - NS NS
RIO 30 6.5 2.5 6.4 4.0 NS NS
Placebo
0 30 7.0 2 . 0 6.9 3.2 - -
0 . 2 15 7.2 1 . 6 7.4 2 . 8 NS -
0.3 29 7.5 2.3 7.5 3.1 NS -
0.4 15 6.5 2 . 1 6.9 3.8 NS -
0.5 15 7.6 2.3 7.6 3.3 NS -
0.75 13 7.7 3.1 7.2 4.7 NS -
RIO 29 7.0 2.7 7.1 4.2 NS -
Enflurane
0 15 6 .6 2.3 6.9 4.3 - NS
0.17 15 6.3 2.7 5.3 4.9 NS NS
0.42 15 6 . 2 2.3 5.8 3.6 NS NS
0 . 6 13 5.0 1.9 5.0 3.1 NS S
RIO 15 6.5 2 . 1 6 . 1 2 . 8 NS NS
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FIGURE 17. The graph illustrates values for NlOO amplitude 
(median values). Values for enflurane and isoflurane show 
significant reductions in amplitude, compared with placebo.
Table 9. Long-latency cortical AER P200 latency. A, 
indicates significance with respect to the previous 
concentration. B, indicates significance with 
respect to the placebo concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane
0 30 166.2 11.35 164.8 16.5 - NS
0 . 2 15 174.1 16.03 170.9 27.8 NS NS
0.3 30 177.1 21.5 171.9 34.8 NS NS
0.4 14 183.2 20.3 185.1 21.5 NS S
0.5 14 184.0 27.7 176.9 50.5 - S
0.75 2 161.4 9.32 161.4 - NS NS
RIO 30 170.3 13.4 169.2 19.8 NS NS
Placebo
0 29 169.5 13.3 167.5 20.3 - -
0 . 2 15 167.1 14.7 165.0 16.1 NS -
0.3 30 168.2 17.4 166.0 23.8 NS -
0.4 15 165.8 19.7 157.7 24.2 NS -
0.5 15 161.0 10.5 161.1 14.6 NS -
0.75 13 171.6 16.6 163.6 25.6 NS -
RIO 29 164.2 11.3 163.6 18.1 NS -
Enflurane
0 15 166.5 12.5 167.5 18.1 - NS
0.17 15 170.5 20.9 166.5 2 1 . 0 NS NS
0.4 15 176.5 22.3 169.4 2 2 . 0 NS S
0 . 6 13 176.9 19.7 180.7 27.1 NS NS
RIO 14 158.1 14.2 153.7 23.3 NS NS
Table 10. Long-latency cortical AER P200 amplitude. A, 
indicates significance with respect to the previous 
concentration. B, indicates significance with respect 
to the placebo concentration.
Cone No Mean SD Median IQR A B
Isoflurane
0 30 -7.0 2.5 -6.8 2.71 - NS
0.2 15 -6.0 1.4 -5.6 2.1 NS NS
0.3 30 -5.8 1.9 -5.4 2.3 NS HS
0.4 14 -5.0 2.0 -4.9 3.6 NS NS
0.5 14 -5.1 2.2 -5.0 3.3 - S
0.75 2 -7.4 0.5 -7.4 - NS NS
RIO 30 -6.7 2.5 -5.8 3.7 NS NS
Placebo
0 29 -6.7 3.0 ■ -6-7.0 3.3 - -
0.2 15 -6.7 1.3 -6.8 2.1 NS -
0.3 30 -7.2 2.2 -7.3 2.9 NS -
0.4 15 -6.5 2.1 -6.3 3.4 NS -
0.5 15 -7.2 2.4 -7.5 3.5 NS -
0.75 13 -7.6 2.7 -7.0 3.8 NS -
RIO 29 -7.3 2.1 -7.0 3.4 NS -
Enflurane
0 15 -6.5 2.1 -6.4 2.8 - NS
0.2 15 -6.5 2.1 -6.1 3.8 NS NS
0.4 15 -6.2 2.0 -5.9 3.3 NS NS
0.6 13 -4.1 2.1 ■ -4.2 3.1 S HS
RIO 15 -6.2 1.8 -6.5 2.3 S NS
Table 11. Brainstem AER Wave I latency. A, indicates 
significance with respect to the previous concentration 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane 
0 26 1.6 0.1 1.6 0.1 NS
0.2 15 1.6 0.1 1.6 0.1 NS NS
0.3 28 1.6 0.1 1.6 0.1 NS NS
0.4 13 1.7 0.1 1.6 0.2 NS NS
0.5 15 1.6 0.1 1.6 0.1 - NS
0.75 3 1.6 0.1 1.6 0.1 NS NS
RIO 13 1.6 0.12 1.6 0.2 NS NS
Placebo
0 27 1.7 0.2 1.6 0.2 - -
0.2 12 1.6 0.1 1.6 0.2 NS -
0.3 25 1.7 0.1 1.7 0.2 NS -
0.4 12 1.8 0.5 1.6 0.2 NS -
0.5 15 1.7 0.1 1.7 0.2 NS -
0.75 13 1.7 0.1 1.6 0.3 NS -
RIO 24 1.6 0.1 1.6 0.2 NS -
Enflurane 
0 14 1.6 0.1 1.6 0.1 NS
0.17 15 1.6 0.1 1.7 0.1 NS NS
0.4 15 1.7 0.1 1.7 0.2 NS NS
0.6 13 1.7 0.2 1.7 0.2 NS NS
RIO 14 1.5 0.3 1.6 0.3 NS NS
Table 12. Brainstem AER wave I amplitude. A, indicates 
significance with respect to the previous concentration. 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane
0 26 0.1 0.2 0.2 0.3 - NS
0.2 15 0.1 0.1 0.1 0.2 NS NS
0.3 28 0.1 0.1 0.1 0.1 NS NS
0.4 13 0.2 0.1 0.2 0.2 NS NS
0.5 15 0.1 0.1 0.2 0.1 - NS
0.75 3 0.2 0.1 0.2 0.2 NS NS
RIO 27 0.1 0.1 0.1 0.2 NS NS
Placebo
0 27 0.1 0.1 0.1 0.2 . ,
0.2 12 0.1 0.2 0.1 0.2 NS -
0.3 25 0.2 0.1 0.2 0.1 NS -
0.4 12 0.1 0.2 0.1 0.2 NS -
0.5 15 0.1 0.3 0.1 0.1 NS -
0.75 13 0.1 0.1 0.1 0.1 NS -
RIO 23 0.1 0.2 0.1 0.2 NS -
Enflurane 
0 14 0.1 0.2 0.1 0.2 . NS
0.17 15 0.2 0.3 0.1 0.1 NS NS
0.42 15 0.2 0.1 0.2 0.1 NS NS
0.6 13 0.1 0.1 0.1 0.1 NS NS
RIO 14 0.1 0.2 0.1 0.2 NS NS
Table 13. Brainstem AER wave II latency. A, indicates 
significance with respect to the previous concentration 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane 
0 29 2.7 0.2 2.70.2 NS
0.2 14 2.7 0.2 2.7 0.3 NS NS
0.3 26 2.8 0.2 2.8 0.2 NS NS
0.4 13 2.8 0.2 2.8 0.3 NS NS
0.5 14 2.7 0.2 2.8 0.2 - NS
0.75 2 2.8 0.0 2.8 - NS NS
RIO 26 2.8 0.1 2.8 0.2 NS NS
Placebo
0 29 2.8 0.2 2.7 0.2
0.2 14 2.9 0.2 2.8 0.2 NS -
0.3 26 2.8 0.1 2.8 0.2 NS -
0.4 13 2.9 0.3 2.8 0.3 NS -
0.5 13 2.8 0.1 • 2.8 0.2 NS -
0.75 12 2.9 0.1 2.9 0.2 NS -
RIO 23 2.8 0.1 2.8 0.2 NS -
Enflurane 
0 13 2.8 0.2 2.8 0.2 NS
0.17 12 2.8 0.1 2.8 0.1 NS NS
0.42 14 2.8 0.1 2.8 0.1 NS NS
0.6 11 2.8 0.1 2.8 0.1 NS NS
RIO 13 2.6 0.4 2.8 0.5 NS NS
Table 14. Brainstem AER wave II amplitude. A, indicates 
significance with respect to the previous concentration. 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No Mean SD Median
Isoflurane
0
0.2
0.3
0.4
0.5
0.75
RIO
Placebo 
0 
0.2 
0.3 
0.4 
0.5 
0.75 
RIO
Enflurane
29 0.1 0.1 0.1
14 0.1 0.1 0.1
26 0.1 0.1 0.1
13 0.1 0.1 0.1
14 0.1 0.1 0.1
2 0.1 0.0 0.1
26 0.1 0.1 0.1
29 0.1 0.1 0.1
14 0.1 0.2 0.1
26 0.1 0.1 0.1
13 0.1 0.2 0.1
13 0.0 0.2 0.1
12 0.1 0.1 0.1
23 0.1 0.2 • 0.1
IQR A B
0.1 - NS
0.2 NS NS
0.1 NS NS
0.1 NS NS
0.1 - NS
- NS NS
0.2 NS NS
0.1 - -
0.2 NS -
0.1 NS -
0.2 NS -
0.1 NS -
0.2 NS -
0.2 NS _
0 13 0.0 0.2 0.1 0.1 - NS
0.2 12 0.1 0.3 0.1 0.1 NS NS
0.4 14 0.1 0.1 0.1 0.1 NS NS
0.6 11 0.1 0.1 0.1 0.1 NS NS
RIO 13 0.0 0.3 0.1 0.2 NS NS
Table 15. Brainstem AER wave III latency. A, indicates 
significance with respect to the previous concentration 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No Mean SD Median
0 29 3.7 0.1 3.7
0.2 15 3.7 0.2 3.7
0.3 28 3.7 0.2 3.8
0.4 13 3.8 0.2 3.8
0.5 15 3.8 0.1 3.8
0.75 3 3.9 0.0 3.9
RIO 27 3.8 0.2 3.8
Placebo
30 3.8 0.1 3.8
0.2 15 3.8 0.2 3.7
0.3 29 3.8 0.2 3.8
0.4 14 3.9 0.3 3.8
0.5 15 3.8 0.1 3.8
0.75 13 3.9 0.1 3.8
RIO 28 3.8 0.2 3.8
Enflurane
0 15 3.8 0.1 3.8
0.17 15 3.8 0.1 3.8
0.42 15 3.8 0.1 3.8
0.6 13 3.9 0.1 3.9
RIO 15 3.7 0.4 3.8
IQR A B
0.2 - NS
0.3 NS NS
0.2 NS NS
0.3 NS NS
0.1 - NS
0.1 NS NS
0.2 NS NS
0.2 _ _
0.3 NS -
0.3 NS -
0.3 NS -
0.3 NS -
0.2 NS -
0.2 NS -
0.2 - NS
0.3 NS NS
0.2 NS NS
0.2 NS NS
0.3 NS NS
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FIGURE 18. The graph illustrates the values for brainstem 
wave 111 latency (median values). No significant difference 
can be noted for any of the values for placebo, enflurane 
and isoflurane.
Table 16. Brainstem AER wave III amplitude. A, indicates 
significance with respect to the previous concentration. 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No 
Isoflurane
Mean SD Median IQR A B
0 29 3.7 0.1 3.7 0.2 - NS
0.2 15 3.7 0.2 3.7 0.3 NS NS
0.3 28 3.7 0.2 3.8 0.2 NS NS
0.4 13 3.8 0.2 3.8 0.3 NS NS
0.5 15 3.8 0.1 3.8 0.1 - NS
0.75 3 3.9 0.0 3.9 0.1 NS NS
RIO 27 3.8 0.2 3.8 0.2 NS NS
Placebo
0 30 3.8 0.1 3.8 0.2 - -
0.2 15 3.8 0.2 3.7 0.3 NS -
0.3 29 3.8 0.2 3.8 0.3 NS -
0.4 14 3.9 0.3 3.8 0.3 NS -
0.5 15 3.8 0.1 3.8 0.3 NS -
0.75 13 3.9 0.1 3.8 0.2 NS -
RIO 28 3.8 0.2 3.8 0.2 NS -
Enflurane
0 15 3.8 0.1 3.8 0.2 - NS
0.17 15 3.8 0.1 3.8 0.3 NS NS
0.42 15 3.9 0.1 3.8 0.2 NS NS
0.6 13 3.9 0.1 3.9 0.2 NS NS
RIO 15 3.7 0.3 3.8 0.3 NS NS
Table 17. Brainstem AER wave IV latency. A, indicates 
significance with respect to the previous concentration 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No Mean SD Median
Isoflurane
0 27 4.9 0.3 5.0
0.2 11 5.1 0.2 5.1
0.3 24 5.1 0.2 5.1
0.4 11 5.1 0.2 5.1
0.5 14 5.3 0.2 5.3
0.75 3 5.2 0.0 5.2
RIO 24 5.1 0.2 5.1
Placebo
0 21 5.0 0.3 5.0
0.2 11 5.0 0.2 5.1
0.3 24 5.1 0.2 5.1
0.4 10 5.1 0.3 5.1
0.5 14 5.2 0.2 5.1
0.75 11 5.2 0.1 5.1
RIO 21 5.1 0.3 5.1
Enflurane 
0 14 5.2 0.2 5.1
0.17 13 5.2 0.2 5.1
0.42 12 5.2 0.1 5.2
0.6 11 5.2 0.1 5.2
RIO 14 5.2 0.3 5.1
IQR A B
0.4 - NS
0.4 NS NS
0.2 NS NS
0.5 NS NS
0.3 - NS
0.0 NS NS
0.3 NS NS
0.2 - -
0.4 NS -
0.4 NS -
0.4 NS -
0.2 NS -
0.2 NS -
0.4 NS -
0.3 - NS
0.3 NS NS
0.2 NS NS
0.2 NS NS
0.2 NS NS
Table 18. Brainstem AER wave IV amplitude. A, indicates 
significance with respect to the previous concentration 
B, indicates significance with respect to the placebo
IQR A B
concentration at each level.
Cone No Mean SD Med;
Isoflurane
0 27 0.2 0.1 0.2
0.2 11 0.2 0.1 0.3
0.3 24 0.3 0.1 0.3
0.4 11 0.2 0.1 0.2
0.5 14 0.2 0.1 0.2
0.75 3 0.2 0.0 ■ 0.2
RIO 23 0.2 0.1 0.2
Placebo
0 21 0.1 0.1 0.2
0.2 11 0.2 0.1 0.2
0.3 25 0.2 0.1 0.2
0.4 10 0.2 0.1 0.2
0.5 14 0.2 0.1 0.2
0.75 11 0.2 0.1 0.2
RIO 21 0.2 0.1 0.3
Enflurane
0 13 0.2 0.1 0.2
0.17 13 0.2 0.1 0.2
0.42 12 0.2 0.1 0.2
0.6 11 0.2 0.1 0.2
RIO 14 0.2 0.1 0.2
0.2 - NS
0.2 NS NS
0.1 NS NS
0.2 NS NS
0.1 - NS
0.1 NS NS
0.2 NS NS
0.2 - -
0.3 NS -
0.1 NS -
0.2 NS -
0.1 NS -
0.1 NS -
0.2 NS -
0.2 NS NS
0.2 NS NS
0.2 NS NS
0.1 NS NS
0.2 NS NS
Table 19. Brainstem AER wave V latency. A, indicates 
significance with respect to the previous concentration. 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane 
0 29 5.7 0.2 5.7 0.3 NS
0.2 15 5.7 0.3 5.7 0.3 NS NS
0.3 29 5.7 0.2 5.8 0.3 NS NS
0.4 14 5.8 0.2 5.7 0.5 NS NS
0.5 15 5.9 0.2 5.9 0.2 - S
0.75 3 5.8 0.2 5.8 0.4 NS NS
RIO 27 5.8 0.2 5.8 0.2 NS NS
Placebo
0 30 5.6 0.2 5.6 0.2
0.2 15 5.7 0.3 5.6 0.4 NS -
0.3 29 5.7 0.2 5.7 0.2 NS -
0.4 15 5.8 0.4 5.7 0.3 NS -
0.5 15 5.7 0.2 5.7 0.2 NS -
0.75 13 5.7 0.2 5.7 0.3 NS -
RIO 28 5.8 0.2 5.7 0.2 NS -
Enflurane 
0 15 5.7 0.2 5.8 0.3 NS
0.17 15 5.8 0.2 5.8 0.2 NS NS
0.42 15 5.8 0.2 5.8 0.1 NS S
0.6 13 5.9 0.2 5.8 0.2 NS NS
RIO 15 5.8 0.2 5.8 0.2 NS NS
Table 20. Brainstem AER wave V amplitude. A, indicates 
significance with respect to the previous concentration 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane
0 29 0.2 0.1 0.3 0.1 - NS
0.2 15 0.2 0.1 0.2 0.1 NS NS
0.3 29 0.3 0.1 0.3 0.1 NS NS
0.4 14 0.2 0.1 0.2 0.1 NS NS
0.5 15 0.2 0.1 0.2 0.1 - NS
0.75 3 0.2 0.1 0.2 0.1 NS NS
RIO 27 0.2 0.1 0.2 0.2 NS NS
Placebo
0 30 0.3 0.1 0.3
0.2 15 0.2 0.2 0.2
0.3 29 0.3 0.1 0.3
0.4 14 0.1 0.2 0.2
0.5 15 0.2 0.1 0.2
0.75 13 0.3 0.1 0.3
RIO 28 0.2 0.2 0.2
Enflurane
0 15 0.2 0.2 0.3
0.17 15 0.3 0.2 0.3
0.42 15 0.3 0.1 0.3
0.6 13 0.3 0.1 0.2
RIO 15 0.2 0.3 0.3
0.1
0.2 S 
0.2 S 
0.3 HS 
0.1 NS 
0.2 NS 
0.2 NS
0.1 - NS
0.1 NS NS
0.2 NS NS
0.1 NS NS
0.12 NS NS
MEAN TRACKING TIME
GROUPS A & B
MEAN TRACK TIME
4
3
2
1
0
0.75 Rec 10 Rec 200.6 0.60.3 0.40.20.10
% GONG AND REG TIMES
Isoflurane Placebo — Enflurane
Median Values
FIGURE 19. Graph illustrating median values for mean 
tracking time. Significant differences can be seen for 
values for enflurane and isoflurane compared with placebo. 
The maximum impairment in MTT occuring at 0.6% enflurane 
and 0.75% isoflurane. Values have returned to baseline at 
the lOmin recovery time.
Table 21. Values for Mean Tracking Time. A, indicates 
significance with respect to the previous concentration 
B, indicates significance with respect to the placebo 
concentration at each level.
Cone No 
Isoflurane
Mean SD Median IQR A B
0 30 0.7 0.2 0.7 0.2 - NS
0.2 15 1.0 0.6 0.8 0.6 S NS
0.3 30 1.4 1.0 1.0 0.9 s HS
0.4 14 1.7 1.2 1.3 1.1 NS HS
0.5 15 2.0 1.9 1.0 1.7 - HS
0.75 3 2.9 1.0 3.2 1.9 NS HS
RIO 30 0.8 0.2 0.7 0.2 NS NS
R20 30 0.7 0.2 0.7 0.1 NS NS
Placebo
0 30 0.7 0.2 0.7
0.2 14 0.7 0.2 0.7
0.3 30 0.7 0.2 0.7
0.4 15 0.8 0.2 0.7
0.5 15 0.7 0.1 0.7
0.75 14 0.7 0.1 0.7
RIO 30 0.7 0.2 . 0.7
R20 30 0.7 0.1 0.6
Enflurane
0 15 0.7 0.1 0.7
0.17 15 0.8 0.1 0.8
0.42 15 1.23 0.9 1.0
0.6 13 1.6 1.1 1.2
RIO 15 0.7 0.1 0.7
R20 15 0.7 0.1 0.7
NS
NS
NS
NS
NS
NS
NS
0.1 - NS
0.1 NS NS
0.3 S HS
1.0 NS HS
0.2 S NS
0.1 NS NS
Table 22. Values for Tracking coefficient of variation 
A, indicates significance with respect to the previous 
concentration.B, indicates significance with respect 
to the placebo concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane
0 30 44.8 13 41.6 12.4 - NS
0.2 15 67.4 33.5 52.3 61.8 NS HS
0.3 30 68.6 43.8 47.2 37.0 NS HS
0.4 14 79.0 41.0 64.4 64.7 NS S
0.5 15 75.9 39.9 57.7 74.9 - HS
0.75 3 316.0 340.0 167.0 629 NS S
RIO 30 43,6 18.5 38.9 12.5 NS NS
R20 30 42.5 27.5 37.1 10.5 NS NS
Placebo
0 30 41.8 8.65 41.0 10.2 _ _
0.2 15 41.8 7.6 40.0 11.8 NS -
0.3 30 43.2 10.8 43.0 11.4 NS -
0.4 15 59.7 51.1 47.7 9.9 NS -
0.5 15 45.6 20.7 39.2 11 NS -
0.75 14 48.5 17.2 43.7 14.2 NS -
RIO 30 41.1 9.0 39.2 9.5 NS -
R20 30 41.8 10.6 39.0 10.5 NS -
Enflurane
0 15 66.4 77.6 40.6 9.1 - NS
0.17 15 46.1 11.5 42.6 16.5 NS NS
0.42 15 94.4 146.6 56.3 19.1 S HS
0.6 13 83.3 54.9 74.8 60.2 NS S
RIO 15 44.1 11.6 40.5 14.7 S NS
R20 15 47.2 11.9 44.6 17.8 NS NS
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FIGURE 20. Graph illustrating median values for tracking 
time coefficient of variation. Variation increases for 
volunteers inhaling isoflurane and enflurane compared with 
control values. Values have returned to baseline at the 
lOmin recovery time.
Table 23. Values for Mean Reaction Time.
A, indicates significance with respect to the previous 
concentration.B, indicates significance with respect 
to the placebo concentration at each level.
Cone No 
Isoflurane
Mean SD Median IQR B
0 30 0.9 0.1 0.9
0.2 15 1.1 0.2 1.0
0.3 30 1.3 0.3 1.2
0.4 14 1.5 0.5 1.3
0.5 15 1.7 0.8 1.4
0.75 3 1.6 0.5 1.5
RIO 30 1.0 0.1 0.1
R20 30 1.0 0.1 1.0
Placebo
0 30 0.9 0.1 0.9
0.2 15 0.9 0.2 0.9
0.3 30 0.9 0.2 0.9
0.4 15 0.9 0.2 0.9
0.5 15 1.0 0.1 1.0
0.75 14 1.0 0.1 0.9
RIO 30 0.9 0.1 0.9
R20 30 0.9 0.1 0.9
Enflurane
0.2 - NS
0.3 S NS
0.4 - HS
0.7 NS HS
0.7 - HS
0.9 NS HS
0.2 NS S
0.2 S NS
NS
NS
NS
NS
NS
NS
NS
0 15 0.9 0.1 0.9 0.2 - NS
0.17 15 1.0 0.2 1.0 0.2 S NS
0.42 15 1.4 0.6 1.2 0.3 s HS
0.6 13 1.5 0.6 1.3 0.9 - HS
RIO 15 1.0 0.2 1.0 0.3 - S
R20 15 1.0 0.2 0.9 0.3 NS NS
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FIGURE 21. Graph showing median values for mean reaction 
time. Mean values for enflurane and isoflurane show a 
significant difference from those for the control. At the 
lOmin recovery period the MRT has not attained baseline 
values, but at 2Omin the values have reached baseline 
levels.
Table 24. Values for MRT - Coefficient of Variation.
A, indicates significance with respect to the previous 
concentration.B, indicates significance with respect 
to the placebo concentration at each level.
Cone No Mean SD Median IQR A
Isoflurane
0 30 13.5 5.4 12.2 4.7 -
0.2 15 17.0 8.7 14.5 7.3 S
0.3 30 25.6 22.6 19.4 13.4 NS
0.4 14 32.6 26.7 21.5 41.9 NS
0.5 15 40 50.8 30.6 21.3 -
0.75 3 14.4 0.7 14.3 1.4 NS
RIO 30 13.2 3.9 12.6 4.5 NS
R20 30 13.1 3.5 11.9 3.1 NS
Placebo
0 30 13.0 4.2 11.7 4.1 _
0.2 15 13.1 2.7 12.8 2.4 NS
0.3 30 14.2 9.9 11.9 2.4 NS
0.4 15 15.2 7.8 12.6 5.1 NS
0.5 15 15.2 6.4 14.4 3.3 NS
0.75 14 27.4 45.4 13.1 7.9 NS
RIO 30 12.8 3.8 11.8 4.0 S
R20 30 13.0 2.9 12.7 3.7 NS
Enflurane
0 15 15.7 7.6 13.2 4.3 -
0.17 15 15.9 7.0 12.8 9.1 NS
0.42 15 20.0 11.4 18.6 7.2 NS
0.6 13 32.6 39.5 18.9 12.4 NS
RIO 15 12.2 3.0 11.8 4.1 S
R20 15 12.4 3.5 11.6 4.1 NS
B
NS
NS
HS
NS
HS
NS
NS
NS
NS
NS
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FIGURE 22. Graph illustrating the median values for the 
reaction time coefficient of variation. Values for enflurane 
and isoflurane show significant differences compared with 
the control. The maximum change in variation occurs at 0.6% 
enfluane and 0.5% isoflurane, but decreases at 0.75% 
isoflurane, only 3 volunteers were left in the 0.75% group. 
This may explain the unusual result.
Table 25. Values for Reaction Success.
A, indicates significance with respect to the previous 
concentration.B, indicates significance with respect 
to the placebo concentration at each level.
Cone No Mean SD Median IQR A B
Isoflurane
0 30 98.2 3.0 100 3.3 - NS
0.2 15 97.1 2.5 97.0 3.3 S NS
0.3 30 94.9 5.2 • 96.7 10 NS S
0.4 14 95.0 3.9 96.7 7.5 NS HS
0.5 15 82.9 17.6 90.0 26.7 - HS
0.75 3 94.4 2.0 93.3 3.4 NS NS
RIO 30 99.0 2.2 100 0 NS NS
R20 30 98.1 4.8 100 4.2 NS NS
Placebo
0 30 98.2 2.7 100 3.3 _ _
0.2 15 98.7 2.1 100 3.3 NS -
0.3 30 98.0 3.1 100 3.3 NS -
0.4 15 98.9 3.0 100 0 NS -
0.5 15 98.5 2.5 100 3.3 NS -
0.75 14 96.9 6.7 100 1.7 NS -
RIO 30 98.3 2.8 100 3.3 NS -
R20 30 97.8 3.6 100 3.3 NS -
Enflurane
0 15 97.1 5.8 100 6.7 - NS
0.17 15 99.0 1.5 100 3.3 NS NS
0.42 15 93.1 6.24 . 93.3 6.7 NS HS
0.6 13 92.3 7.0 93.3 13.4 NS S
RIO 15 97.3 4.0 100 6.7 S NS
R20 15 97.6 3.7 100 3.3 NS NS
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FIGURE 23. Values for reaction success are illustrated. The 
enflurane and isoflurane cause a significant decrement in RS 
compared with placebo.
TABLE 26. LEVEL OF CONSCIOUSNESS AT VARIOUS CONCENTRATIONS 
OF VOLATILE AGENTS. Grade 1-Conscious. Grade 2-Unconscious
i.e. loss of verbal contact. Grade 3-Poorly coordinated.
not unconscious. Grade 4-not attempted.
Cone Grade 1 Grade 2 Grade3 Grade 4
ISOFLURANE
1
0 30
0.2 15 - - -
0.31 29 - - -
0.4 7 3 4 -
0.5 4 9 2 -
0.75 1 2 - 12
RIO 30 - - -
R20 30 - - -
PLACEBO
I
0 30 _
0.2 15 - - -
0.31 30 - - -
0.4 15 - - -
0.5 15 - - -
0.75 14 - - 1
RIO 30 - - -
R20 30
0 15
0.17 15 - - -
0.42 12 2 - 2
0.6 6 7 - 2
RIO 15 - - -
R20 15
CHAPTER SEVEN
DISCUSSION AND SUMMARY
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DISCUSSION
RESULTS
Auditory Evoked Responses
The principle findings of this study in relation to auditory 
evoked responses were that the long-latency cortical NlOO 
showed the most significant changes at 0.3%, 0.4%, 0.5% 
isoflurane compared with placebo, and 0.42% enflurane 
compared with placebo. No significant change was noted at 
0.75% isoflurane compared with placebo but only two 
individuals were left in this category. 0.6% enflurane 
compared with placebo showed no significant change. The NlOO 
amplitude showed significant changes at 0.2%, 0.3%, and 
0.5%,isoflurane and enflurane 0.6% compared with placebo.
The PlOO waveform showed only a significant change in 
amplitude at 0.75% isoflurane compared with placebo and no 
other significant changes in either latency or amplitude.
The P200 latency showed significant changes at 0.4% and 0.5% 
isoflurane compared with placebo, but no significant change 
at 0.75% isoflurane compared with placebo although there 
were only two in the group. Enflurane 0.4% showed a 
significant change compared with placebo. P200 amplitude 
showed significant changes at 0.3%, 0.5% isoflurane and 0.6% 
enflurane compared with placebo.
The brainstem waveforms did not change significantly with 
the exception of the V waveform. This showed a significant 
change at 0.5% isoflurane and 0.42% enflurane compared with
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placebo. V amplitude showed significant changes between 0, 
0.2%, 0.3% placebo levels.
In general the long-latency cortical waveform NlOO was the 
most sensitive to the volatile agents, for both latency and 
amplitude. The brainstem waves were unaffected by the 
effects of volatile agents at these low concentrations.
Performance Tests
The tracking task showed highly significant changes from 
0.3-0.75% isoflurane and 0.42-0.6% enflurane compared with 
placebo.
The coefficient of variation showing significant changes at 
0.2-0.75% isoflurane and 0.42-0.6% enflurane compared with 
placebo, indicating that not only does the tracking time 
increase, but also the variability increased.
Mean reaction time shows the same pattern with significant 
changes in the range of isoflurane 0.3-0.75% and enflurane 
0.42-0.6% and recovery at lOmin indicating that a 
significant decrement in performance occurs again at 0.3% 
isoflurane and 0.42% enflurane, although non-significant 
changes do occur below this.
Again the variability increases with 0.3% and 0.5% 
isoflurane (MCV), the reaction success changing with both 
isoflurane (0.3-0.5%) and enflurane (0.4% and 0.6%), the 
volunteers ability to accurately perform the test decreased.
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All the psychomotor test parameters MTT, TCV, RS,MCV 
returned to non-significant levels compared with placebo by 
recovery at 10 mins. Only MRT for both isoflurane and 
enflurane showed significant differences compared with 
placebo.
Millar (1992) states that the effect of an anaesthetic may 
be to make performance more variable, an effect which is 
often masked by expressing the data as mean values and not 
median, our data confirm this finding.
SOURCES OF ERROR
There were various problems that arose throughout the course 
of the study:-
Initially we attempted to measure the end - tidal 
concentration of volatile agent by placing a narrow 
catheter, between the nose and the mouth, which was 
connected to a Normac vapour analyser. Unfortunately this 
provided no useful measurements.
The alternative methods, had to be simple to use, accurate, 
non - invasive, as we werç using volunteers. The main 
alternative was to place a nasopharyngeal catheter into the 
pharynx, place a nose clip on the nose and measure the end- 
tidal concentration of volatile agent. This scheme was 
impractical for two reasons. The volunteer would have had to 
undergo an unpleasant procedure, and the tests lasted for 
2i- 3hours, thus a hose clip would have been extremely 
unpleasant for such a time.
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The only other alternative was an anaesthetic face-mask, 
attached firmly onto the face with a Clausen harness to 
enable a small connector to be attached to the circuit, to 
allow a continuous measure of inspired and expired gases, 
which would have been the ideal method. In view of the above 
problems we decided that by accurately calibrating the 
vaporisers at the required gas flows, we could use inspired 
concentrations instead of end-tidal concentrations.
We felt there was no need to measure end - tidal carbon 
dioxide concentrations in view of the above problems and 
also because the volunteers were sedated as opposed to 
anaesthetised, were therefore at a lighter plane and more 
responsive, controlling their airway, and if consciousness 
was lost (under the protocol for the ethics committee) the 
volatile agent was discontinued.
We attempted to measure the middle latency auditory evoked 
response, as this in previous studies had been shown to be 
the most useful waveform. We were unable to obtain 
reasonable waveforms due to the presence of interference. We 
excluded the interference from the mains AC current, by 
switching off equipment that was unnecessary. We obtained 
good brainstem and long-latency cortical waveforms with 
these measures. We felt the source was probably muscle 
artifact. The previous authors who used this waveform have 
either used anaesthetised or paralysed patients.
The problem of asymmetric transfer is one which affects all
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authors in this field. The use of a separate-groups design 
to avoid the within - subject design and to reduce 
intersubject variability by expressing performance as a 
change score from pretreatment baseline was advocated by 
Miller 1991. He cited other authors who suggest that 
benzodiazepine experience should be given to volunteers 
before they participate in crossover studies of such drugs 
because the major change in impairment tends to occur 
differentially between the first and second exposure to the 
drug [File, Lister, 1983].
We attempted to maintain a constant environment. The 
variation that occurred with natural light, when decreased, 
was supplemented with tungsten lamps, to increase the 
ambient light to allow the keyboard to be seen.
We reduced the effects of practice by ensuring an adequate 
level of practice prior to the commencement of the study.
McMenemin and Parbrook in 1988 assessed the effect of 0.4% 
isoflurane in healthy volunteers from an anaesthetic 
department. In our study at 0.4% isoflurane 3 volunteers had 
lost verbal contact, four volunteers were poorly coordinated 
and the remaining seven were conscious. The above authors 
make no reference to loss of verbal contact, which 
presumably means all 12 volunteers remained conscious. The 
reason for this could be that McMenemin used volunteers who 
were familiar in some way with the effects of anaesthesia 
and were therefore biased. We used volunteers who had no 
connection with anaesthesia. McMenemin and coworkers
Page No 158
described that objective tests of recovery demonstrated no 
marked impairment of function once the administration of the 
gas had been discontinued, at 5min,15min, 25min,35min. The 
subjective tests on the other hand showed impairment in the 
recovery period.
The values for mean reaction time in our study showed a 
significant impairment at five mins compared with placebo 
for both enflurane and isoflurane. The other parameters ie 
mean tracking time, tracking coefficient of variation, 
reaction success, and reaction coefficient of variation were 
all non-significantly changed at 5 and lOmin when compared 
with placebo for both enflurane and isoflurane. McMenemin 
used the mean of 15 responses for the mean reaction time, 
whereas we used 30 trails. Wilkinson 1969 suggested that if 
a test is too short, a subject can arouse himself to 
maintain performance at a satisfactory level even when 
severely stressed. Short tasks may miss the effect of the 
stress on performance and a subject may return to normal 
although :hey are severely impaired. These authors noted 
that two subjects were nauseated, while one vomited. 
Likewise in our study two vomited at the higher doses.
GENERAL CONSIDERATIONS
The group of volunteers selected were all reasonably young 
(mean age 24y). This raises the problem of how relevant are 
these results to geriatric patients. Although the population 
of dental patients tend to be younger at the present, in
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future years this may alter with improved dental care in the 
community.
We exclude the possibility of hearing defects by examination 
of the ears and the use of an audiometric test. Therefore 
our population had normal hearing, but if the AERs were to 
be used as tool in the investigation of awareness, one might 
ask whether the likelihood of impaired hearing in the 
subjects used, particularly an older population, might 
impair the usefulness of the measure.
The time of each task was just long enough to ensure that 
volunteers became "bored" and did not just arouse themselves 
long enough to complete the task. In 1969 Wilkinson 
suggested that stress effects upon performance might be 
missed if the test period was too short. A short test 
allowing a subject to arouse himself to maintain performance 
at a satisfactory level even when severely stressed. But if 
the test is prolonged, this ability cannot be sustained. 
Therefore very short tasks may miss the effect of the stress 
on performance. In the case of day-case surgery, subjects 
may be discharged when their performance returns to 'normal' 
although they are severely impaired.
We initially sought advice on the likelihood of the changes 
in AER expected with low concentrations of volatile agent. 
We knew from previous work about changes associated with the 
MLAEP and selected waves of the brainstem response. After a 
through literature review no work at that time appeared to 
have been completed using low concentrations of volatile
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agent and the AER.
We therefore decided to examine the MLAEP and BSAEP. This 
was expanded to include the long -latency AEP after a 
personal communication from Dr Weir (Consultant 
Neurophysiologist, SGH, Glasgow). He indicated to us that 
the waveform which was most sensitive to anaesthetic agents 
was the LLAEP NlOO waveform, and was therefore of no use in 
monitoring the effects of neurosugical procedures on the 
brain.
The NlOO wave was demonstrated by Picton and Hillyard in 
1974 to increase in amplitude in the conscious subject when 
attention was aroused. Nààtânen and Picton in 1987 reviewed 
the literature on the NlOO component. They concluded that in 
most conditions auditory selective attention causes the 
superimposition on the NlOO wave of a negative deflection 
consisting of two components (5&6) that overlap the true 
NlOO components. It is possible that under certain 
conditions attention may selectively enhance a true NlOO 
component, as suggested by Hillyard and coworkers in 1973. 
In that case, the enhanced component would be the 
supratemporal component.
Plourde and Picton in 1991 stated that simple auditory 
attention does not usually affect the NlOO, provided the 
level of arousal remains the same. The NlOO amplitude is 
larger for attended than for nonattended stimuli when near­
threshold intensities are used, when difficult
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discriminations are required or when selective attention is 
necessary.
Various authors have assessed the effect of isoflurane and 
enflurane on the AER, few up to the last year have 
attempted to do so in low doses with no other drugs 
involved, [Newton, Thornton,Konieczko, 1992].
The effect of enflurane and isoflurane has been assessed on 
the BAER by various authors. Dubois and co authors found 
that enflurane administrated at concentrations of 0.5-3% 
significantly increases the latencies of peaks III,IV,V 
[Dubois, Satto, Chassy, et al,1982]. Similar results were 
reported by others.
Manninen and co-investigators stated isoflurane increased 
the latencies of peaks III,IV,and V occuring at an end-tidal 
concentration of 1%. Other authors have also shown these 
changes. Few actually state at which concentrations these 
changes begin to occur.
The marking of waveforms can often lead to a source of 
error. Figure 24 illustrates how specific rules are needed 
to mark the waves in a concise fashion on each occasion.In 
Figure 25 the long-latency cortical waveform can be seen 
with changing isoflurane concentrations. At 0.2% isoflurane 
the waveform developed two negative peaks. This occurred 
frequently at the higher concentrations and lead to a 
problem with defining the NlOO peak. We defined the NlOO in 
these situations as being at the mid-point of the waveform.
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(NlOO), from above down, at concentrations of isoflurane 0, 
0.1%, 0.2%, and recovery. Note presence of double peak of 
wave, NlOO taken as mid-point.
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usually between the two outlying peaks. We concluded that 
this "double peak" could be explained by a differential 
slowing of the components that comprise the NlOO waveform, 
with the volatile agents.
Newton and colleagues assessed consciousness in volunteers 
breathing sub-MAC concentrations of isoflurane. Eight 
volunteers from the anaesthetic department inhaled 
isoflurane in concentrations of 0.1, 0.2 and 0.4MAC and a
control of 100% oxygen (MAC of isoflurane 1.15%). Their
findings were more in keeping with those of ours. At 0.4MAC
isoflurane all subjects failed to respond to commands, five 
had no eyelash reflex. Seven were obviously sleeping, 
snoring or requiring airway support, and the eighth was 
making uncoordinated movements similar to the excitatory 
movements seen at Guedel's stage two of anaesthesia. At 
0.2MAC seven of the eight subjects opened eyes on command. 
At O.IMAC isoflurane the response to commands was impaired 
in three subjects and lost at 0.2MAC. One has to remember 
that these authors were measuring end-tidal concentration 
rather than inspired as in our study. No mention was made of 
I randomisation in this study, [Newton, Thornton, Konieczko
I 1990]. Conscious level can be seen in Table 26.
DEDUCTIONS
The technique would be useful for dental sedation, in that 
all volunteers had returned to pre-anaesthetic levels of 
performance by twenty minutes after the termination of the 
volatile agent.
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Originally the study was designed to assess the effect of 
these sub-anaesthetic concentrations of volatile agents on 
the psychomotor tests. The AER was included to give a 
neurophysiological parameter against which the psychomotor 
tests could be compared. When the BSAER are related to the 
psychomotor tests it becomes apparent that they are very 
much less sensitive than the psychomotor tests. But when the 
NlOO waveform is compared we can see that highly significant 
changes occur at 0.3% isoflurane and 0.42% enflurane for 
latency, and significant changes at 0.2% isoflurane and 0.6% 
enflurane for amplitude, these changes in latency mirror the 
changes in the psychomotor test quite closely.
Finally the AER has been used as an assessment of awareness 
under anaesthesia. Working with this measure over the last 
year, I feel that in its present form it would be a less 
than ideal way of assessing awareness under GA due to the 
practicalities of the equipment. In theatre it may be 
difficult to exclude the interference from other power 
sources. The subjective nature for marking the waveforms may 
lead to problems, experience has to be gained before one can 
confidently mark the waves. Often interference is present 
which can markedly alter the appearance of the wave, which 
may lead to mis-interpretation in inexperienced hands. About 
2000 stimuli are required for the BSAER and MLAER, which may 
take 2-3mins to measure. The LLAER requires 50 stimuli and 
may take less time to measure. This would prove difficult in 
theatre when one would want to use such a measure for many
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cases on a busy list. Therefore the concept would require 
some refinement for use in theatre.
The hypothesis is true for the effect of subanaesthetic 
doses of isoflurane and enflurane on the two tests of 
psychometric function and long-latency cortical AER, but is 
untrue for its effect on the brainstem AER.
IN SUMMARY
We have found that subanaesthetic doses of enflurane and 
isoflurane have no effect on the BSAER, but alter the NlOO 
component of the LLAER. The two computerised psychometric 
tests, choice reaction time and tracking time are affected 
by the two agents in low concentrations. There is a 
correlation between the point at which the psychometric 
tests start to alter and the point at which the NlOO latency 
and amplitude alters i.e. 0.3% isoflurane and 0.42% 
enflurane.
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